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Abstract 
 
Chemical Interactions between Drugs Containing Reactive Amines with 
Acrylates in Aqueous Solutions 
Mary Mc Grath 
Acrylate monomers are widely used components of inks, varnish and 
adhesive applied to labels for pharmaceutical packaging.  LDPE bottles used to 
dispense ophthalmic solutions are generally a poor barrier to volatile compounds 
which may migrate both into and out of the bottle. The mild reaction conditions of 
the aza-Michael addition of a nitrogen containing drug substance and unreacted 
acrylic monomers migrating from pharmaceutical packaging mean that this is a 
feasible mechanism by which unwanted adducts could be formed in prepared drug 
formulations.   
The reaction stoichiometry, temperature and rate of stirring were 
investigated for conjugate addition of 1-phenylpiperazine to methyl acrylate under 
solvent free and aqueous conditions.  A number of common organic solvents were 
screened. Significant rate acceleration of this reaction was observed in polar protic 
compared to aprotic solvents.   
Chemical reactions between 1-phenylpiperazine.HCl with methyl acrylate 
and acrylic acid, in aqueous buffered solutions were investigated. Products were 
identified by UPLC-Q-TOF/MS.  Both acrylic acid and the amine salt were 
unreactive under nominal reaction conditions.  However, the amine salt reacted with 
both methyl acrylate and acrylic acid on standing for 6 and 12 days, demonstrating 
that given sufficient time, even the less reactive amines and acrylates will form 
adducts.  A drug-acrylate compatibility screening model was developed to predict 
potential stability problems due to interactions of amine drug substances with 
acrylate leachables in ophthalmic buffered solutions. Eight ophthalmic formulations 
containing various amine drugs (primary, secondary, tertiary and salt counter-ions) 
were spiked with acrylates and tested for the formation of acrylic adducts.   
This case study demonstrates that leachable compounds that migrate into 
the drug product can react with the active ingredients to form impurities and the 
results obtained here strongly suggest that formation of amine-acrylate adducts may 
constitute a significant problem upon long-term storage of ophthalmic solutions in 
their final packaged configuration. 
 
1 
 
 
Chapter 1: 
Literature Review 
Mechanisms of the aza-Michael Reaction in Pharmaceutical 
Formulations 
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1.0 Introduction to the Michael Addition Reaction 
The Michael addition [1, 2] is a conjugate addition reaction, and is one of the most 
useful ways to create carbon-carbon bonds.  It describes the addition of a 
nucleophile, the Michael donor, to an activated electrophilic olefin (usually an          
,-unsaturated carbonyl compound), the Michael acceptor, resulting in formation of 
an adduct.[3] The reaction is noted for high yields under mild reaction conditions 
and its use is widespread in polymerisation reactions such as the anionic 
polymerisation of alkyl methacrylates and cyanoacrylates.[4] The classic reaction 
refers to the base catalysed addition of enolate nucleophiles such as acetoacetic or 
malonic ester to activated olefins, as shown in Section 1.1.[5]   
1.1  Mechanism of the Carbon-Michael Addition Reaction  
The classic Michael addition reaction consists of three key steps, as illustrated in 
Scheme 1.  A base catalyst is typically used to deprotonate the Michael donor, 
generating the enolate anion. The α-carbon of the resulting enolate anion is 
negatively charged and highly reactive towards the acrylate acceptor.  The enolate 
reacts with an activated α,β-unsaturated carbonyl containing compound via 1,4-
conjugate addition at the β-carbon.  The intermediate product of a conjugate 
addition is itself a potential donor i.e. an enolate anion, and reaction of the product 
donor with the acceptor must be controlled to avoid Michael polymerization. The last 
step of the reaction involves rapid proton transfer to produce the final Michael 
adduct and regenerate the base catalyst. [5] In the classic Michael condensation the 
product enolate is much more basic than the donor enolate, and is thus rapidly 
discharged by protonation by the solvent, other proton donors (e.g., by ethanol if 
sodium ethoxide is used as base) or by the starting β-dicarbonyl compound.  Proton 
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abstraction from the protonated base regenerates the base catalyst.  The reaction is 
terminated by protonation of the adduct. 
  
Scheme 1:  General Carbon-Michael Reaction Mechanism using Acetoactate, 
Ethyl Acrylate and Sodium Ethoxide as Base. [5] 
 
The kinetics of the Michael addition reaction are dependent upon base type and 
concentration as well as the concentrations of both the Michael donor and the 
Michael acceptor. Pre-equilibration of the Michael donor with a base catalyst results 
acetoacetate donor 
enolate 
anion 
acrylate 
acceptor 
Acid work-up 
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in a steady-state concentration of the enolate anion and a rate law which follows 
pseudo-first order kinetics with respect to the concentration of the Michael acceptor 
(acrylate).[6] 
Michael addition reactions have been conducted in a wide range of molecular 
solvents; from non-polar solvents toluene and tetrahydrofuran (THF) to polar 
solvents such as N,N dimethylformamide (DMF), dimethylsulfoxide (DMSO), 
methanol (MeOH) and acetonitrile (ACN).[7-9] Ranu and co-workers have shown 
that imidazolium ionic liquids with a hydroxide counter-anion provide both the 
reaction medium and the catalyst in a self-catalysed Michael addition of methylene 
compounds to conjugated ketones and esters.[10]  The role of the solvent is tied to 
that of the catalyst; the synthetic utility of the reaction has expanded with the design 
of chiral catalysts where the choice of solvent has proved to be a controlling factor 
in the enantioselectivity of the product. [11-13] 
A review of the literature would suggest that 1,3 dicarbonyl and nitroalkane 
compounds are the starting point for most Michael carbon donor selection and , - 
unsaturated carbonyl compounds the predominant choice for Michael acceptors. [9, 
14, 15]  The synthetic utility of the reaction is due in part to the wide range of donors 
and acceptors that can be employed in this reaction; the variety in acceptors 
resulting from the many possible activating groups (ketones, aldehydes, esters, 
amides, nitriles, nitro).   
The carbon Michael reaction is driven by base activation of the nucleophile and the 
literature review has shown that the reaction will not take place in the absence of 
the base.  For example, while extensive work has been carried out by Ballini on the 
synthetic utility of nitroalkanes as nucleophiles, he has also demonstrated that the 
carbon Michael reaction cannot occur in the absence of a base.[16] The bulk of the 
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research carried out relates to developments in the area of organic base catalysts. 
[6] The limitations of the alkoxide bases saw them replaced by phosphazene and 
guanidine organobase catalysts and recently by the bi-functional thiourea base 
catalysts. [17-19] 
1.2 Aza Michael Reaction 
Of particular interest to this study is the amine or ‘aza-Michael’ reaction.  The aza- 
Michael reaction is a nitrogen-carbon bond forming reaction between a nitrogen 
nucleophile and an ,-unsaturated carbonyl compound.  Many drug substances 
contain amines, which are ideal Michael donors (Scheme 2), while pharmaceutical 
packaging (label ink and adhesives) routinely contains acrylic monomers which 
could readily act as Michael acceptors.  The mild reaction conditions of Michael 
addition of a nitrogen containing drug substance and unreacted acrylic monomers 
migrating from pharmaceutical packaging mean that this is a feasible mechanism by 
which unwanted adducts could be formed in prepared drug formulations. 
Over the last two decades, the aza-Michael reaction has gained popularity as the 
mild reaction conditions typically required are in line with the aims of green 
chemistry i.e. the elimination or reduction of volatile solvents in organic 
synthesis.[20] The reaction is central to the generation of β-amino carbonyl 
compounds.[21]  Among the chemical methods employed in accelerating the aza-
Michael reaction are the use of aqueous solutions [22, 23] or hydrogen donor 
solvents,[24] ionic liquids,[25] highly basic amines [26] and Lewis acid catalysts.[4] 
Sonication or ultrasound [27, 28] and temperature variation [29] are among the most 
widely used physical methods. 
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Paroxetine Fluvoxamine 
 
Indalpine 
 
Rasagline  Ciprofloxacin 
 
Scheme 2: Active pharmaceutical ingredients containing potential amine Michael 
donors, source PubChem 2013. 
1.3 Mechanism of the Aza-Michael Reaction 
If the amine donor is sufficiently nucleophilic, direct addition will proceed without the 
addition of an acid or base catalyst, rendering Step 1 of the Michael reaction, which 
for carbon-carbon bond formation is the rate limiting step (as discussed in Section 
1.1), unnecessary. [30] In contrast, the aza-Michael reaction follows second order 
kinetics based on the concentration of both the amine and the olefin acceptor in 
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what was Step 2 of the carbon- carbon reaction. The mechanism of the reaction is 
illustrated in Scheme 3.   
 
 
 
 
 
 
 
 
 
Scheme 3:  Mechanism of the Aza- Michael Reaction.[30] 
 
The reaction begins by nucleophilic attack of the secondary amine on the β-carbon 
of the conjugated alkene acceptor (as before) generating a zwitterionic intermediate.  
Proton abstraction from the solvent or from the nitrogen of the amine donor is the 
final step. Once again, the carbonyl group stabilises the resulting anion until proton 
transfer occurs. 
The difference between the reaction equilibrium for primary and secondary amines 
compared to that of tertiary amines was investigated by Bunting and Heo,[31] and is 
illustrated in Scheme 4 for primary and secondary amines and Scheme 5 for tertiary 
amines.   
 
 z itterion  
intermediate 
protonation of  
carbanionic 
intermediate 
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1.3.1  Mechanism for Primary and Secondary Amines 
Scheme 4 is a typical aza-Michael nucleophilic addition for primary and secondary 
amines.  Bunting and Heo demonstrated that nucleophilic attack by the amine was 
the rate limiting step for primary and secondary amines when the reaction was 
carried out in aqueous base.[31]   The scheme involves an additional acid base 
equilibrium step between 2 and 3 for the deprotonation of the ammonium ion of the 
carbanionic intermediate 2.  The scheme demonstrates that two possible routes to 
the protonation of the carbanionic intermediate are available; Route A to 4 via 
protonation of 2 or Route B to 4 via protonation of 3.  In aqueous base, 
deprotonation of the ammonium ion first, followed by protonation of the carbanion 
would be expected to be fast and favour the formation of 3.  Protonation of 3 by 
water would therefore be expected to be the fastest route.   A third option, initial 
protonation of the negatively charged carbon followed by deprotonation of the amine 
was dismissed as an unviable pathway.[32]  
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Scheme 4: Aza-Michael reaction between a secondary amine and methyl 
acrylate, adapted from Bunting and Heo [31]     
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1.3.2  Mechanism for Tertiary Amines 
For the majority of primary and secondary amines the rate of reaction was 
determined by nucleophilic attack of the amine.  This was not the case for tertiary 
amines where the rate limiting step proved to be protonation (by a water molecule) 
of the carbanionic intermediate 2.[31].  Subsequent protonation needed to be 
sufficiently rapid (seconds) in order that the intermediate did not revert back to the 
starting amine.  The reaction was carried out in aqueous base (Scheme 5).  The 
product 3 retained the net positive charge of the ammonium ion.   
 
Scheme 5: Aza-Michael Reaction between a tertiary amine and methyl acrylate, 
adapted from Bunting and Heo [31] 
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1.4 Amine Nucleophilicity 
If the amine donor is sufficiently nucleophilic, no catalyst is required and the driving 
force behind the reaction is the nucleophilicity of the amine donor.  Studies of amine 
reactivity examine the role of the amine nucleophile rather than its action as a base 
catalyst, i.e. their direct addition to the reference electrophile (R+) and the stability of 
the product following protonation of the intermediate [33] 
Nucleophilic reaction:   R+   + R'2NH                   RNR'2 + H
+ 
General base catalysis in water: R+   + H2O     R'2NH      ROH 
General base catalysis of amine: R+   + R'2NH   R'2NH      RNR'2
 
 
For successful nucleophilic reactions of primary or secondary amines, proton loss 
from the ammonium ion must be faster than the reverse reaction as illustrated in 
Scheme 4.  Several scales exist, but the order of nucleophilicity (N) for primary and 
secondary amines shows good general agreement using a variety of reference 
electrophiles.[30, 31, 34-39] 
The reactivity of a given nucleophile is dependent on the substrate, solvent and 
reaction conditions i.e. the nucleophilicity of an amine can change from one reaction 
to the next. [31] As such, it is not possible to determine whether an amine donor 
requires a catalyst to initiate Michael addition without knowing the solvent and 
reaction conditions. The most comprehensive scale of amine nucleophilicity was 
established by Bunting and Heo (1994) using a single acceptor and solvent 
system.[31] The study investigated the reactivity of 91 amines toward the 1-methyl-
4-vinylpyridinum cation 5 (Scheme 6) in aqueous base at  25 °C. 
12 
 
The study demonstrated that the nature of the amine substituent plays a greater role 
than basicity in the aza-Michael reaction, as discussed below.  This poor correlation 
between nucleophilicity and basicity is in agreement with the earlier work of Richie. 
[40]. 
 
Scheme 6: Aza- Michael reaction for secondary amine with 1-methyl-4-
vinylpyridinum cation 5 [30] 
 
 
 
5 
6 
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1.4.1 Primary and Secondary Amine Nucleophilicity 
Contrary to expectation, the less hindered primary amines are often less reactive 
than secondary amines of the same basicity. Bunting and Heo divided primary, 
secondary and tertiary amines into a number of sub-classes based on structural 
features, e.g. substitution at the  and  carbon of the amine donor.[31]  
For the primary and secondary amines examined it was noted that reactivity 
decreased with increasing substitution at the  carbon of the amine.[31]  This was 
attributed to the fact that increasing steric hindrance at the  carbon atom of the 
amine led to an increase in non-bonded interactions in the carbanionic intermediate 
(6) following nucleophilic attack on the Michael acceptor.  
Reactivity increased in the case of primary and secondary amines in which the  
carbon of the amine was unsaturated (sp2 or sp hybridized).[31]  The increase in  
electron density on the  carbon atom increased reactivity regardless of the electro-
negativity of the atom attached e.g. carbonyl, vinyl and nitrile all showed an increase 
in reactivity.  The enhanced reactivity was also observed in the aromatic primary 
amine, benzylamine.  In general, secondary amines were found to be more reactive 
than primary amines of the same basicity.  The increase in reactivity is attributed to 
the role played by the additional alkyl group of the secondary amine in stabilising 
the positively charged intermediate (6) formed following nucleophilic attack on the 
electrophile.  It is this stabilising influence that is thought to be responsible for 
increased reactivity rather than any role the electron donating alkyl group might play 
in activating the amine lone pair of electrons prior to nucleophilic attack.   
 
 
14 
 
A 2007 study by Mayr supports the earlier findings or Bunting and Heo regarding 
the general reactivity of primary and secondary amines.[30]  Using a variety of 
benzhydrylium ions (7) (Ar2CH
+) as the electrophile, Mayr noticed a dramatic 
increase in reactivity when the hydrogens of ammonia were replaced by one and 
two alkyl groups.  
  
 
 
 
The nucleophilicity parameter (N) increased across the series from ammonia (N = 
9.48) to methylamine (N = 10.66) to dimethylamine (N = 17.12).[30]  The increase in 
nucleophilicity was attributed to the decrease in hydration energy as each of the 
hydrogen atoms of ammonia was replaced by a methyl group. [33] The 
nucleophilicity parameters N calculated by Mayr are listed in Table 1.1 alongside the 
pKaH of the various amines. 
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Table 1.1  Nucleophilicity Parameters (N) Calculated by Mayr for Primary and 
Secondary Amines in Water and Acetonitrile [30, 38] 
Primary and Secondary Amines pKaH [41] 
 N, Water 
[30] 
N,ACN 
[38] 
Ammonia 
 
NH3 9.21 9.48  
n-Propylamine 
 
10.53  15.11 
n-Butylamine 
 
10.59  15.27 
Methylamine 
 
10.62 13.85  
Ethylamine 
  
10.63 12.87  
Isopropylamine 
 
10.63 12.00 13.77 
t-Butylamine 
 
10.86 10.84 12.35 
Dimethylamine 
 
10.64 17.12  
Di-n-
propylamine 
 
11.00  14.51 
Diethylamine 
 
11.02 14.68 15.10 
Benzylamine 
 
9.34 13.44 14.29 
16 
 
Steric factors played a greater role in the nucleophilicity of secondary amines 
compared to primary amines.  For example, the N parameter for methylamine and 
ethylamine are 13.85 and 12.87 respectively whereas those for dimethyl and 
diethylamine are 17.12 and 14.68 in the Mayr study.[30]  Similar differences were 
observed by Bunting and Heo in the earlier study.[31] 
Compared to acylic amines, their cyclic analogs have a higher basicity; the N atom 
in the ring is less sterically hindered and therefore more easily prontonated. 
Piperidine and related cyclic unsaturated secondary amines were 1.9 times more 
reactive than N-Methyl secondary amines and 8.37 times more reactive than N-
Ethyl secondary amines.[31] Bunting and Heo observed that reactivity decreased 
four fold with increasing ring size from a five-membered (pyrrolidine) to an eight-
membered ring (perhydroazocine) despite there being very little difference in 
basicity for the ring amines (pKa in the range 11.00 to 11.27).   However, the 
reverse trend was noted by Mayr.[30] In this case, the 5 membered ring was the 
least nucleophilic, with nucleophilicity increasing with ring size.  The difference in 
reactivity for the amine rings demonstrates that nucleophilicity is reaction specific 
i.e. attack on the vinylic carbon electrophile generates an ammonium ion which 
must be stabilised, whereas the benzhydrylium cation used by Mayr yields a neutral 
adduct.  See Table 1.2  for nucleophilicity parameters N calculated by Mayr.[30, 38] 
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Table 1.2 Nucleophilicity Parameters Calculated by Mayr for Cyclic Aliphatic 
Amines in Water and Acetonitrile [30, 38] 
Cyclic Aliphatic Amines pKaH [41] 
Nucleophilicity  
parameter, N 
in water [30] 
Nucleophilicity 
parameter, N 
in ACN  [38] 
Pyrrolidine 
 
11.27 17.21 18.64 
Piperidine 
 
11.12 18.13 17.35 
Piperazine 
 
9.72 17.22 n/a 
Morpholine 
 
8.36 15.62 15.65 
 
Overall, the Mayr study supports the earlier findings regarding the general reactivity 
of primary and secondary amines.[30]  The results for the reactivity of primary and 
secondary amines reacting with acrylamine in aqueous solution [40] were also in 
good agreement with the findings of Bunting and Heo. [31].  Irrespective of the 
choice of electrophile or solvent, a variety of studies confirm that the correlation 
between nucleophilicity N and basicity (pKaH) is poor for amines, with the N 
parameter providing a better indication of reactivity for several classes of amine.  
 
18 
 
1.4.2 Aniline Nucleophilicity 
Though considerably less basic than ammonia, aniline proved to be a much 
stronger nucleophile when reacted with the benzhydrylium ions (7) in both water 
and acetonitrile.[30]  The nucleophilicity parameter (N = 12.99) of aniline was similar 
to that of primary alkyl amines, as shown in Table 1.1.  However, reversibility of the 
initial attack was noted when less electrophilic benzhydrylium ions were used and a 
higher excess of aniline was required for the reaction; a linear relationship between 
the concentration of the amine and the rate of reaction showed that the attack of the 
amine on the benzhydrylium ion remained the rate determining factor.  The β-
carbon effect noted by Bunting [31] is evident in the nucleophilicity of benzylamine 
(N = 13.44), which has a pKaH close to that of ammonia but more reactive than 
aniline (see Tables 1.1 and 1.3) 
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Table 1.3 Nucleophilicity Parameters Calculated by Mayr for Aromatic 
Amines in Water and Acetonitrile [30, 38] 
Aromatic Amines pKaH  
Nucleophilicity  
parameter, N 
in water [30] 
Nucleophilicity 
parameter, N 
in ACN  [38] 
Aniline 
  
4.59 
[42] 
12.99 12.64 
4-Methoxyaniline 
  
5.16 
[42] 
 
16.53 13.42 
 
1.4.3 Tertiary Amine Nucleophilicity 
The zero order linear relationship noted between nucleophilicity and basicity for 
groups of primary and secondary amines was not replicated for tertiary amines.  
There was a poor relationship between the reactivity (nucleophilicity) and basicity of 
the amines investigated by several groups.[31, 40, 43]   In general tertiary amines 
were less reactive than primary and secondary, with trimethylamine proving 
unreactive.[31] The N, N-dimethyl amines [XCH2CH2N-(CH3)2] did react providing 
that X was an oxygen or nitrogen containing constituent. The most reactive tertiary 
amine was N-methyldiethanol amine, which was one of the least basic studied.[31]  
The cyclic amines N-methylpyrrolidine, N-methylpiperidine and N-methylmorpholine 
all proved unreactive with the vinylic electrophile employed by Bunting.   
Mayr investigated the same tertiary amines using the same methodology that had 
been previously used to qualify the nucleophilic reactivities of the primary and 
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secondary amines.[44]  The reactions were monitored by a colour change as the 
benzhydrylium ions were coloured and the reactions with the amines yielded 
colourless adducts. However, the formation of the quaternary ammonium salts 
proved thermodynamically unfavourable and the methodology used previously could 
not be applied successfully.  The reaction with triethylamine was highly reversible 
and could not be measured directly.  In addition the reaction was carried out in the 
aprotic solvents acetonitrile and dichloromethane which would not be expected to 
promote the reaction as was demonstrated by Bunting.[31] 
A ‘real life’ application of the scale of amine reactivity  as demonstrated in an 
investigation into the aza-Michael reaction of trifunctional amines and diacrylates by 
Wu et al.[45].  The reaction was carried out in chloroform and monitored in-situ 
using NMR.  The initial reaction between the diacrylate (1, 4-butanediol diacrylate) 
and 1-(2-aminomethyl) piperazine took place exclusively at the secondary amine on 
the piperazine, with an 80% conversion within 2 hours, as shown in  Scheme 7.  
The reaction at the primary amine and subsequent polymerisation was monitored 
over a period of 50 hours.   No reaction took place at the tertiary amine on the 
piperazine, supporting the contention by Bunting and Heo[31] that nucleophilic 
attack by the amine is no longer the rate limiting step for tertiary amines; rather the 
ease at which the carbanionic intermediate is protonated by the reaction medium 
now determines whether the reaction goes to completion or not.   
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Scheme 7:   Higher reactivity of secondary amines in aza-Michael addition.  The 
reaction took place exclusively at the secondary amine on the 
piperazine.  Adapted  from Wu et al [45] 
 
1.4.4 Solvent Effect on Amine Nucleophilicity 
Mayr also noted that the rates of the reactions of amines with benzhydrylium ions 
were strongly affected by solvent polarity.[30]  Anilines reacted 2 times faster in 
water than in acetonitrile.  The authors reasoned that hydrogen bond stabilisation of 
anilines in water plays a minor role because of their low basicity.  
Previously Mayr had determined that the rates of reaction of carbocations with 
neutral π and   nucleophiles were only slightly affected by solvent polarity because 
charges are neither created or destroyed in the rate determining step, but this was 
found not to be the case for amines.[46] Amine nucleophiles were strongly 
dependant on the solvent.[38] For amine nucleophiles, the rate of reaction 
decreased with increasing polarity of the solvent (ET
N values).  For example, 
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morpholine reacted 72 times more slowly in water than in DMSO.[30] Solvation of 
amines in acetonitrile is still a significant factor as the intermediate tertiary 
ammonium ion formed is generally a stronger acid than the corresponding 
secondary or primary ion.[34]  See Tables 1.1, 1.2 and 1.3 for details of 
nucleophilicity parameters (N) determined in acetonitrile and water.  As with water, 
the nucleophilic reactivities of the amines in acetonitrile correlated poorly with their 
corresponding pKaH values. Aniline was found to be 5 times more nucleophilic in 
water than n-propylamine despite the higher basicity of the aliphatic amine.[30]  In 
acetonitrile the opposite was observed; primary alkylamines were 10 times more 
reactive in acetonitrile than in water.  This reversal was attributed to the different 
solvent effects on the aromatic and aliphatic amines; either decreased solvation of 
aromatic amines or increased solvation of aromatic ammonium ions by water. [34] 
However, the reactivity of aniline in acetonitrile is still considerably higher than 
would be predicted on the basis of its basicity.[38].   
1.5  Michael Acceptor 
Michael acceptors, such as ,-unsaturated carbonyl compounds, are more stable 
than non-conjugated carbonyl compounds. ,-Unsaturated ketones and aldehydes 
are also more polar than simple ketones and aldehydes. Interaction bet een the π 
electrons of the C=C double bond and those of the C=O group leads to a partial 
delocalization of the π electrons across all four atomic centres.  The carbonyl group 
is therefore crucial to the success of the overall Michael reaction.  Without it, the 
C=C double bond would not be polarised and no transfer of electron from the 
acetoacetate donor to the acrylate acceptor would occur.  The resonance structures 
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of an , -unsaturated carbonyl acceptor (Scheme 8) show that the positive charge 
is allylic and is shared by the -carbon, rendering it electrophilic.  
 
Scheme 8: Resonance structures of , -unsaturated carbonyl compound [3] 
Nucleophilic addition of the donor can take place at either of two sites: at the 
carbonyl carbon (direct 1,2-addition) or at the electrophilic -carbon of the acceptor 
to give the conjugate (1, 4-addition) product. Conjugate addition is favoured over the 
competing 1, 2-addition of the enolate since the more stable carbon–oxygen π bond 
is maintained (versus the less stable carbon–carbon π bond). [5] 
The 1,4 adduct is almost always thermodynamically more stable, so selecting 
conditions where the 1,2-addition is reversible will result in formation of 1,4 
products.  1,4-addition results in a ketone-enol tautomer.  At room temperature the 
chemical equilibrium of the two forms is thermodynamically driven and favours the 
keto form, as illustrated in Scheme 9 and Scheme 10.  
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Enol Tautomer (less favoured)  Keto Tautomer (favoured) 
 
Scheme 9:  The product of 1,4-addition is an enol that will tautomerize rapidly at 
room temperature to the more stable carbonyl compound, i.e. the 
thermodynamic product.[3] 
 
Scheme 10:   1,4  conjugate addition of enolate anion to the -carbon of acrylate  
Predicting Michael acceptor reactivity as a determinant of their toxicity has been the 
subject of a number of studies which use both experimental and computational 
calculations.  The model nucleophile methane thiol, glutathione (GSH), acts as the 
donor in a buffered aqueous solution.  A 10 fold difference in reactivity was 
observed between acrylates and their methacrylate analogs when reacted with GSH 
in a buffered non-enzymatic system.[47] The difference was attributed to (i) steric 
hindrance as a result of α-methyl substitution and (ii) a decrease in the partial 
positive charge on the β-carbon of the methacrylates. 2-Hydroxy ethyl acrylate was 
found to be the most reactive ester, with the addition of the hydroxy group leading to 
enhanced electrophilicity.  α,β-Unsaturated aldehydes, ketones and esters 
rapid 
k2, slow 
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(acrylates) were the subject of a 2011 study, again using the GSH model 
nucleophile.[48]  The acceptors were further divided into sub-groups depending on 
the level of substitution at the α and β carbon; those  ith no substitution at either 
the α or β-carbon, α-carbon only, β-carbon only and both the α and β-carbons.  The 
α and β substitution have distinctive effects on reactivity i.e. steric accessibility to 
the β-carbon has an impact on reactivity.  The relative reactivity’s are determined by 
the 2nd-order rate constant of the reaction with glutathione (GSH), with both 
experimental and predicted values, kGSH (L mol-1 min-1).  Results in Table 1.5 have 
been reproduced from Mulliner et al. [48]   
The effect of substitution at the β carbon  as sho n in a base catalysed (0.025M 
aq. NaOH,) reaction between nitromethane and various acrylates.[16]  Increasing 
the ester alkyl chain from methyl to ethyl slowed the rate of reaction from 1 to 2 
hours but the addition of a methyl group at the β-carbon increased the reaction time 
to 15 hours with a reduction in yield from 76 to 60% (see Table 1.4).  The following 
reaction times and yields were recorded by Ballini.[16] 
Table 1.4 Reaction time and yield for addition of Nitromethane to Various 
Acrylates [16] 
 Time hours %Yield 
Methyl acrylate 1 85 
Ethyl acrylate 2 76 
n-Propyl acrylate 1 68 
Ethyl 2-butenoate 15 60 
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In terms of general reactivity, aldehydes were found to be more reactive than 
ketones, and ketones more reactive than esters.  The polarizing effect of the 
carbonyl oxygen is responsible for activation of the β-carbon.  This partial negative 
charge is somewhat diluted by the acetate oxygen of the ester.  As the electron 
density is spread bet een the t o oxygen’s, the positive charge on the β-carbon is 
reduced making it less electrophilic.  This general acceptor reactivity (aldehyde > 
ketone > ester) appears to be a feature of the buffered aqueous conditions used in 
the GSH studies and was not observed in other studies using amine donors as the 
nucleophile.   In a neat reaction using pyrrolidine as the Michael donor, Ranu found 
methyl acrylate to be highly reactive, producing 92% of the adduct in 30 minutes, 
whereas the ketone  3-buten-2-one proved very sluggish yielding only 60% after a 
prolonged reaction time.[49]  When an identical reaction was performed in 1 mL 
water, 3-buten-2-one and methyl acrylate both yielded > 90% in 20 minutes but α, β 
unsaturated aldehydes were unreactive.   
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Table 1.5 Michael-Acceptor Reactivity of Various Aldehydes, Ketones and Esters 
Aldehyde Experimental log kGSH (L mol-1 min-1) 
Prop-2-enal 
 
4.27 a 
2 Methyl prop-2-enal 
 
2.31 
(2E)-but-2-enal 
 
1.70 a 
Ketones   
3-buten-2-one 
 
3.51 a 
3-penten-2-one 
 
1.43 
3-methyl-3-penten-2-one 
 
-0.11 
a  No experimental value available.  Predicted log kGSH (L mol-1 min-1) given 
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Table 1.5 Michael-Acceptor Reactivity of Various Aldehydes, Ketones and Esters 
Acrylates Experimental log kGSH (L mol-1 min-1) 
Methyl acrylate 
 
1.06 
2-hydroxyethyl acrylate 
 
1.29 
Propyl acrylate 
 
1.01 
 
Methyl methacrylate 
 
-1.14 
Ethyl methacrylate 
 
-1.24 
Methyl (2E)-2-methylbut-
2-enoate (methyl tiglate) 
 
 
 
-2.15 
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The rate constants of the cyclopropanation reactions of Michael acceptors with a 
sulfur ylide in DMSO, indicated that the enones 8, 9 and 10 showed a moderate 
increase in reactivity in-line with their electron-withdrawing substituents.[50]  Overall 
the reactivity’s of the α, β-unsaturated ketones 8 to 13 illustrated in Scheme 11 
differed by less than a factor of 25.  The variation of the alkyl group attached to the 
ketones 11, 12 and 13 had almost no effect on reactivity at the C=C double bond, 
however the corresponding phenyl compound 8 was 25 times more reactive than 
13.  
 
 
 
 
   R = NO2 8 
 R = CN  9 
R = H    10 
    R = t-Bu 11 
 R = i-Pr  12 
R = Me  13 
 
Scheme 11:   The electron withdrawing substituents on enones 8 to 10 had little 
impact on their reactivity.  The phenyl substituted ketone 8 was 25 
times more reactive than the methyl substituted ketone 13. [50] 
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1.6  Base Catalysed Aza-Michael Reaction 
In the event that the amine Michael donor is not sufficiently nucleophilic e.g. 
dibenzylamine,  a base catalyst can be used to promote the reaction.[51]  In 2005, 
Shi and co-workers reported high yielding 1,4-diazabicyclo[2.2.2]octane (DABCO) 
catalysed aza-Michael additions of N-tosylated hydrazone with activated olefins, 
such as methyl vinyl ketone, methyl acrylate, acrylonitrile and phenyl vinyl 
ketone.[52] The role of the base catalyst in the reaction mechanism was established 
by deuterium labelling experiments. The tertiary amine catalyst DABCO served as a 
Brønsted base or ‘proton-sponge’ rather than a nucleophilic Lewis base as 
previously reported in the Baylis–Hillman reaction mechanism (the coupling of an 
activated alkene derivative with an aldehyde).[53] The proposed mechanism is 
given in Scheme 12.  The catalytic cycle begins with DABCO acting as a Brønsted 
base, directly abstracting a proton from hydrazone 14 to produce nucleophilic 
intermediate A. Intermediate A is now a strong enough nucleophile to donate an 
electron to the Michael acceptor. The subsequent conjugate addition of A to methyl 
vinyl ketone generates enolate B. Re-protonation of enolate B affords 15 and 
regenerates DABCO to complete the catalytic cycle.   
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Scheme 12: Proposed reaction mechanism of DABCO catalyzed reaction of 
hydrazone 14 with methyl vinyl ketone, adapted from [52] 
 
In a further study by Shi et al (2010), the N-tosylated hydrazone was replaced by N-
tosylated amines (TsNH2 and TsNHNH2).[54]  The product yields were reduced from 
> 99% for the hydrazone to less than 15% for the amines.  The authors suggest that 
the acidity of the hydrazone N–H proton in plays an important role in the DABCO 
catalysed reaction.  The C=N double bond of the hydrazone renders the alpha 
hydrogen atom highly acidic and it is readily deprotonated. The nucleophilicity and 
hence the reactivity of the amine anion towards the acceptor is greater than that of 
the neutral amine. 
14 
 
 
15 
B 
A 
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1.7 Acid Catalysed Aza-Michael Reaction 
In addition to activation of the donor nucleophile via base catalyst as seen in 
Section 1.6, both Lewis and Brønsted acids have been used to activate the olefin 
acceptor in an effort to reduce the reaction time and increase the yield of the aza-
Michael reaction.[4, 55, 56] Wabnitz and Spencer investigated the idea of using 
catalytic amounts of Brønsted acid to activate the Michael acceptor by protonation 
of the carbonyl group. Benzyl carbamate 16 and 1-phenyl-2-penten-1-one 17 were 
chosen as a model system. [56] Strong acids such as bis(trifluoromethanesulfon) 
imide ((CF3SO2)2NH), triflic acid (CF3SO3H) and tetrafluoroboric acid yielded 86 to 
98% of the aza-Michael adduct in only 10 minutes. 
 
Reaction rates were significantly reduced for weaker sulfonic acids and hydrated  
acids. Conversions were rapid for reactions carried out in dichloromethane, ACN 
and nitromethane.  Solvents with weakly basic oxygen functionalities such as THF, 
ether, and acetone interfered with carbonyl protonation and gave little or no 
conversion.[56] 
The mechanism of acid catalysis was further explored by Spencer in 2004.[4]  The 
group investigated the role played by the metal ion in a variety of Lewis acid (e.g. 
 
 
16 17 
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platinum group metal complexes) activated aza-Michael reactions. Four possible 
mechanisms were investigated, (Scheme 13).      
 
Scheme 13: Four principal mechanisms of Lewis acid catalyst action in conjugate 
addition reactions to enones under non basic conditions, reproduced 
from Spencer [4] 
 
Coordination of the metal ion to the carbonyl (18a) or to the π-olefin metal complex 
(18c) were ruled out when the reaction proceeded in the presence of a non-
coordinating base 2,6-di-tert-butylpyridine. Similarly, co-ordination of the metal ion 
(18d) resulting in a free radical reactive intermediate was ruled out by addition of 
free radical scavenger to the reaction system as the reaction proceeded in the 
presence of the scavenger.  Finally, activation of the enone can occur via direct 
protonation of the carbonyl oxygen by Brønsted acids (H+ donating).  The catalytic 
mechanism was attributed to the ability of certain Lewis acids to liberate hydrogen 
atoms i.e. hydrolyse in organic solvents and behave as a Brønsted acid (18b).  
Authors used 1H NMR to correlate catalytic activity with proton generation in the 
presence of one or more equivalents of water.  The addition of up to two equivalents 
of water led to a significant increase in reaction rate.  However, the addition of four 
 
18a 18b 18c 18d 
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equivalents of water slowed the reaction rate due the rate limiting effect of  aters’ 
Brønsted basic properties. [4] 
Encouraged by the work of Spencer,[4] Chaudhuri and his co-workers set about 
showing that it is this Brønsted acid behaviour that is responsible for the aza-
Michael condensation regardless of whether the reaction was catalytic or not.[55] A 
10% solution of boric acid in water was used as the catalyst.[55] Boric acid does not 
disassociate in water as a Brønsted acid, but interacts with the water molecules to 
form the tetrahydroxyborate ion which liberates the hydrogen atom;                 
B(OH)3 + H2O   B(OH)
-
4 + H
+
. [3] As expected, secondary amines reacted faster 
and gave a higher yield than primary amines.  While the results show high yields 
and fast reaction times for the aliphatic amines, they are no better than those 
performed in water alone.[22].   
1.8  Role of the Solvent in the Aza-Michael Reaction 
The studies into amine nucleophilicity [30, 31] and also that of McClelland et al. into 
desolvation of the amine [35] indicate that the choice of solvent is important to 
success in the aza-Michael reaction.   
1.8.1 Aza-Michael in Aqueous Medium 
The work of Rideout and Breslow on Diels Adler reactions [57] led to a huge interest 
in water as an accelerant in reactions between non-polar compounds, with 
accelerations up to 200 times noted in certain cases.  The ‘on- ater’ method 
ascribed to Sharpless et al. [58] describes the rate acceleration observed when an 
insoluble organic reactant(s) is stirred in an aqueous suspension.   
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A theoretical investigation of “on  ater” catalysis postulated that free hydroxy (OH) 
groups of interfacial water molecules play a key role in catalysing reactions via the 
formation of hydrogen bonds. Interfacial water molecules with OH groups protruding 
into the organic phase form stronger hydrogen bonds with the transition state than 
with the reactants, resulting in acceleration through stabilisation of transition 
state.[59]   
 
 
 
Figure 1:  Increased interfacial hydrogen bonding in the transition state resulting in 
rate acceleration in ‘on  ater’ reactions.  Reproduced from Jung and 
Marcus [59]   
The amount of water used was not considered crucial as long as there was 
sufficient water to generate an aqueous emulsion.[58]  The authors reasoned that 
the acceleration resulted from the formation of an oil-water interface as substituting 
perfluorohexane (in which reactants were fully soluble) for water negated the effect 
and the rate was similar to that of the neat reaction (48 hours).  Non-polar liquids 
that formed a heterogenous mixture resulted in large rate acceleration.  In the 
reaction of quadricyclane (19) with dimethyl azodicarboxylate (20) in various 
solvents, a 3:1 ratio of methanol:water resulted in a homogeneous mixture and the 
reaction time slowed to four hours compared to 10 minutes for the water only 
reaction. 
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The mechanism of on-water catalysis was examined in a 2010 paper by Beattie, Mc 
Ellean and Phippen.[60]  Again, a Diels-Alder [4+2] cycloaddition reaction (between 
cyclopentdiene and di-methylfumarate) formed the basis of the study.  In order to 
qualify as a true ‘on- ater’ catalysis the authors propose that the following must 
apply; the reaction mixture must be heterogeneous i.e. there must be an interface 
between the reactants and the bulk water of the mixture, the interface must be with 
the aqueous phase and the reaction should be stirred vigorously to create an 
emulsion.  They note that reactions described as accelerated on-water are also 
subject to acid catalysis.    Reactions performed using D2O could not be described 
as accelerated with % conversion to product similar to that of the neat reaction, 
demonstrating a solvent isotope effect.  The on-water acceleration was independent 
of the pH of the aqueous medium and was not affected by the addition of sodium 
chloride to the water.   
The observations made in relation to acceleration of the Diels-Alder reaction on-
water find a direct application in the aza-Michael addition of amines and conjugated 
alkenes in water reported by Ranu and Banerjee. [22]  A  significant rate 
acceleration using the on-water method resulted in reaction times of 20 to 50 
minutes at room temperature without the use of a catalyst; significantly faster than 
comparable reactions involving aprotic solvents such as THF and methylene 
chloride (1 to 15 hours).  Primary and secondary aliphatic amines showed 
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accelerated reaction times in water giving high yields in a short reaction time.  
However, aromatic and tertiary amines did not react with conjugated alkenes in 
 ater using the procedure.  α, β-Unsaturated aldehydes were unsuccessful Michael 
acceptors.  In addition, while water has been shown to be a viable solvent for the 
aza-Michael reaction, it does not provide a route to enantiomerically pure products. 
The authors reported that the amount of water used in the reaction did not have any 
significant impact on the overall rate of reaction or the product yield.[22]  The role 
played by the water molecule in the rate acceleration of the reaction was discussed 
by the authors and shown in Scheme 14 below.  They proposed that hydrogen bond 
formation involving the oxygen atom of water and the H-atom of the amine 
increased the nucleophilic character of the N atom of amine.  The mechanism in 
Scheme 14 has elements of the earlier theoretical studies of Bernasconi (1986) and 
Pardo (1993).[32, 61]  For Pardo, the barriers calculated for the addition reaction 
were found to be significantly reduced by the assistance of a solvent molecule in the 
intra-molecular proton-transfer process. In the case of the aza- Michael reaction the 
aqueous solution provides not only a polar medium for the reaction but also a 
discrete water molecule acts as a shuttle for the proton between the nitrogen and 
the carbanion of the intermediate.  The role of the water molecule in accelerating 
the reaction is a consequence of the zwitterion intermediate and is not a feature of 
the classic reaction. 
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Scheme 14:   Dual action of water molecule during the aza-Michael reaction, 
adapted from Ranu and Banerjee  [22] 
It was noted that the reaction mixture must be stirred continuously.  Typical reaction 
times were 20 to 35 minutes when the mixture was stirred with yields in excess of 
85% for the majority of reactants examined.[22] A standing mixture was shown to be 
only 50% complete after 20 hours.  Vigorous mixing was also advocated by 
Sharpless et al. in the ‘on  ater’ method described earlier and indicates that the 
creation of an emulsion is an import feature of the reaction on-water.[58]  The 
reaction was noted to be slightly exothermic but no temperature control was 
required.   Compared to the aliphatic amines, anilines are poor nucleophiles and 
reaction with methyl acrylate in water at room temperature was unsuccessful even 
after 40 hours.[22]  Aromatic amines and tertiary amines did not react with 
conjugated alkenes in water using the procedure.  This supports the idea that if the 
amine is sufficiently nucleophilic the reaction will take place under mild reaction 
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conditions and is second order overall with respect to the concentration of the amine 
and the olefin.  Ho ever, α, β-unsaturated aldehydes were unsuccessful as Michael 
acceptors.  This is unexpected as the reactivities of various Michael acceptors with 
respect to GSH model nucleophile showed that in terms of general reactivity, 
aldehydes were more reactive than ketones, and ketones more reactive than 
esters.[48]    However, with reference to the earlier study by Pardo, the preferred 
reaction mechanism for the simple aldehyde acrolein in water proved to be 1, 2 
conjugate addition rather than the 1, 4 mechanism.[61]   
The poor performance of aniline in water is surprising given that its nucleophilicity is 
similar to that of other primary amines.[30]  The addition of anilines to unsaturated 
ketones and esters was explored by several groups.  Directly referencing the work 
of Sharpless, a 2010 study by McErleans group had limited success using methyl 
acrylate as the Michael acceptor.[62]  Increasing the reaction temperature from 
room temperature to 50ºC yielded 35% for the aniline and 94% for the more 
nucleophilic p-methoxyaniline.  Replacing methyl acrylate (MA) with methyl vinyl 
ketone (MVK) as the acceptor saw the yield for aniline increase to 100%.  The 
authors propose that the underlying mechanism behind the rate acceleration is one 
of acid catalysis at the oil-water interface rather than ‘hydrophobic-driven 
concentration effects’.   To prove that this  as the case the neat reaction  as 
carried out and yields compared after a fixed reaction time.  After 11 hours the neat 
reaction between aniline and MVK yielded only 66% compared to the on water 
result of 100%.   Results are contrary to those of Jiang et al. detailed below.  In this 
study, the neat reaction yielded 84% (in 6 hours at r.t).[63]  The only difference 
between the two studies is the molar ratios of the reactants.  In the 2010 study 
Phippen, Beattie and McErlean used a 1.1 equivalents of MVK whereas Jiang et al. 
used 1.3 equivalents in their 2011 study.   
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1.8.2 Solvent Free 
The role of the solvent was central to a 2011 study by Jiang et al. in the preparation 
of   β-amino ketone compounds (Scheme 15).[63] The challenge of aza-Michael 
addition of anilines to MVK was taken up and good to excellent yields were reported 
at room temperature without the addition of catalyst or solvent.  In a solvent 
screening study they observed that protic solvents such as ethanol, water, glycerol 
and polyethylene glycol (PEG 300) increased the yield of adducts whereas aprotic 
solvents ACN, DMF and THF performed very poorly with yields of less than 20%.  
However, the highest yield for the model system was achieved under solvent free 
conditions.  A yield of 84% was achieved for the neat reaction between aniline and 
MVK after 6 hours at room temperature.  This reaction was unsuccessful for Ranu 
and Banerjee [22] in water, when using methyl acrylate as the electrophile.  The 
choice of substrate may have contributed to the failure of the reaction.  For Jiang et 
al., phenyl vinyl ketone failed to produce the desired adduct.[63] 
 
 
R = H, Me, Br, Cl, I, CN, NO2,COOH, Ac     
R1, R2= alkyl or H 
Scheme 15: Aza-Michael addition of aromatic amines to α, β -unsaturated 
ketones[63] 
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Yang et al. (2005) found that a small amount water can promote the Michael 
addition of secondary amines to α, β-unsaturated ferrocenes.[28]  High temperature, 
acidic media and microwave were all disadvantageous to the reaction rate.  At least 
10 mol equivalent of amine was required. Contrary to the findings of Ranu, [22] 
reaction optimisation showed that increasing the amount of water in the system 
stopped the reaction.   
 
Scheme 16: Water-assisted Michael reaction of amines to ferrocenylenones [28] 
Addition of a small amount of water (1 mol equivalent) resulted in a 58% yield of the 
1, 4-addition product after 16 hours. [28] When the experiment was repeated under 
neat conditions but using ultrasound irradiation, the result was a 98% yield of the 
adduct in 1 hour (Scheme 16).  A variety of amines and acceptors were subjected to 
the ultrasound protocol.  Secondary amines were more reactive than primary 
amines.  In all cases, the 1, 4-addition products were observed in good to excellent 
yield within 2 hours.  Once again the aromatic amine failed to produce an adduct 
when ethyl acetate was used as the acceptor. Compared to the work by Ranu and 
Banerjee [22] yields were lower and reaction times longer (2 hours as opposed to 
20 minutes) for the neat ultrasound reaction with similar amines.  The molar ratio of 
the reactants was significantly different for both systems.  Ranu and Banerjee used 
a 1:1.3 ratio for amine to acceptor whereas  Yang et al. [28]  used a 1:0.1 ratio.  The 
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molar ratio of 1:1.3 was also adopted by Jiang et al. [63] in the neat reaction 
mentioned above. 
A single experiment examining the effect of solvent on the aza-Michael reaction of 
piperidine and methyl acrylate compared the effects of water + ultrasound, water + 
stirring, and the neat + ultrasound reaction.  The water + ultrasound reaction was 
incredibly fast with 98% yield in 5 minutes, followed by neat + ultrasound, 93% in 15 
minutes and finally water + stirring, 96% in 30 minutes.[27]  Remarkably, aniline 
reacted with ethyl acrylate (EA) to yield 92% in only 5 minutes.  No side products or 
bis-adducts were formed.  Isolation of products was facilitated by their reduced 
solubility in the aqueous medium post reaction cooling.  The physical acceleration 
by ultrasound is not fully understood but thought to occur through the formation of 
gas cavities in the liquid  hich implode resulting in ‘localized transient high 
temperature and pressures’[27].  Water, with its high energy of activation and heat 
capacity would be an ideal medium for such a reaction.[64] The molar ratios of the 
reactants and the amount of water would appear to be significant; the 1:1 ratio of 
reactants in 1 mL of water would seem to be ideal protocol for reactants that are 
diffusion controlled and for the formation of the mono adducts.   
An early paper by Jenner describes a reaction protocol similar to that of Ranu and 
Banerjee [22] but with very different results.[23]  Using a molar ratio of 1:1 amine to 
acrylate in 3.5 mL of water, no product was generated for the addition of 
isopropyl(methyl) amine to MA.  While this is not the most nucleophilic of amines the 
result is still at variance with other studies.  For example, Ranu achieved a yield of 
85% in 35 minutes for the addition of di-isopropyl amine to MA.[22] In Jenner’s 
experiment, the reaction mixture was not monitored at regular intervals for the 
formation of product; rather all reactions were run for 24 hours.  The anomaly is 
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interesting because the literature surveyed presents the same protocol of monitoring 
the rate of reaction and presumably isolating the products as soon as they are 
formed.  Jenner reasoned that the reaction with MA in water is reversible at room 
temperature as the same reaction with acrylonitrile yielded 72% of product after 24 
hours i.e. ‘the zero yield is simply explained by the fast reversibility of β-aminoesters 
in highly polar media  hereas β-aminonitriles are quite stable in  ater’[23]. To test 
this, the β-amino products were stored in both water and acetonitrile under the 
same conditions as the forward reaction, as shown in Table 1.6.  Not unsurprisingly 
the β-aminoester underwent hydrolysis in water at 50ºC.  Therefore, the difference 
in outcome for the Jenner and Ranu reactions may simply be attributed to the 
reaction conditions. The Jenner experiments were carried out in a sealed 
polytetrafluoroethylene (PTFE) tube containing the reactants and 3.5 mL of water 
(no stirring or mixing of the contents is described) whereas the Ranu reactions were 
monitored by thin layer chromatography (TLC) and the products isolated after they 
were formed.  
Table 1.6  Occurrence of Reverse Reactions for β-amino Compounds, 
reproduced from Jenner [23] 
 Storage 
Temperature 
% Residual Amino Compound After 
24 Hours 
 
 ºC Acetonitrile Water 
β-aminoester  
(iPr)(Me)N-
CH(Me)CH2COOCH3 
50 98 4 
β-aminonitrile  
(iPr)(Me)N-
CH(Me)CH2CN 
30 100 100 
β-aminoamide 
(CH2)5N-CH2CONH2 
30 98 95 
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In contrast to the carbon – carbon reaction the solvent is an important component of 
the aza-Michael reaction and plays a direct role in the protonation of the carbanionic 
intermediate, either through intramolecular bonding and proton transfer from the 
nitrogen atom, or through direct protonation of the carbanionic intermediate.    
Protonation of the carbanionic intermediate by protic solvents such as water and 
methanol is rapid and makes the reaction pseudo second order. In aprotic solvents 
(and neat reactions) the nitrogen atom of the intermediate is the source of the 
necessary proton and without the hydrogen bonds the reaction is slower and more 
likely to revert to the reactants.[65] .  It is unclear from the literature what the 
optimum solvent conditions are as various studies report using different amounts, 
with no consensus emerging. 
1.9  Aza-Michael Reaction in Formulated Dosage Forms 
1.9.1 Reaction between drug substances and pharmaceutical 
excipients 
Drug formulation compatibility testing is carried out to ensure that excipients used in 
the formulation do not react adversely with the active pharmaceutical ingredient 
(API).  Excipients used in the formulation of pharmaceuticals should ideally be 
chemically unreactive.  However, since many excipients (sugars, parabens, salts) 
contain functional groups, reactions with the drug substance are possible.  The 
Maillard reaction of a secondary amine with reducing sugars such as maltose and 
lactose is one of the most commonly cited examples of a drug excipient 
interaction.[66-69] 
Examples of the aza-Michael reaction, as a consequence of drug-excipient 
interaction, have been described in the literature, particularly in relation to liquid 
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dosage forms. The most common aza-Michael addition is that of an API – salt 
interaction where the molecular weight of the adduct is the sum of API and the 
counter ion. [70-73]  
The Michael addition of seproxetine 19 to its maleic acid 20 counter ion was 
described by Schildcrout, Risley, and Kleemann (1993).[70]  The bulk drug 
seproxetine maleate hemihydrate (SMH) was found to be stable when stored at 
40C for 1 month.  Solutions of the drug were prepared and stored at 40C to 
identify potential degradation products.  A pH 8 buffered solution stored for 1 month, 
resulted in the formation of the 1, 4-addition product of seproxetine and maleic acid, 
see Scheme 17.  A range of pH adjusted aqueous solutions indicated that optimum 
adduct formation occurred in the pH range of 5.5 to 8.5, with no adduct formation 
below pH 3.0 (when stored at 40C for 2 weeks).    The 1, 4-addition product proved 
to be stable in the pH adjusted solutions for a further two weeks at both room 
temperature and 40C, with no reversal of reaction observed.  
Pre-formulation isothermal stress testing was carried out with a number of 
excipients to determine compatibility in a capsule dosage form.  Formulation with 
pregelatinized starch (PGS) as a 1 and 20 mg free base equivalent gelatine capsule 
resulted in the formation of the 1, 4 adduct described above, when stored at 25 and 
40C.[70] The free water (7-15%) contained in the starch was thought to contribute 
to the adduct formation.  Stability data generated for two capsule strengths stored at 
25 and 40C showed the 1, 4 adduct to be the sole degradation product.  The rate 
of formation was significantly higher at 40C; 14 times greater for the 1 mg capsule 
and 7.4 times greater for the 20 mg capsule.  The data (and further testing at 50C) 
fits a zero order reaction equation, with 1 month at 40C corresponding to 1 year at 
25C. The percent adduct formed at 40C was 17.34% for the 1 mg capsule versus 
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1.57% for the 20 mg capsule.  While this was not remarked on, the ratio of SMH to 
pregelatinized starch would be greater for the capsule containing 1 mg of SMH, and 
the percentage of free water in the system would also be greater.  The higher 
percentage of water in the system could be responsible for the increase in formation 
of the adduct.   
 
Scheme 17:  1, 4 addition product of seproxetine and maleic acid counter ion, 
adapted from Schildcrout.[70] 
An alternative capsule formulation of SMH and talc was prepared and evaluated 
under the same isothermal stress conditions as the pregelatinized starch.  Talc was 
selected as it is hydrophobic and contains neither surface water or water of 
crystallisation.  When stored at 50C, the interaction with maleate salt resulted in 
exclusive formation of the amide adduct with the subsequent loss of a water 
molecule.  
A Michael addition reaction between the anti-hypertensive drug amlodipine 21 and 
maleic acid 20 was described by Pan et al. (2011) in a review of pharmaceutical 
impurities in formulated dosage forms. [73]  
19 
20 
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Authors note that two possible reactions could occur between the primary amine in 
amlodipine and maleic acid; nucleophilic attack by the amine at either the carbonyl 
carbon or the β-carbon of maleic acid as shown in Scheme 18.[73] There are also 
two available amine nucleophiles, the primary amine and the secondary amine of 
the 1,4 dihydropyridine ring. However, the product ratios and reaction rates were not 
discussed.  Nevertheless, potential routes for excipient formation from amine API’s 
were identified. 
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Scheme 18: Two possible reaction mechanisms for the addition of amlodipine 21 
to maleic acid; the 1, 2 addition to the carbonyl or the 1,4 Michael 
addition to the beta carbon. Adapted from Pan et al. [73] 
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1.9.2   Reaction between Drug Substance and Leachables 
Ophthalmic pharmaceutical formulations have been classified as having a high 
likelihood of packaging component-dosage form interactions (FDA)[74]. Indeed, 
numerous interactions of plastic container components and drug components have 
been documented in literature [75]. For this reason, migration of components, in 
particular phthalates, from polymer containment systems, has been the subject of 
multiple research projects [76, 77].   Interestingly, low-density polyethylene (LDPE) 
containers, typically used in ophthalmic formulation packaging, were found to have 
the highest diffusion coefficient of a range of polymer containment systems 
investigated, significantly increasing the likelihood of migration of components from 
outside the container itself [78]. A number of studies have been concerned with the 
potential migration of components from the adhesive, inks and lacquers used to 
label the plastic containers. In one study benzophenone was detected, probably as 
a result of incomplete UV adhesive curing [79], while in an other, a component from 
the lacquer applied over the label was found to have migrated through to the 
pharmaceutical formulation (and interacted with a known excipient therein).[80]  
While the migration of labelling and adhesive components into liquid pharmaceutical 
formulations has not been extensively researched, the migration of leachables from 
these components when utilised in food packaging has been the subject of 
considerably greater investigation. Each new innovation in food packaging 
technology is accompanied by the risk of new contaminants migrating into 
foodstuffs.[81] For example, antioxidants added to ne  ‘active’ packaging materials 
to extend the shelf life of packaged food resulted in the migration of non-volatile 
impurities into a variety of food simulants [82].  The challenge of identification of 
unknown impurities migrating from food packaging, in particular non-volatile 
components was discussed in a recent review by Nerin et al. [83].  Interaction of the 
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leachable with the food substance has also been observed.  For example, bisphenol 
A diglycidyl ether (BADGE), a lipophilic monomer used for coating cans and 
lightweight food containers, formed adducts with the primary amino groups of food 
proteins following its migration into foodstuffs [84]. 
The migration of these leachables therefore has a potential to chemically interact 
with constituents of liquid formulations. For this reason, their migration into 
ophthalmic pharmaceutical formulations potentially poses a significant risk, 
particularly if they can initiate or propagate degradation reactions such as oxidation, 
hydrolysis or Mallaird reactions etc.  The presence of acrylate monomers in both 
adhesives and inks utilised in pharmaceutical packaging labelling is potentially 
concerning, as if they migrated to the pharmaceutical formulation, they could act as 
Michael acceptors in aza-Michael addition. Aza-Michael addition reactions have 
previously been documented between APIs containing amine functional groups and 
drug excipients in pharmaceutical formulations [85-87].  While they have been 
described as analogous to classic Michael additions, there is one difference, which 
is of critical importance – while a catalyst is required in the classic reaction,  none is 
required for the aza reaction. For this reason, the migration of acrylate acceptors 
into ophthalmic solutions (which are frequently housed in LDPE containers with high 
diffusion coefficients) which have APIs containing amine groups is of concern. 
While there is some consideration of drug excipient interactions as part of quality 
risk management in pharmaceutical development there is no tolerance for reactions 
between drug packaging and drug product; as the choice of packaging is entirely 
the responsibility of the manufacturer [88].  It is expected that packaging 
components are selected to provide adequate protection of the drug and that they 
are compatible with the dosage form and the route of administration.  The guidelines 
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for sterile liquids are particularly stringent.  Modifications to bottle caps, cap liners 
and seals and an increases in wall thickness are generally considered minor for 
non-sterile semisolids and liquids and do not require prior approval.  In contrast, 
almost all packaging changes to sterile drugs (ophthalmic solutions) are considered 
major, especially those that might affect sterility. Container – content compatibility 
studies are required as part of the regulatory submission of a new product market 
authorisation file or for a change relating to the primary product packaging.  
Changes that have even moderate adverse potential require the submission to the 
appropriate regulatory agency for prior approval.[89]  All ophthalmic solutions fall 
into the category of sterile drugs, therefore the impact of minor changes to the 
packaging as a consequence of leachable interactions with the drug substance are 
of major concern.  Regulatory publications are available (Table 1.7), however these 
guidelines are not precise enough to allow a consistent and standardised approach 
when interpreting technical requirements.  The onus is on the drug product 
manufacturer to assess the risk to the patient without overestimating the effect of 
the material on the safe use of the product.   
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Table 1.7 Regulatory Publications 
Regulatory Agency and Publication 
Title 
Details 
 
US Food and Drug Administration 
(FDA) 
Center for Drug Evaluation and 
Research (CDER)  
Center for Biologics Evaluation and 
Research (CBER) 
 
Guidance for Industry Container 
Closure Systems for Packaging 
Human Drugs and Biologics (1999) 
 
Guidance on general principles for 
submitting information on packaging 
materials used for human drugs and 
biologics.  All forms of packaging, not 
only plastic are considered.  
Requirements are based on the 
protection, safety, compatibility and 
performance of the packaging. 
 
European Medicines Agency (EMEA)  
CPMP/QWP/4359/03 
EMEA Guideline on Plastic Immediate 
Packaging Materials December 2005 
 
Introduces the quality aspect in which 
information on primary packaging has to 
be provided.  Migration studies are 
included for ophthalmic studies. 
 
World Health Organisation  
WHO Technical Report Series, No. 
902, 2002 
 
Review of the various elements of the 
packaging of a pharmaceutical product is 
aimed at ensuring that medicines arrive 
safely in the hands of the patients for 
whom they are prescribed. 
 
ICH Harmonised Tripartite Guideline 
Pharmaceutical Development 
Q8(R2).  International Conference on 
Harmonisation of Technical 
Requirements for Registrations of 
Pharmaceuticals for Human Use 
(ICH), Geneva, (2009). 
 
Guidance on the contents of section 
3.2.P.2 (Pharmaceutical Development) 
for drug products as defined in the scope 
of Module 3 of the Common Technical 
Document (ICH M4: Common Technical 
Document for the Registration of 
Pharmaceuticals for Human Use) 
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1.9.3 Source of Acrylates Migration into Packaged Pharmaceutical 
Liquid formulations 
A typical container closure system of a finished ophthalmic solution contains primary 
packaging components such as LDPE bottles or vials, and secondary packaging 
such as pressure sensitive label, ink, foil laminate, paper insert and cardboard 
boxes.  Of the above components, the main sources of acrylate migrants are the 
pre-printed pressure sensitive label and foil laminate.  Both the UV cured ink and 
the acrylate adhesive used on the label contain low molecular acrylate monomers 
used as reactive diluents in the UV curing process and in the formulation of the 
adhesive. 
UV cured ink formulations consist of a blend of light sensitive photo-initiators (PI), 
pigments and variety of acrylic resins.  The radiation curing process involves the 
photo-generation of a radical species that catalyses the polymerisation of acrylates 
in the coating once it has been applied to the substrate.[90] The use of digital ink is 
becoming increasing popular as the process is very cost effective for low volume 
printing.  Digital inks are made up of polymer based pigment particles (as small as 1 
micron) dispersed in a carrier liquid.   The oil based carrier liquid may comprise a 
combination of different resins in an iso-paraffin liquid solvent.  Typical resins used 
in HP Electra ink include polyethylene methacrylic acid (PEMAA) and polyethylene 
acrylic acid (PEAA) copolymer.  As the composition of both acrylic adhesives and 
ink formulations are proprietary, with only the major components declared, 
pharmaceutical companies must establish that the labels are compatible for use 
with their products.  For example, hexane diol di-acrylate migration has been traced 
to a digital ink formulation by our laboratory during trials for new packaging 
configurations.  The compound was not declared by the vendor. Table 1.8 provides 
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a list of acrylates commonly found in UV cured inks with reference to both the 
literature [91] and results of extraction studies performed in our laboratory. 
Table 1.8  Acrylate Monomers  
Compound Abv Source Property 
Hexane diol di-acrylate, 
 
HDDA UV Cured and Digital 
Ink  
Reactive 
monomer/diluent 
Dipentaerythritol penta-
acrylate 
DPHPA UV Cured Ink  
Pentaerythritol tri-
acrylate 
PETA UV Cured Ink  
Phenoxy ethyl acrylate PEA UV Cured Ink  
Glycerine propoxylate 
tri-acrylate 
Ebecryl 
OTA-480 
UV Cured Ink  
Polyester acrylate 
oligomer 
EB450 UV Cured Ink Binder 
Acrylic acid  AA 
 
Label Adhesive Reactive diluent 
Methyl acrylate MA Label Adhesive Reactive diluent 
2-Ethylhexyl acrylate - Label Adhesive  
Polyethylene methacrylic 
acid 
PEMAA Digital Ink Resin 
Polyethylene acrylic acid PEAA Digital Ink Resin 
Trimethyl propane tri-
acrylate 
TMPTA UV Cured Ink 
Label Over varnish 
Reactive diluent 
Dipropylene glycol di-
acrylate 
DPGDA UV Cured Ink 
Adhesive in 
Laminated foil pouch.  
Reactive diluent  
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1.10 Conclusion 
A review of the literature demonstrates ample evidence of the viability of the aza-
Michael reaction in water without catalyst.  The rates of reactivity and yields 
obtained are broadly similar for a variety of studies and are in line with the 
nucleophilicity parameters of the amine donors. The reaction conditions 
summarized in Table 1.9 demonstrate that nucleophilicity of the amine donor is the 
driving force behind the reaction.  For example, piperidine, one of the most reactive 
amines is high yielding when reacted with methyl acrylate under both water and 
neat conditions.  Aniline at the lower end of the nucleophilicity scale is only reactive 
 hen combined  ith the more electrophilic methyl vinyl ketone or β-nitroacrylate.  
Yields of 100% and 84% have been reported for aniline and methyl vinyl ketone 
(runs 6a and 12b) in both water and for the neat reaction.  The ultrasound promoted 
reaction between aniline and ethyl acrylate in water has a standout yield of 92% in 5 
minutes.[27] 
In contrast to the classic carbon-carbon Michael reaction described in Section 1.0, 
the aza-Michael reaction will proceed in the absence of a catalyst.  Whereas the 
effect of the solvent in the classic reaction was closely tied to the choice of catalyst, 
in the aza reaction the choice of solvent is crucial to the reaction. Much of the 
literature has focused on this element especially in light of the rate accelerations 
seen in the Diels-Alder reaction.[57]  The solubility of the reactants is no longer 
essential and one reaction being insoluble in water can be an advantage as it forms 
an oil-water partition.[58]  
Moving from synthetic to analytical chemistry there is evidence of the aza-Michael 
reaction occurring in both solid and liquid formulated drug products through the 
interaction of drug substance and excipients.  Adduct formation as a result of 
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interaction between components of packaging and an amine drug substance is 
equally viable. To date however, in spite of the chemical basis for aza-Michael 
mediated adduct formation, there are no published studies examining the possibility 
of adducts being generated from a packaging interaction.  
Table 1.9 Key: 
MA = Methyl acrylate 
MVK = Methyl vinyl ketone 
a Ratio of amine donor to acceptor in mmol. 
b Reactions were left stirring for a fixed period of time and were not 
monitored during that time.  
c Reaction left stirring overnight, yield reported as ‘ ent to completion’. 
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Table 1.9  Summary of Aza-Michael Reactions in Water and Solvent Free  
from Literature 
 Ratio a/b 
a
 
Solvent       (mL) Amine Acceptor Yield 
% 
Time 
hour 
Ref 
1 1:1 Water 3.5 Isopropyl(methyl) 
amine 
MA 
Acrylonitrile 
0 
100 
24 
b
 [23, 
92] 
2 1:1.3 
 
Water  
+ 
Boric acid 
3 
 
Piperidine  
Aniline  
MA 90 
0 
1.5 
 
[55] 
3 1:1.5 Water 1 Diisopropyl amine 
Piperidine 
Aniline  
 
MA 85 
92 
0 
0.5 
0.5 
24 
[22] 
4 6:5 
 
Water 20  Aniline 
Benzylamine 
 
β-nitroacrylate 
 
85 
45 
4
 b
 [93] 
5 1:1 
 
Water 1  n-propyl amine 1,4 -
naphthoquinone 
95 5 
mins 
[94] 
6a 1.2:1 
 
Water  4  Aniline  MA 
 
21 
 
24
 b
 
 
[62] 
 
6b 1.2:1 
 
Water 50C 4  Aniline  
 
MA 35 
 
24
 b
 [62] 
 
6c 1.2:1 
 
Neat  Aniline  
 
MA 0 24
 b
 [62] 
6d 0.66:0.6 
 
Water  4  Aniline 
 
MVK  100 11 [62] 
 
7 1:1 
 
Water 1 Piperidine  MA 96 
 
0.5 
 
[27] 
8 1:1 
 
Water Plus 
Ultrasnd 
 
1 Piperidine  
Aniline 
 
MA 
Ethyl acrylate 
98 
92 
5 min [27] 
9 2.4:2 Neat  Piperidine  
Aniline 
 
MA 90 
0 
0.75 [49] 
10 2:2 
 
Neat 
 
 Aniline 
Piperidine 
 
β-nitroacrylate 
 
92 
80 
2 
1.5 
[95] 
11 2:2 Neat  Morpholine  
Piperidine  
Aniline 
 
MA 90 
60 
0 
2 
3 
24 
[96] 
12a 1:1 Neat  4-chloroaniline 
 
MVK 
 
60 4 [63] 
12b 1:1.3 Neat  Aniline 
 
MVK 
 
84 6 [63] 
12c 1:1.3 Water 2 4-chloroaniline  MVK 87 10 [63] 
13 0.5 - 
5:0.5 
Neat  Piperidine:  
 
Ethyl acrylate 98 0.5 [28] 
14 1:1.5 PEG 400, 
2.5 g 
 N-
methylpiperazine  
MA 99 0.5 [97] 
15 57.5:57.5 methanol 20 Methylbutylamine MA 100
c
 24
 b
 [65] 
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1.11 Project Aims 
The focus of this project was to examine whether reactions that are viable in mild 
aqueous conditions are likely to proceed, to explore if the potential interactions 
between the drug substance and packaging components occur under these 
conditions and to develop a a platform to screen for these interactions in ophthalmic 
systems.  As per ICH Q3B Guidelines, an adduct yield of between 0.5 and 0.9% of 
the concentration the active pharmaceutical ingredient in the final dosage form must 
be structurally identified.[98]  For a synthetic chemist this level of yield would be 
considered ‘trace’, but for pharmaceutical companies, the costs associated  ith the 
identification and qualifications of unknown impurities are considerable.    
Several papers attest to the acceleration of the aza-Michael reaction in water when 
compared to the reaction in organic solvent or indeed neat without solvent. In 
Chapter 2, the aza-Michael reaction was explored using 1-phenylpiperidine (1PP) 
and methyl acrylate (MA). 1PP was chosen as a model amine containing drug 
substance and MA was chosen as a probable packaging constituent.  To determine 
whether water acted as an accelerant for the aza-Michael reaction, an ultra-high 
performance liquid chromatography (UHPLC) method was developed to accurately 
monitor reactants and products in situ in order to determine extent of reaction 
acceleration by water. It was determined in this chapter that the aza-Michael 
addition reaction with 1PP as the amine donor and MA as the acrylate acceptor was 
rapid in aqueous solutions, and proceeded without the requirement of a catalyst. 
In Chapter 3 the possibility and extent of the aza-Michael addition reaction occurring 
in ophthalmic solutions was examined.  The reaction was investigated using a 
variety of buffered solutions using multiple acrylate acceptors commonly found in 
pre-printed labels.  The effect of the amine salt was investigated as the free base is 
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seldom encountered in the final drug product. It was shown that aza-Michael 
addition adducts were formed in all systems analysed: occurring in buffered 
solutions of both acidic and basic pH, with both free base and salt drug substances, 
and with both acrylic acid and esters. The adduct yields varied for different 
permutations, in agreement with what was expected based on their chemical 
parameters. Hydrolysis of the ester products was also observed. 
Pharmaceutical formulations frequently comprise of more than one active 
ingredient, and this may impact on the profile of impurity adducts formed during both 
preparation and storage. Chapter 4 describes the application of a design of 
experiment (DoE) methodology to the development of a stability indicating UHPLC 
method for the simultaneous analysis of the APIs brimonidine tartrate and timolol 
maleate and their related substances.  Two of the impurities quantitated using the 
method were the result of an aza Michael addition reaction.  There are currently no 
accredited methods for ophthalmic drug substances which monitor both APIs and 
their related impurities. 
The UPLC method developed in Chapter 4 was one of several used in the 
screening platform discussed in Chapter 5.  Commercial formulations of eight 
amines were reacted with packaging components methyl acrylate and acrylic acid 
and screened for adduct formation over a period of 40 days. By investigating the 
conditions under which the reaction was most likely to take place, a protocol was 
developed for screening of products in the early stages of analytical method 
development and validation. The screening study combined elements of drug-
excipient/packaging compatibility studies and forced degradation studies, and 
comprised immersing the acrylate packaging components directly in the ophthalmic 
formulation and monitoring for the presence of adducts under accelerated storage 
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conditions.  The role of the acrylate acceptor reactivity was shown to be of particular 
importance in terms of the nitrogen nucleophile reaction. It was also illustrated that 
both secondary and tertiary amine APIs undergo the aza-Michael reaction with both 
methyl acrylate and acrylic acid under pharmaceutically relevant conditions. 
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Chapter 2: 
Reaction monitoring using UHPLC: 
Investigation of the Parameters which Affect the Rate and Yield 
of the Aza-Michael Reaction 
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2.1 Introduction 
The aza-Michael reaction describes the conjugate addition of amines to α,β-
unsaturated carbonyl compounds and nitriles.  This important reaction has wide 
application in the production of β-amino derivatives which serve as useful 
intermediates in the synthesis of a large number of products with a wide range of 
biological activity such antibiotics, β-amino alcohols and other nitrogen-containing 
molecules.[99-102]   
Several papers attest to the viability of the reaction in multiple configurations, 
including neat without any solvent or catalyst, [49, 63] neat with catalyst, [96, 103] 
and in aqueous solutions such as sodium carbonate [104], boric acid [55] and as a 
co-solvent with trifluoroethanol.[105] In addition, several simple, catalyst-free 
protocols demonstrate that the reaction in water is both fast and high yielding.[10, 
27, 62, 94] 
Initial interest in water as the sole reaction medium stems from Breslo ’s reports on 
the remarkable acceleration of the Diels–Alder reaction performed in water.[57] 
Many more experiments have been reported since then for other types of organic 
reactions that are accelerated in water and are discussed in a number of reviews. 
[64, 106, 107]  These reactions are described differently in various papers, 
sometimes as “in  ater” and sometimes as “aqueous”.  Sharpless and co-workers 
described “on  ater” conditions under which substantial rate acceleration was 
observed when the organic reactants were insoluble in the aqueous phase.[58]  
There have been several reports on the aza-Michael reaction using water as the 
reaction medium.[8, 62, 108]  However, there is no firm evidence that the rate in 
water is greater than for the neat reaction.  Jiang et al. [63] investigated the rate and 
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yield of reactions using aniline as the amine using the same the methodological 
approach as Phippen et al. [62] but reported conflicting findings.  For the reaction of 
aniline and methyl vinyl ketone in water, Phippen et al. achieved a 100% yield 
compared to 66% for the neat reaction (6 hrs, r.t.), whereas Jiang et al. reported a 
yield of 84% for the neat reaction.   A 2002 paper by Ranu, Dey, and Hajra 
describes the neat reaction of various amines and acceptors.  All reactions were 
high yielding with reaction times of 30 min to 3 hours.[49] When the experiment was 
repeated in water several years later by Ranu and Banerjee [22] the authors 
reported a significant rate enhancement despite the fact that the reaction rates and 
yields were comparable to those of the neat reactions. 
The purpose of this study was to carry out a detailed investigation of the the aza 
Michael addition of an amine and acrylate using water as the reaction medium to 
determine whether the reaction can truly be described as accelerated by water.  
This study considers the effect of solvent type and volume upon reaction rates. A 
number of common solvents were screened and the effect of variation in solvent 
compared to that achieved using water as the reaction medium. In addition, the 
effects of the reaction stoichiometry, temperature and rate of stirring were 
investigated for the neat reaction. 
A key aspect of the ‘on- ater’ rate phenomenon proposed by a number of groups is 
the chemistry between water and reactants that occurs at an oil-water phase 
boundary [58, 59, 62].  To achieve this phenomenon, one of the reactants must be 
insoluble in water.  1-phenylpiperazine (1PP) (1) was selected as the model amine 
nucleophile as it is insoluble in water but soluble in methanol (MeOH); if the reaction 
was catalyzed by water, no rate enhancement would be expected for the same 
reaction in MeOH. Methyl acrylate (MA) (2) was chosen as the model acceptor 
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(Scheme 1).  The addition to MA was not reversible under the conditions tested and 
the products therefore resulted from kinetically and not thermodynamically 
controlled reactions. The rates of reaction were compared by monitoring the 
conversion of 1PP to methyl 3-(4-phenylpiperazin-1-yl)propanoate (MPP) (3) 
product using varying  amounts of reactant for a pre-determined time.  The amine 
loss was quantitatively analyzed by UHPLC. 
 
Scheme 1:  Aza-Michael reaction of 1-phenylpiperazine (1) and methyl acrylate (2) 
to produce methyl 3-(4-phenylpiperazin-1-yl) propanoate (3) 
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2.2 Experimental 
2.2.1 Chemicals and Reagents 
1-Phenylpiperazine (P30004) and methyl acrylate (M27301) were purchased from 
Sigma Aldrich.  Potassium phosphate monobasic and ortho-phosphoric acid 85% 
were purchased from Applichem.  HPLC grade acetonitrile and methanol were 
purchased from Merck.  Tetrahydrofuran ‘Super purity solvent’  as purchased from 
Romil.  Water deionised to a resistance of greater than 18 MΩ was obtained from a 
Millipore Corporation Milli-Q system, Millipore (Bedford, MA, USA).   LC-MS grade 
acetonitrile was purchased from Merck.  All other chemicals were of analytical grade 
and were used without further purification.  
2.2.2  Sample Preparations 
All reactions were conducted at room temperature (22 - 24ºC) in 20 mL screw-top 
round bottomed test tubes that had been washed in distilled water and air dried. 
Vigorous stirring was performed at 800 rpm on a hotplate stirrer. Room temperature 
reactions were carried out using a Variomag, Telemodul C (Thermo Fischer 
Scientific, Waltham, MA).  For reactions carried out at 50ºC, a SD162 Stuart 
stirrer/hotplate (Bibby Scientific, UK) was used. 
2.2.3 Standard Conditions for aza-Michael Reactions 
The experimental procedure was adapted from Ranu and Banerjee [23] and 
was as follows for the neat aza-Michael reaction: MA was added to 1PP in a 
round bottomed test tube containing a magnetic stir bar.  The test tube was 
immediately transferred to the stir plate and stirred vigorously for the 
prescribed time.  After the required time the reaction vessel was removed 
from the stir plate and 10 mL of tetrahydrofuran (THF) was added directly to 
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the reaction mixture.  The test tube was capped and shaken vigorously by 
hand 3-4 times.  0.5 mL of sample was removed and added to a 50 mL 
volumetric flask containing approximately 30 mL of MeOH.  The flask was 
brought to volume with MeOH and shaken vigorously by inversion 10 times.  
2 mL of sample was immediately pipetted into a glass vial and placed in the 
UHPLC autosampler for injection.  The entire process from addition of the 
THF to sample injection took < 90 s.   
2.2.4 Determination of the effect of solvent type on yield 
1.0 mL of solvent (water, MeOH, ACN or THF) was transferred to the test tube 
containing 1PP prior to addition of MA.  1PP was not stirred in the solvent prior to 
addition of the MA.  The reaction mixture was stirred vigorously (800 rpm) for 20 
mins at room temperature.  Samples were prepared for analysis by addition of 9 mL 
THF to the test-tube. Preparation of solvent samples for UHPLC analysis was 
analogous to the water preparations described in Section 2.2.3. 
2.2.5 Determination of the effect of solvent volume on yield 
For reactions in water, 0.5, 1.0, 3.0 or 5.0 mL of water was transferred to the test 
tube containing 1PP prior to addition of MA.  1PP was not stirred in the solvent prior 
to addition of MA.  The reaction mixture was stirred vigorously (800 rpm) for the 
prescribed time at room temperature.  Samples were prepared for analysis by 
addition of the appropriate amount of THF to obtain total volume of 10 mL in the 
test-tube e.g. 9 mL of THF to the test tube containing 1 mL of water.  See Table 2.1 
for details.  Each sample was prepared for analysis as described in Section 2.2.3. 
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Table 2.1 Reaction Conditions for Variation in Solvent Volume and Type 
Molar Ratio 
1PP:MA 
(mmol) 
Solvent 
Volume 
mL 
Temp. 
ºC 
Reaction 
Time/min 
Amount 
THF, mL 
1:1.5 H2O 0.5 r.t 0.5 9.5 
1:1.5 H2O 0.5 r.t 1 9.5 
1:1.5 H2O 0.5 r.t 2 9.5 
1:1.5 H2O 0.5 r.t 5 9.5 
1:1.5 H2O 1.0 r.t 5 9.0 
1:1.5 H2O 3.0 r.t 5 7.0 
1:1.5 H2O 5.0 r.t 5 5.0 
1:1.5 H2O 1.0 r.t 20 9.0 
1:1.5 MeOH 1.0 r.t 5,10, 20 9.0 
1:1.5 THF 1.0 r.t 20 9.0 
1:1.5 ACN 1.0 r.t 20 9.0 
 
2.2.6 Determination of the effect of molar ratio of reactants on yield 
in the neat reaction 
The molar ratios of amine to acrylate were adjusted as summarised in Table 2.2.  All 
reactions were conducted at room temperature (22 - 24ºC).  Each reaction mixture 
was stirred vigorously (800 rpm) for 2 mins.  The 2 mmol equivalent of amine was 
analysed at additional time-points as detailed in Table 2.2. 
Table 2.2 Reaction Conditions for the Neat Addition of 1PP and MA  
 Molar Ratio of Reactants 
1PP:MA (mmol) 
Stirring rate  
rpm 
Temp. 
ºC 
Reaction 
Time/min 
1:1 800 r.t 2 
1:1.5 800 r.t 2 
1:2 800 r.t 2 
1.5:1 800 r.t 2 
2:1 800 r.t 2, 5, 10, 20 
3:1 800 r.t 2 
1:1.5 300 r.t 20 
1:1.5 600 r.t 20 
1:1.5 800 50 20 
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2.2.7   Determination of the effect of reaction temperature on yield 
in the neat reaction 
An aluminium beaker containing a mixture of sand and silica beads was placed in 
an oven at 50ºC for 45 minutes.  A 20 mL round bottomed test tube was placed into 
the vessel containing the heated sand/silica mixture, covered and re-equilibrated to 
50ºC on a heated stir-plate.  1PP followed by MA was added to the test tube in a 
1:1.5 mmol ratio.  The reaction mixture was stirred vigorously (800 rpm) for 20 mins. 
2.2.8 Determination of the effect of stirring rate on yield in the neat 
reaction 
A 20 mL round bottomed test tube containing a magnetic stir bar was placed on a 
magnetic stir-plate set to 300, 600 or 800 rpm.  1PP followed by MA was added to 
the test tube in a 1:1.5 mmol ratio.  Each reaction mixture was stirred at the 
designated speed for 20 minutes. 
2.3 Chromatographic Instrumentation and Conditions 
2.3.1  Reaction monitoring using UHPLC 
UHPLC analyses were carried out using a Waters ACQUITY UPLC H-Class system 
(Waters Corporation, Milford, MA, USA) connected to an ACQUITY TUV detector 
(Waters Corporation, Milford, MA, USA).  Data acquisition and integration were 
performed by using the accompanying Waters Empower software.  The analytical 
column was a Waters ACQUITY CSH C18 (50 mm × 2.1 mm, 1.7 µm particles) from 
Waters (Waters Corporation, Milford, MA, USA), and was maintained at 30ºC.   The 
autosampler was held at ambient room temperature.   The column flow rate was set 
to 0.4 mL/min, and the injection volume was 1.0 µL. Detection was performed at 240 
nm. Chromatographic separations were carried out using isocratic elution.  Mobile 
phase consisted of a mixture of 30 mM potassium phosphate buffer pH 2.8: 
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acetonitrile (93:7, v/v).  The mobile phase was filtered through 0.22 µm Millipore 
HVLP membrane filters prior to use. 
2.3.2 Liquid Chromatography-mass spectrometry (LC-MS) 
High resolution mass spectrometry was carried out using an Agilent 1260 Ultra 
Performance Liquid Chromatography system coupled with an Agilent 6250 Q-TOF 
(Agilent Technologies, Palo Alto, CA, USA) by electrospray ionization (ESI).  The 
analytical column was a Waters ACQUITY CSH C18 (50 mm × 2.1 mm, 1.7 µm 
particles) from Waters (Waters Corporation, Milford, MA, USA), maintained at 30ºC.  
The column flow rate was set to 0.4 mL/min, and the injection volume was 1.0 µL. 
UV detection was performed at 240 nm. Chromatographic separations were carried 
out using isocratic elution.  Mobile phase consisted of a mixture of 10 mM 
ammonium formate, pH 2.8: acetonitrile (93:7, v/v). The mobile phase was filtered 
through 0.22 µm Millipore HVLP membrane filters prior to use. Full scan spectra 
were taken at a cone voltage of 3500 V using positive electrospray ionisation (ESI).  
QTOF Parameters Values 
Gas Temp. (ºC) 300 
Gas Flow (l/min) 8 
Nebulizer (psig) 35 
Sheath Gas Temp. (ºC) 350 
Sheath Gas Flow (l/min) 11 
Capillary Voltage (V) 3500 
Nozzle Voltage (V) 1000 
2.4  UPLC Method Development 
A sensitive and selective reversed phase UHPLC method was developed to allow 
simultaneous fast reaction monitoring of the reactants and product.  All three 
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compounds (1PP, MA and the product MPP) contain UV active chromophores, 
enabling UV detection.  See Figure 2.1 for photodiode array (PDA) UV spectra of 
each.   
 
 
 
 
 
 
 
Figure 2.1:  UV spectra for 1PP, MA and MPP (product) 
 
2.4.1 HPLC Mobile Phase Optimisation 
The chromatographic separation and detection had to first be optimised in terms of 
runtime, resolution and limit of detection. Sub 5 minute runtimes are common for 
UHPLC instruments, making it an ideal choice for this type of reaction monitoring 
where samples are reacted and prepared for analysis within minutes.  In this 
instance the reactants and products eluted within 4 mins, as illustrated in the 
chromatogram in Figure 2.2.   
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Figure 2.2: Typical UV chromatogram (240 nm) of 1PP, MA and product MPP.  
All three peaks have eluted within 4 minutes. 
 
Montesano et al. detailed a LC-MS screening method for piperazine derived drugs, 
including 1PP, using a gradient method consisting of 30 mM acetate buffer pH 4.5 
and acetonitrile.[109]  This mobile phase was chosen as the starting point for 
method development as it had the added advantage of being LC-MS compatible.  
While baseline resolution of both reactants and product was achieved, baseline drift 
and high background noise at the retention time of the 1PP peak meant the method 
was not sufficiently sensitive for quantitation of 1PP at low concentration.  Replacing 
the acetate buffer with 30 mM potassium phosphate, pH 2.8 had several positive 
effects; the baseline interference was eliminated and the lower pH reduced tailing 
factor of the 1PP peak giving better resolution between it and MA.  At pH 2.8, the 
1PP reactant, which contains both secondary and tertiary amine functional groups 
(estimated pKa values of the protonated amines are 6.30 and 8.80)[110], would 
carry a positive charge. Ionisation of the compound reduced the retention time to 
1.4 minutes.  A number of gradients were investigated but an isocratic elution was 
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found to be most suitable as it eliminated the baseline drift caused by the mixing of 
gradient buffers.  A mobile phase containing 30 mM potassium phosphate buffer pH 
2.8: acetonitrile (93:7, v/v) was found to be optimal for this method.   
2.4.2 UHPLC Column Selection 
A number of sub 2 micron reverse phase UHPLC columns were trialled as part of 
method development; Waters ACQUITY CSH (Charged Surface Hybrid) C18 (100 
mm × 2.1 mm, 1.7 µm particles) and Waters ACQUITY HSS (High Strength Silica) 
C18 (50 mm × 2.1 mm, 1.7 µm particles).  The CSH column is recommended by the 
manufacturer for analysis of basic compounds using a low pH, weak ionic strength 
mobile phase.  The HSS column is described as having general purpose silica 
based C18 chemistry, which may provide increased retention in comparison to the 
hybrid based C18 columns.  The HSS column was trialled to determine if there was 
any effect on the elution order of the 1PP and MA peaks.  While no difference in the 
elution order was noted, the CSH column gave an improved peak shape for the 1PP 
amine (due to the presence of positive surface charges) and development continued 
using the CSH column.  The retention time and resolution of peaks obtained with 
the 100 mm column exceeded requirements and the column was replaced with a 50 
mm column to reduce overall runtime. 
2.4.3 Sample Preparation for Analysis 
Prior to analysis by UHPLC-UV it was necessary to stop or sufficiently slow the 
reactions to ensure that the reactants did not continue to react during sample 
preparation.  Before injection onto the column it was also necessary to dilute the 
samples sufficiently to adjust the concentrations of reactants/product to between the 
linear range of UV absorption (0.1 – 1.0 aufs).  Due to the very small volume of 
reactants used, it was not possible to remove an aliquot of the reaction mixture, 
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therefore it was necessary to dissolve each reaction mixture completely in a solvent 
that both stopped the reaction and uniformly dissolved both reactants and products.  
In addition, sample preparation for injection onto the column required a diluent 
compatible with the mobile phase.   
The aprotic solvents ACN and THF slowed the rate of reaction and resulted in low 
yields in a number of papers for the aza-Michael reaction [22, 63, 65], and this 
proved to be the case in this study also.  5 mL of ACN or THF was added to the 
reaction test tube containing 1PP and MA.  The test tube was immediately capped 
and shaken, followed by immediate dilution with 50% MeOH (1 in 50).  The THF 
sample yielded 9% of product and the ACN sample yielded 17%.  Increasing the 
volume of THF or ACN added to the test tube from 5 to 10 mL and reducing the final 
sample preparation to a 0.5 mL in 50 mL dilution in 100% MeOH resulted in optimal 
conditions for sample preparation.   
1PP peak shape for the sample prepared in THF + diluted in MeOH was superior to 
that prepared in ACN + diluted in MeOH and therefore this was chosen as the final 
preparation.  See Figure 2.3.   Less than 2% of the 1PP reacted with MA in the time 
taken to prepare and analyse the samples (< 90 s) when the THF + Methanol 
protocol was used. 
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Figure 2.3: Poor peak shape exhibited by reaction sample prepared in ACN 
followed by dilution in MeOH when compared to sample prepared in 
THF and MeOH. 
2.4.4 Method Verification 
Linearity of the detector for 1PP was demonstrated from 0.075 to 300 µg/mL by 
plotting the peak area of 1PP versus its concentration. Each linearity solution was 
prepared in duplicate using MeOH as a diluent. A linear least-squares regression 
was performed, and the correlation coefficient (R) for the regression was 0.999, thus 
demonstrating a good linear response for 1PP across the concentration range of 
interest. The linearity plot passed through the origin within 95% confidence interval. 
Table 2.2 contains the linearity data.  
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Table 2.2 Linearity Data for 1PP 
Parameter Result 
Concentration range, µg/mL 0.075 - 300 
Slope, m 8065.4  
Y intercept, c 1454.2 
Y100, (n = 2) 1228045.9 
Y0/ Y100*100 0.1% 
Correlation coefficient, r 0.999 
 
 
Figure 2.4:  Calibration curve for 1PP from 0.075 to 300 µg/mL, n = 2. (error bars 
are included, but are smaller than the data point icons.) 
2.4.5 Internal Standard 
The 1PP reagent used in the experiments contained a small impurity.  The impurity 
peak was observed in all 1PP standard chromatograms at approximately 0.4 – 0.6% 
of the 1PP peak area.  The peak area of the impurity with respect to the main 1PP 
peak proved to be very consistent for each run.  As the impurity was unaffected by 
the reaction with MA, it was possible to use its area to calculate the peak area of 
y = 8065.4x + 1454.2 
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1PP starting material in each reaction. A number of 1PP standard controls were run 
for each assay and the average peak areas of both the 1PP peak and the impurity 
peak were calculated. This impurity served as an internal standard throughout the 
reaction monitoring experiments.  The presence of this impurity in every injection 
allowed calculation of the 1PP starting material for each reaction.  Analysis of the 
1PP standard using LC/MS yielded a molecular formula of C11H14N2O and an exact 
mass of 190.11 m/z and a possible structure 4-phenylpiperazine-1-carbaldehyde. 
 
 
 
 
 
Figure 2.5 TIC for 1PP (1.4 min), MPP (2.5 min) and Impurity (11.1 min) 
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Figure 2.6 ESI scan of impurity peak (which elutes at 11.1 min) showing M+H 
ion 191.118 m/z  
2.4.5.1  Calculation of the Peak Area of the 1PP Starting Material 
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2.4.5.2 Calculation of 1PP Starting Material in Sample using 1PP 
Impurity as Internal Standard 
 
 
 
  
 
2.5 Results and Discussion 
2.5.1 Reaction Monitoring by UHPLC 
Analysis by UHPLC proved simple and repeatable.  Reactions were monitored over 
a time span of 30 s to 80 min.  At time-zero, addition of reactants followed by 
immediate sample preparation and analysis resulted in a 2% loss of amine.  Using 
the internal standard described in Section 2.4.5, it was possible to accurately 
quantitate the % loss of 1PP starting material and conversion to product, MPP, and 
monitor small differences in the reaction yield over time.  Figure 2.6 shows that in 
0.5 mL of water, initial conversion of 1PP was rapid, with 98% used up in the first 5 
min.  The reaction slowed after 2 min (90% conversion) as the reactants were 
consumed. Using the UHPLC technique to investigate the effect of solvent type on 
the rate of the reaction, it was possible to determine that of the two aprotic solvents 
examined, the rate in ACN was 1.5 times faster than THF under identical conditions.  
UHPLC results also demonstrated that the reaction was reproducible for replicates 
at each time-point.   
 [
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Example:   
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Figure 2.6 % Conversion of 1PP over time for reaction of 1PP and MA in 0.5 mL 
of water (23ºC).  % conversion was determined by UHPLC, using 
parameters detailed in Table 2.1, n = 2 
 
2.5.2 Effect of Solvent Type on Yield  
A comparison of the reaction in protic and aprotic solvents is reported in Table 2.4.  
The reaction of 1PP with MA was slower with lower yields in aprotic solvents THF 
and ACN, with only 19 and 28% converted in 20 min compared to 98% conversion 
in only 5 min for the reaction in water.  A 92% conversion was achieved in MeOH 
after 5 min demonstrating that it is almost on a par with water in terms of its 
reactivity.   
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Table 2.4 Reaction Conditions for the Addition of 1PP and MA in Various 
Solvents 
Ratio 1PP:MA 
(mmol) 
Solvent  
(1 mL) 
Temp. 
ºC 
Time/min Yield % 
1:1.5 H2O  r.t 5 99.0 ±0.6 
1:1.5 MeOH  r.t 5 91.8 ± 0.1 
1:1.5 ACN  r.t 20 28.1 ± 1.5 
1:1.5 THF  r.t 20 19.4 ±1.4 
 
The conjugate addition of secondary amines to α,β-unsaturated carbonyls proceeds 
through an intermediate state that is accelerated by more polar solvents.[111] The 
increased reactivity in polar solvents suggests that the intermediate is ionic in nature 
and more polar than the reactants. In protic solvents such as water and MeOH, 
protonation of the carbanionic intermediate by the solvent would be rapid (see 
Scheme 1.3, Chapter 1).  Where no proton is available, as is the case with the 
aprotic solvents, the nitrogen atom of the ammonium moiety provides the proton 
required for stabilisation.[30]   
Systematic investigations into the effect of solvent on the reaction mechanism were 
carried out by Um and co-workers in the reaction of 1-Phenyl-2-propyn-1-one with 
alicyclic secondary amines in ACN and water.[112, 113]  The amines studied were 
less reactive in ACN than in water, even though they are more basic in the aprotic 
solvent by 7-9 pKa units.  In contrast to the “on- ater” acceleration proposed by 
Phippen et al., here the authors proposed that the reaction proceeded through a 
stepwise mechanism, whereby the formation of the addition intermediate remained 
the rate determining step, and in which proton transfer followed after the rate-
determining step. The nature of the transition state was proposed to be responsible 
for the decreased reactivity in the aprotic solvent; where the proton transfer from the 
positively charged nitrogen atom to the negatively charged carbon atom occurred 
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after the rate-determining step. The results are in agreement with the earlier studies 
of Bernasconi [114]. 
In the aprotic solvents THF and ACN the reaction has previously been described as 
‘third order”, that is, second order in amine and first order in acrylate [65].  Therefore 
it can be hypothesised that when the solvent cannot provide the proton required in 
the transition state, a second molecule of amine is necessary to allow the reaction 
to occur.  To provide insight into the reaction rate, the ratio of amine to acrylate was 
maintained at 1:1.5 for all experiments.  Being pseudo second order, the protic 
solvents water and MeOH were indeed much faster, as hypothesised.  As expected, 
the rate was depressed in both of the aprotic solvents.  In the case of 1PP, MA and 
MPP, both the reactants and products are neutral (as shown in Scheme 1).  As the 
zwitterionic intermediate is charged, stabilisation of the intermediate favours the 
polar, protic solvents water and methanol.[115]  
2.5.3  Effect of Water Volume on Yield  
For practical monitoring of the reaction, the ratio of amine to acrylate was 
maintained at 1:1.5.  In this way, any acceleration noted in the rate of reaction could 
be attributed purely to the solvent.   Initial reaction in water was rapid with 75% of 
the 1PP converted in just 30 s and 98% in 5 mins.  Complete conversion of the 
reaction was reached after 10 min.   
All reactions in  ater  ere performed  ith vigorous stirring (800 rpm) to create an 
emulsion. The amount of  ater added to the reaction had no effect on the yield as 
sho n in Table 2.5, entries 4 – 7.  Volumes of 0.5 to 5 mL were analysed and an 
identical result, 98% conversion in 5 min, was achieved in each case.  Both 
Sharpless and Ranu reasoned that the amount of  ater used  as not considered 
crucial as long as there  as sufficient  ater to generate an aqueous emulsion [20, 
106 
 
23].  While the amount of water used in this study did not have an impact on the 
yield, the requirement for an aqueous emulsion does not appear to be a feature of 
the reaction.  The results for the reaction in MeOH were almost as high yielding as 
those in water yet no emulsion was formed in MeOH. 
Table 2.5  Reaction conditions for the addition of 1PP and MA  
Entry Ratio 1PP:MA 
(mmol) 
Solvent 
H2O (mL) 
Temp. 
ºC 
Time/min Yield/% 
1 1:1.5 0.5 r.t 0.5 75 
2 1:1.5 0.5 r.t 1 84 
3 1:1.5 0.5 r.t 2 91 
4 1:1.5 0.5 r.t 5 98 
5 1:1.5 1.0 r.t 5 98 
6 1:1.5 3.0 r.t 5 98 
7 1:1.5 5.0 r.t 5 98 
 
2.5.4  Investigation of “on-water” and neat reaction acceleration  
Interest in performing neat reactions is part of an overall trend towards the reduction 
and elimination of hazardous solvents and catalysts in chemical processes and is 
often promoted as ‘green’ in the literature.[28, 63, 116] Of interest to this study were 
conflicting reports in the literature, often from the same group, describing the aza-
Michael reaction as ‘accelerated’ both in solvent and under solvent free conditions.  
A 2002 report by Ranu gives a 90% yield in 45 minutes for the solvent free reaction 
of piperidine and MA.[49] In the highly cited 2007 study by the same author, the 
reaction was described as accelerated in water for the same reactants, with a 92% 
yield reported in 30 min.[22] The neat reaction was carried out with a molar excess 
of the amine (2.4:2), whereas for the reaction in water the opposite ratio was used 
with the acrylate in excess (1:1.5).  As discussed in Section 2.5.1, in the absence of 
suitable solvent the amine itself can provide the proton necessary to complete the 
reaction.  On both occasions reactions were monitored by TLC. To investigate 
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 hether the reaction  as truly ‘accelerated’ in  ater, 1PP  as reacted  ith MA 
under the same conditions as those in water (molar ratio 1:1.5).  Monitoring the 
reaction by UHPLC allowed small differences in the conversion of the amine to be 
tracked. 
Results show that the amine was sufficiently nucleophilic, and the neat reaction 
proceeded smoothly to give 54% conversion in just 2 minutes, as illustrated in 
Figure 2.7. An initial high reaction rate was expected in the neat reaction due to the 
high concentration of reactants.  The reaction rate slowed considerably thereafter 
with 90% conversion at 30, 45 and 60 minutes.  A 99.5% yield was achieved after 
80 min.  In the absence of a proton donor (solvent), the nitrogen atom of the 
zwitterionic intermediate was the source of the necessary proton.[111, 117] This 
was hypothesised to be the reason why the initial rate of conversion was high, as 
the amine concentration was greater, but the conversion rate subsequently slowed 
considerably with the last 10% of the conversion taking almost 1 hour to complete.   
As the neat reaction proceeded, the test tube was occupied by an excess of product 
with reducing  opportunity for the reactants to collide and dwindling opportunities for 
protonation of the carbanionic intermediate.  The viscosity of the reaction medium 
changed as the reactants were converted to products, turning from a clear liquid to 
a yellowish paste and finally to a white crusty residue.  The reaction rate and yields 
of the neat aza Michael addition reaction had previously been reported as 
‘inconsistent’ [22].  This  as found not to be the case,  ith a high degree of 
reproducibility for all the neat reactions performed.   
Figure 2.7 also clearly indicates that the reaction did proceed more quickly in  ater 
than in the neat reaction. A 90% yield  as achieved in just 2 min in the  ater 
reaction,  hereas it took 20 min for a 90% yield to be achieved in the neat reaction. 
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As discussed in Section 2.5.2, nucleophilic attack by the amine is rate limiting 
follo ed by stabilization of the carbanionic intermediate.  In  ater, protonation of the 
anion by a  ater molecule is rapid and the rate of reaction does not depend on the 
concentration of the reactants.  In contrast, for the solvent free reaction the rate of 
conversion slo ed do n as the reaction progressed and the amine  as used up (in 
the neat reaction, the amine acts as both the nucleophile and the proton source).  
This demonstrates that in the case of the neat reaction, the rate of reaction does 
depend on the concentration of the amine.  
.  
 
Figure 2.7 Comparison of the rate of conversion of 1PP in reactions carried out 
in water, methanol and solvent free.  All reactions were carried out at 
room temperature with vigorous stirring (800 rpm). 
 
2.5.5   Effect of rate of stirring and temperature on the neat reaction 
The effect of stirring and temperature on the yield of the neat reaction after 20 min is 
shown in Table 2.6.  A small reduction in % conversion was observed for the 300 
and 600 rpm rates. This shows that the physical design of the experiment was also 
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a limiting factor on the conversion; product formed quickly and there was a 
reduction in the amount of contact between the reactants.  As the product formed, 
the reaction mixture changed from a liquid to a thick paste.  Increasing the reaction 
temperature to 50ºC had no impact on the reaction yield,  ith 90% conversion 
achieved after 20 mins, just as  as observed for the room temperature reaction.   
Table 2.6 Comparison of the effect of stirring rate (rpm value of the stirrer) and 
temperature of reactants on the yield of the neat reaction  
Stirring, 
rpm 
Solvent 
(mL) 
Temp. 
ºC 
Time 
(min) 
Molar ratio Yield/% 
800 Solvent-free r.t 20 1:1.5 90.6 
600 Solvent-free r.t 20 1:1.5 86.4 
300 Solvent-free r.t 20 1:1.5 85.9 
800 Solvent-free 50ºC 20 1:1.5 90.6 
 
 
2.5.6 Determination of the effect of molar ratio of reactants on yield 
of neat reaction 
 
Small differences in the ratios of amine to acceptor are reported in various studies 
reported in the literature.  Initially, an experimental design developed from Ranu and 
Banerjee [23], as detailed in Section 2.2.3, using the 1:1.5 mmol ratio of 1PP and 
MA was selected to investigate the neat reaction at room temperature.  It would 
appear from several of the published reports, that for the neat reaction an excess of 
the amine nucleophile had a positive effect on the rate and extent of the reaction 
[28, 49, 62]. To examine the effect of the amine concentration on the rate of the 
neat reaction, the ratio of 1PP to MA was altered as per Table 2.2 in the methods 
section.  The results are shown in Figure 2.9.  All reactions were carried out at room 
temperature, with vigorous stirring (800 rpm).   
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Figure 2.8  Comparison of the effect of molar ratio (1PP:MA) on the yield of the 
neat reaction.  All reactions were carried out at room temperature with vigorous 
stirring (800 rpm) for 2 min before the samples were analysed by UHPLC. 
 
The neat reaction was expected to behave in a similar way to the reactions in 
aprotic solvents i.e. with second-order dependence on the amine.  Increasing the 
concentration of the acrylate to 1.5 and 2 mmol, while keeping the concentration of 
the amine constant, had no effect on the rate of reaction.  However, the amount of 
product formed in 2 minutes increased steadily with the increase in amine 
concentration from 1.5 to 3 mmol, confirming the order is no longer 2nd order overall 
(1st order in each of the reactants) as is the case for the reaction in protic solvents 
[111].  Figure 2.8 demonstrates a zero order dependence on the acrylate and a 
partial order dependence on the concentration of the amine. 
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2.6   Conclusion 
Investigation of the aza Michael addition of 1PP and MA was carried out to examine 
the effects of solvent type and volume. The effect of molar ratio of the reactants in 
the neat reaction was also examined.  The reaction was monitored using a UHPLC 
method capable of detecting reactant and products at low levels.  The UHPLC 
method developed for the reaction monitoring demonstrated excellent reproducibility 
of the sampling and analytical methodologies. 
The main focus of this study was to monitor an aza-Michael reaction in such a way 
as to determine if the reaction could be described as accelerated on-water i.e. 
accelerated by water as has been proposed by other authors.  The rate of reaction 
and % conversion of amine was exceptionally fast for the model reaction in water.  
MeOH also proved a fast reaction medium.  The study demonstrates that while 
water did have a positive effect on the process, the results of the neat reaction and 
those of the reaction in MeOH do not support the theory of an oil-water interface. 
The mechanism of ‘on  ater’ catalysis described in Chapter 1 requires a 
heterogenous mixture to promote acceleration.  While the reaction in water is 
heterogeneous, the reaction in MeOH is not, however the reaction yields were 
comparable for both solvents. 
However, there is a marked difference between the yields of the protic and aprotic 
solvents. The reaction rate was poor for the aprotic solvents ACN and THF.  When 
compared to the neat reaction (90% yield in 20 min) the results for the aprotic 
solvents suggest that the neat reaction did not proceed in the same way i.e. the 
amine was not second order in the neat reaction. A difference in the rate reaction 
was observed between the neat, water and aprotic solvents indicating that the 
mechanism at  ork here  as not the ‘on- ater’ catalysis proposed by Phippen et al. 
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[62] but rather a mechanism of nucleophilic addition and proton transfer to the 
carbanion as proposed by Um. [113]  
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Chapter 3: 
Investigation of the Aza-Michael reactions between amine 
containing pharmaceutical ingredients and acrylate packaging 
constituents in ophthalmic solution formulations 
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3.1 Introduction 
Acrylate monomers are widely used components of UV cured ink and adhesives 
applied to labels for pharmaceutical packaging.[118]  For UV inks and adhesives 
intended for labels applied to low density polyethylene (LDPE) bottles (used for 
ophthalmic solutions), special care has to be paid to potential migrating species like 
acrylate monomers not cross-linked in the formed network. [91, 119]  The 
proprietary nature of ink and adhesive formulation makes it difficult for 
pharmaceutical companies to determine the level of risk associated with each new 
packaging component. Migration of ‘non-intentionally added substances’ [120] from 
food packaging has been the subject of a number of studies by Nerin and co-
workers.[83, 121]  The group have shown that multilayer packaging materials can 
be both the source of unwanted impurities and also an effective barrier against 
migration.[120, 122] The result of a reaction between the active drug substance and 
a leachable may be a reduction in the concentration of the active component of the 
drug, but may also result in formation of new impurities of unknown structure and 
biological effect,  which may lead to adverse effects.[66, 123-125]  It is therefore 
important to be aware of such possible reactions during the drug formulation 
process as well as during drug storage.[126-128]  Whilst there is much literature on 
the aza-Michael reaction in aqueous solutions [55, 129-134], there is little 
information in the literature on the extent of adduct formation from acrylates and 
amines migrating from the final packaging into pharmaceutical formulations.   
Chapter 2 systematically investigated the rate and yield of the aza-Michael addition 
of the model amine containing pharmaceutical ingredient 1-phenylpiperazine (1PP) 
and packaging component methyl acrylate (MA) in various solvents and for the neat 
reaction.  Results indicated that the reaction was indeed optimised by water.  
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Ho ever, it  as noted in published literature that Jenner’s experiments  ith MA in 
water resulted in little or no yield of the ester product when the samples were left 
standing overnight; presumably as a result of ester hydrolysis.[23]  The equilibrium 
of the ester product relative to the acrylic acid product in aqueous buffered solutions 
was therefore investigated in a number of standing experiments.   
The aim of this research was to investigate the viability of the aza-Michael reaction 
between amine containing APIs (using 1PP as a model compound) and acrylates 
from packaging materials under conditions directly applicable to the stability of 
ophthalmic solutions.  The reaction of 1PP and MA was examined in the various 
buffered solutions commonly used in the formulation of ophthalmic solutions e.g. 
phosphate buffered saline (PBS) and boric acid.  The aza-Michael reaction was 
found to occur in both of these ophthalmic solution formulations. Profiling 1PP-MA 
formation in appropriate mixtures provided a deeper understanding of the sensitivity 
of the dynamics of adduct formation, over time, under controlled storage conditions. 
Many of the amine drug substances used in in ophthalmic solutions are poorly 
soluble and are formulated as salts to increase the solubility and bioavailability of 
the API.[135] Additionally, acrylate acids and esters are widely used as reactive 
monomers and diluents in the adhesives and UV cured ink formulations used in 
pharmaceutical labels.  Therefore a comparison of the reactivity of 1PP to that of its 
hydrochloride salt (1PP.HCl) was examined in a reaction with both MA and acrylic 
acid (AA).    It was determined that while the reaction was considerably slower, the 
1PP.HCl salt did participate in aza-Michael addition, and the corresponding adduct 
was detected. It was also demonstrated that both the acrylate ester and acrylic acid 
resulted in the formation of aza-Michael adducts. While adducts were previously 
observed for acrylate esters, this is the first time the adduct has been reported for 
the reaction with acrylic acid. 
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3.2 Experimental 
3.2.1 Chemicals and Reagents 
1-Phenylpiperazine (1PP), 1-phenylpiperazine hydrochloride (1PP.HCl), methyl 
acrylate (MA), ethyl acrylate (EA), methyl methacrylate (MMA), methyl vinyl ketone 
(MVK) and acrylic acid (AA) were purchased from Sigma Aldrich.  Phosphate buffer 
saline powder was purchased from Sigma Aldrich.  Boric acid (ACS Grade) was 
purchased from Applichem. Chemicals for UHPLC and LC-MS analysis were 
obtained as described in Chapter 2 in Section 2.2.1 . 
3.2.2 Buffer Preparation  
Phosphate buffered saline (PBS) 0.01 M, pH 7.4 was prepared by dissolving the 
contents of one pouch of PBS powder (P3813) in 1 L of deionized water. Boric acid 
0.3 M solution was prepared by transferring 1.9 g of boric acid into a 100 mL 
volumetric flask and bringing to volume with deionized water.  Sodium phosphate 
buffer (NaPB), 0.05 M, pH 3.0 was prepared by dissolving 6 g of anhydrous sodium 
dihydrogen phosphate in 1 L deionized of water and adjusting the pH with 
phosphoric acid. 
3.2.3  Sample Preparations 
All reactions were conducted at room temperature (22 - 24ºC) in 20 mL screw-top 
round bottomed test tubes that had been washed in distilled water and air dried. 
Vigorous stirring was performed at 800 rpm on a using a Variomag, Telemodul C 
(Thermo Fischer Scientific, Waltham, MA) stirrer at room temperature. 
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3.2.4 Standard Conditions for aza-Michael Reactions 
The experimental procedure described in Chapter 2 Section 2.2.3 was used to 
prepare all reaction mixtures of 1PP and acrylates. Sample preparation for UHPLC 
analysis was as described in Chapter 2 in Section 2.2.3. 
3.2.5 Determination of the effect of amine salt on yield 
For reactions using the 1PP.HCl amine salt the following was applied; 1 mmol of 
1PP.HCl was accurately weighted and transferred to a 20 mL round bottomed test 
tube containing 2 mL of water. The mixture was vortexed for 30 s to dissolve the 
amine prior to addition of the acrylate acceptor (1.5 mmol).  The reaction mixture 
was stirred vigorously (800 rpm) or left to stand for the prescribed time minutes at 
room temperature.  All standing experiments were protected from light.  After the 
required time, 8 mL of THF was added directly to the reaction mixture.  The test 
tube was capped and shaken vigorously by hand 3-4 times.  Sample preparation for 
UHPLC analysis was as described in Chapter 2 in Section 2.2.3.  Note: The pH of 
the 1PP.HCl solution (prior to the addition of the acrylate) was 4.76. 
Table 3.1  Reactions Conditions for 1PP.HCl with MA and AA 
Acrylate 
(1.5 mmol) 
 Volume H2O,  
mL 
Temp. 
ºC 
Stirring (800 rpm) 
Time/min 
Standing, 
days 
MA  2.0 r.t 5, 20, 60 6 
AA  2.0 r.t 20 6 
 
3.2.6 Determination of the effect of solvent type on yield 
1.0 mL of solvent (water, PBS, boric acid, NaPB) was transferred to the test tube 
containing 1PP prior to addition of the acrylate (MA or AA).  The   1PP was not 
stirred in the solvent prior to addition of the acrylate.  The reaction mixture was 
stirred vigorously (800 rpm) or left to stand for the prescribed time minutes at room 
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temperature.  All standing experiments were protected from light.  Samples were 
prepared for analysis by the addition of 9 mL of THF to the test-tube. Preparation of 
the solvent samples for UHPLC analysis was the same as for the water 
preparations described in Chapter 2 in Section 2.2.3. 
Table 3.2  Reactions Conditions for 1PP with MA and AA in buffered and 
unbuffered solvents 
Acrylate 
Solvent,   
(1 mL) 
pH 
Temp. 
ºC 
Stirring (800 rpm) 
Time/min 
Standing, 
days 
MA Water 5.6 r.t 20 6 
MA PBS 7.4 r.t 20 12 
MA Boric 4.7 r.t 20 12 
      
AA Water 5.6 r.t 20 6 
AA Boric 4.7 r.t 20 12 
AA NaPB 3.0 r.t 20 12 
 
3.2.7 Determination of the effect of Michael acceptor on yield 
1.0 mL of water was transferred to the test tube containing 1PP prior to addition of 
the acrylate/ketone (MA, EA, MMA, MVK or AA).  The   1PP was not stirred in the 
water prior to addition of the acrylate/ketone.  The reaction mixture was stirred 
vigorously (800 rpm) for 20 minutes at room temperature.  Samples were prepared 
for analysis by the addition of 9 mL of THF to the test-tube. Preparation of the 
solvent samples for UHPLC analysis was the same as for the water preparations 
described in Chapter 2 in Section 2.2.3. 
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3.3 Chromatographic Instrumentation and Conditions 
3.3.1  Reaction monitoring using UHPLC 
UHPLC analyses were carried out using a Waters ACQUITY UPLC H-Class system 
(Waters Corporation, Milford, MA, USA) connected to an ACQUITY TUV detector 
(Waters Corporation, Milford, MA, USA).  Data acquisition and integration were 
performed by using the Waters Empower software.  The analytical column was a 
Waters ACQUITY CSH C18 (50 mm × 2.1 mm, 1.7 µm particles) from Waters 
(Waters Corporation, Milford, MA, USA), and it was maintained at 30ºC.   The 
autosampler was held at ambient room temperature.   The column flow rate was set 
to 0.4 mL/min, and the injection volume was 1.0 µL. Detection was performed at 240 
nm. The chromatographic separations were carried out using an isocratic elution.  
Mobile phase consisted of a mixture of 30 mM potassium phosphate buffer pH 2.8: 
acetonitrile (93:7, v/v).  The mobile phase was filtered through 0.22 µm Millipore 
HVLP membrane filters prior to use. 
3.3.2 Liquid Chromatography-mass spectrometry (LC-MS) 
High resolution mass spectrometry was carried out using an Agilent 1260 Ultra 
Performance Liquid Chromatography system coupled with an Agilent 6250 Q-TOF 
(Agilent Technologies, Palo Alto, CA, USA) by electrospray ionization (ESI).  The 
analytical column was a Waters ACQUITY CSH C18 (50 mm × 2.1 mm, 1.7 µm 
particles) from Waters (Waters Corporation, Milford, MA, USA), and it was 
maintained at 30ºC.  The column flow rate was set to 0.4 mL/min, and the injection 
volume was 1.0 µL. Detection was performed at 240 nm. The chromatographic 
separations were carried out using an isocratic elution.  Mobile phase consisted of a 
mixture of 10 mM ammonium formate, pH 2.8: acetonitrile (93:7, v/v). The mobile 
phase was filtered through 0.22 µm Millipore HVLP membrane filters prior to use. 
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Full scan spectra were taken at a cone voltage of 3500 V using positive electrospray 
ionisation (ESI). Full MS conditions can be found in Chapter 2, Section 2.3.2. 
3.4 Results and Discussion 
3.4.1  Reaction of 1PP with MA in Aqueous Solutions 
The formation of acrylate adducts under conditions relevant to the storage of 
ophthalmic solutions was tested by performing the reaction in phosphate buffered 
saline (PBS) and boric acid, two of the most commonly used vehicles in the 
formulation of ophthalmic drug products.  PBS (0.01M, pH 7.4) and boric acid 
(1.9%, pH 4.7) were prepared as per guidelines for the preparation of ophthalmic 
solutions.[136]   There are several reports in the literature of the reaction in both of 
these mediums and as anticipated the conversion of 1PP was very high in both 
solvents [55, 133]. The % conversion of amine in the reaction in PBS was identical 
to that in water after 20 min vigorous stirring.  Yield was marginally lower in boric 
acid (97.7%) but the reaction was faster and higher yielding than those reported by 
Chaudhuri using 0.1 M of boric acid as the reaction medium, where a yield of 90% 
for the reaction between piperidine and MA was achieved in 1.5 hours.[55]   
Table 3.3 Reactions of 1PP with MA in buffered/unbuffered solvents 
Acrylate 
Acceptor 
Solvent, 
(1 mL) 
pH 
Temp. 
ºC 
Stirring  
(800 rpm) 
Time/min 
%Yield 
MA Water 5.6 r.t 20 99.5 
MA PBS 7.4 r.t 20 99.4 
MA Boric 4.7 r.t 20 97.7 
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3.4.2   Effect of Standing Experiments  
To model the conditions under which ophthalmic solution are stored, samples were 
prepared in PBS and boric acid as described in Section 3.2.6 and left to stand at 
room temperature for 12 days.  See Table 3.4 for details. 
Table 3.4 Reaction for the Addition of 1PP to  MA in PBS and Boric Acid, 
12 Day Standing Experiment 
Acrylate 
Acceptor 
Solvent, 
 (1 mL) 
pH 
Temp. 
ºC 
Standing, 
days 
%Yield 
Ratio  
Ester:Acid 
MA PBS 7.4 r.t 12 100 54:46 
MA Boric 4.7 r.t 12 100 79:21 
 
Complete loss of the 1PP amine was noted for each sample following analysis by 
UHPLC.  Ho ever, in addition to the β-amino acid product (MPP) peak, a second 
peak at the retention time of the acrylic acid adduct was observed in the 
chromatogram of each sample.  The mass of the second peak was confirmed by 
LC-MS to be the β-amino acid product.  The ratio of the ester:acid product was 
calculated as a % of the total peak area of both peaks.   
The reactions in PBS and boric acid were assayed after 12 days and indicated that 
hydrolysis of the ester product was greater in the PBS solution.  The hydrolysis 
observed was in agreement with the results of a report in 2000 by Lynn and Langer 
on the degradation of poly–β-amino esters in water and buffer at physiological pH 
[137].  At pH 7.4, ester hydrolysis was complete in less than 5 hours, whereas a ½ 
life of 8 hours was reported at pH 5.1. Reaction products were stored at 37ºC.  
Results of this experiment showed a similar pattern.  In PBS, pH 7.4, the acid 
product accounted for 46% of the total peak area, whereas in the boric acid medium 
(pH 4.7) this was reduced to 21%. Results indicate that in the long term storage of 
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ophthalmic solutions, the acid product would dominate in the event of an interaction 
with acrylate esters.  
3.4.3 Reaction of MA and 1PP Hydrochloride 
A search of Reaxys (version 2.19790) for structures containing the 1PP moiety 
resulted in 218 hits, the majority (212) of which were salts with a protonated 
piperazine ring (by an acid group).  This is not surprising as the secondary nitrogen 
of the piperazine group is basic (estimated pKa 8.30) [110]   
In the aza-Michael reaction the nucleophilicity of the amine is a key factor in the 
viability of the un-catalysed reaction.  As the 1PP.HCl salt is already protonated 
(1PP+) it would be expected to perform poorly as a nucleophile when compared to 
its free base counterpart. To compare the effects on the reactivity of adduct 
formation of amines and their hydrochloric salts, 1PP.HCl was reacted with MA in 
water, initially with vigorous stirring and then in a 6 day standing experiment.  See 
results in Table 3.5 
Table 3.5 Results for the Addition of 1PP and 1PP.HCl to MA in Water 
Amine 
Donor 
Acrylate 
Acceptor 
Water, 
(mL) 
Temp. 
ºC 
Stirring 
(800 rpm) 
Time/min 
%Yield Ratio 
Ester:Acid 
1PP.HCl MA 2 r.t 5 0.5 - 
1PP.HCl MA 2 r.t 20 1.2 - 
1PP.HCl MA 2 r.t 60 2.4 - 
Standing, 
days 
1PP MA 1 r.t 6 99.5 81:19 
1PP.HCl MA 2 r.t 6 43.4 99:1 
 
As expected, the 1 hour experiment resulted in a very low yield, but small increases 
were noted when samples were tested after 5, 20 and 60 min. Reaction mixtures of 
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1PP and 1PP.HCl with MA were prepared left to stand at room temperature for 6 
days.  A modest yield of 43% was observed for the reaction of 1PP.HCl with MA. 
The pH of the reaction mixture of 1PP.HCl in 2 mL water was 4.7.  Since 1PP and 
1PP+ are in equilibrium in water, it might be suggested that the small amount of un-
ionized 1PP present at any one time would be sufficient to undergo the conjugate 
addition reaction. A 1994 study by Domb et al. compared the effects on the 
reactivity of amide formation in amines and their hydrochloric salts in PBS.[6]  The 
pH of the reaction medium proved instrumental in the reactivity of the amines.  The 
Domb study showed that the hydrochloric salts were just as reactive when the pH 
was maintained at 7.4 but at pH 5.0 no reaction took place for either the salt or the 
free base.  
Results from this study illustrated that given sufficient time, enough of the amine 
was available to undergo the reaction with MA.  After 6 days 43% of the product has 
converted to the MA adduct.  Only 1% of the acid hydrolysis product was observed 
in the 1PP.HCl sample in sharp contrast to the free base sample, where almost 20% 
of the ester product had hydrolysed.  Results demonstrated that drug product 
formulation using the HCl salt was no barrier to the reaction of amines in ophthalmic 
solutions. 
3.4.4 Reaction with Acrylic Acid 
Reports on conjugate addition to acrylic acid acceptors are rare. In an enzyme 
catalysed Michael addition of imidazoles and acrylates no products were detected in 
the reaction with acrylic acid in pyridine.[138] α,β-Unsaturated acids were used 
instead of esters in a reaction with thiol nucleophiles in THF at -78C.  The resulting 
reaction products were a mix of alpha (anti-Michael) and beta substituted 
products.[139]  With a pKa of 4.25, AA is predominantly ionized in water and the 
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activation of the carbon-carbon double bond would be supressed when compared to 
the esters and ketone acceptors [140, 141].  However, the occurrence of acrylic acid 
adducts in our in-house laboratory investigations are not uncommon.  It is 
hypothesised that the acrylic acid adducts observed are in fact the result of a 
reaction with an acrylate ester followed by  hydrolysis of the ester product as 
discussed in section 3.4.2. Further investigation into the reaction with acrylic acid 
over extended periods of time was carried out and results are given in Table 3.6.  
To investigate whether AA was more reactive at lower pH where the un-ionized form 
was more prevalent, samples were prepared in boric acid and in a sodium 
phosphate buffered solution (pH 3.0). 
Table 3.6 Reactivity of 1PP and IPP.HCl with Acrylic Acid in Various 
Aqueous Solutions 
Amine 
Donor 
Acrylate 
Acceptor 
Solvent  Solvent 
(mL) 
Stirring 
(800 rpm) 
Time/min 
%Yield 
1PP AA Water 1 20 4.8 
1PP AA PBS 1 20 3.7 
1PP AA Boric 1 20 2.2 
    Standing, 
days 
 
1PP AA Water 1 6 90.4 
1PP.HCl AA Water 2 6 25.8 
      
1PP AA Boric 1 12 86.3 
1PP AA pH 3.0 1 12 86.0 
 
As seen in Table 3.6, for the 20 minute experiments, a poor yield for the reaction 
with acrylic acid in water was observed, which was not unexpected as acrylic acids 
are generally less active Michael addition partners [142].  The results indicate that of 
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the aqueous solutions examined, water gave the highest yields for the 20 min 
stirring experiment, though yields were extremely low when compared to the 
reaction with MA. However, over extended time periods, a significant yield of adduct 
was observed for all 1PP interactions, with the 6 day standing experiment in water 
yielding 90% AA adduct.  The reactions in boric acid and phosphate buffer pH 3.0 
both yielded slightly less, with 86% loss of amine after 12 days standing.  This was 
surprising as at the lower pH, it was supposed that a greater proportion of AA would 
be in the un-ionized form and therefore more reactive.  For aza donors, it would 
appear that the impact of acidic catalysis is double edged; while acid may favour the 
activation of the carbonyl, an excess might completely consume the nucleophilic 
amine, by protonation.  Once again, the effect of equilibration on standing was 
evident with 25% loss of amine in the reaction with the 1PP hydrochloride salt.  The 
identical reaction using MA as the acceptor yielded 43%. For amines stored with AA 
for periods of approx. one week and longer, it can be concluded that aza-Michael 
addition is a realistic possibility. 
3.4.5  Effect of Michael Acceptor on Yield 
Schultz and Yarbrough proposed that the different configurations of the of α,β -
arrangement of the olefin and the carbonyl moieties can affect their reactivity with 
nucleophiles [143].  Reaction kinetics and the role of the acceptor in the nucleophilic 
addition of amines to a variety of olefins were discussed in two early studies by 
Friedman and Wall [125, 144]. 
A comparison of the reaction of 1PP with a number of acrylic esters, MVK and AA is 
reported in Table 3.7. Their structures are illustrated in Figure 3.1.  All reactions 
were performed at room temperature in 1 mL of water.  The reaction of 1PP with 
MMA and AA gave low yields, with less than 5% of the amine converted in 20 mins.   
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Methyl Acrylate (MA) Ethyl Acrylate (EA) Methyl Vinyl Ketone (MVK) 
 
 
Methy methacrylate (MMA) Acrylic Acid (AA) 
 
Figure 3.1 Chemical Structures of α, β-unsaturated compounds investigated to 
examine the effect of Michael acceptor on yield. 
 
Table 3.7 Reactivity of 1PP with Various α,β-Unsaturated Compounds in 
Water  
Acceptor 
 
Time, min % Yield 
 
Methyl acrylate (MA) 20 99.06 ± 0.6 
Methyl vinyl ketone (MVK) 20 98.73 ± 0.2 
Ethyl Acrylate (EA) 20 96.06 ± 0.8 
Methyl Methacrylate (MMA) 20 4.96 ± 1.4 
Acrylic Acid (AA) 20 4.80  ± 0.6 
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There was no significant difference noted between the reactivity of 1PP with MA and 
MVK. These results are in agreement with those of Ranu and Banerjee; who using a 
similar protocol reported 90% yield for MVK and 95% yield for MA in the reaction 
with pyrrolidine in water [22].  Several studies into the reactivity of olefins rate MVK 
as being more reactive than its acrylate counterpart, MA [128, 144, 145].  It is 
proposed that the polarising effect of the carbonyl oxygen is responsible for the 
activation of the β-carbon, and dilution of this charge by the second oxygen of the 
acetate group can lower the reactivity of the esters[48]. In the enzyme catalysed 
Michael addition of imidazoles with acrylates and acrylic acid in pyridine, Cai et al. 
reported that the yield decreased with increasing chain length of acceptor; methyl, 
ethyl and n-butyl acrylate gave yields of 76, 65 and 62% respectively[138]. 
However, in this present study, increasing chain length of the alkyl group of the 
ester from did not change the reactivity significantly with yields of 99 and 96% 
recorded for the methyl and ethyl acrylates respectively.  
3.4.5.1  Substitution at the α-carbon 
In the aza-Michael reaction, the reactivity of the electrophile depends on the ability 
of the carbonyl group to stabilise the negative carbanionic intermediate by either 
inductive or resonance effects.[143]  Substitution at the α-carbon as in the case of a 
methacrylate results in a tertiary carbanionic intermediate.  Since tertiary carbanions 
are known to be less stable than their secondary counterparts, the reactivity of MMA 
would be expected to be slower than the corresponding rate with MA on purely 
electronic grounds.[144]  In the case of the reaction with amine nucleophiles such 
as pyrrolidine and morpholine, the zwitterionic nature of the intermediate is the 
same for all intermediates i.e. follo ing addition of the nucleophile the β-carbon is 
cationic for all electrophiles in the series, therefore it is the stability of the 
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carbanionic intermediate that governs the reaction order, with resonance effects 
more important than inductive.[117] Results of this experiment are in agreement 
with previous studies. As illustrated in Table 3.7, a 20-fold difference in reactivity 
between the slowest (methyl methacrylate) and the fastest reacting ester (MA) was 
observed. 
3.5 Conclusions  
The reactivity of 1PP with various olefins, typically found in packaging components, 
in aqueous solutions was examined.  Results were in agreement with the literature 
for MVK, EA and MMA. MA, MVK and EA all resulted in over 95% adduct yield after 
just 20 minutes. In contrast, MMA and AA resulted in less than 5% adduct formation 
after 20 min. Nonetheless, this result was highly significant, as the reaction between 
1PP and AA has not previously been reported in the literature.  AA was poorly 
reactive in water at room temperature, however 90% conversion of the 1PP amine 
was observed in a 6 day standing experiment using water as the reaction medium.  
The same experiment carried out in boric acid and sodium phosphate buffer (pH 
3.0) over 12 days was less reactive than in water, but nonetheless resulted in 86% 
loss of amine.   
Results of the investigation into the reactivity of the 1PP.HCl salt showed a similar 
pattern to that of AA; initial reaction was slow with only 2.2% yield after 1 hour but 
after standing for 6 days at room temperature a 43% loss of the amine was 
observed in the reaction with MA and 26% loss in the reaction with AA.   
Investigation of the aza-Michael addition of 1PP and MA was carried out in aqueous 
solutions of boric acid and PBS to examine the effect of pH on the stability of 
adducts at different pH.  As expected, the β-amino ester products were highly 
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susceptible to hydrolysis at higher pH.  Hydrolysis of the ester adduct in PBS was 
double that of boric acid when stored at room temperature for 12 days. 
Overall, the results demonstrate that the viability of the aza-Michael reaction 
between acrylates migrating from drug packaging and amines present in ophthalmic 
solutions.  Both of the ophthalmic buffers investigated proved to be an excellent 
reaction medium.  Neither the amine salt nor the poorly reactive acrylate acid 
prevented the formation of adducts under conditions of longer term storage.  
Therefore, this study raises a concern regarding the interaction between amine 
drugs and acrylate leachables in ophthalmic solutions. 
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Chapter 4: 
Application of statistical experimental design to the 
development of a UHPLC method for the simultaneous 
quantification of brimonidine tartrate, timolol maleate and 
related substances in ophthalmic solution 
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Abstract 
It cannot be assumed that the impurity profile of a combined drug product is simply 
the sum of the impurities of the individual active pharmaceutical ingredients (APIs). 
HPLC analysis of APIs brimonidine tartrate (BMT) and timolol maleate (TIM) in 
samples of a new combined drug product highlighted the appearance of an aza-
Michael adduct; formed by an interaction between the amine BMT and the maleate 
salt of TIM under routine stability storage.  An accelerated stability study was carried 
out at elevated temp and humidity (40ºC/75RH) to investigate the new impurity 
profile.  A second adduct was also detected during the accelerated study which was 
identified as an acrylic acid adduct of the BMT amine. The two new aza-adducts 
eluted at the same retention time and were poorly resolved using the existing HPLC 
drug product method.   Accurate quantification of the new adducts required 
development of a new stability indicating method that was capable of resolving the 
known impurities of the API and the new adducts.  Simultaneous quantitation of 
BMT, TIM and their impurities in a single method was desirable from a quality 
perspective as the combined product is a top tier product in our laboratory.    The 
existing HPLC assay has a runtime of 65 min per injection and as the mobile phase 
contains an ion-pairing reagent, column equilibration can take several hours before 
system suitability can be established. The aim of this chapter was to develop a fast 
UHPLC method for the simultaneous quantitation of BMT, TIM and their related 
substances.  Relative response factors (RRF) values for the aza-Michael adducts 
(RS5 and RS9) were calculated using qualified reference standards by calculating 
the ratio of the responses of the impurities to the response of the BMT drug 
substance at 264 nm. 
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Brimonidine Tartrate (BMT) Related Substance 1 (RS1) 
 
 
Related Substance 5 (maleate adduct) Related Substance 9 
(acrylic adduct) 
 
 
Timolol Maleate (TIM) Related Substance TIM2 
 
Fig. 4.1  Chemical structures of the investigated substances. 
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4.1 Introduction 
4.1.1. Combined Ophthalmic Drug Products 
The eye contains a clear, watery liquid (aqueous humor) that nourishes the inside of 
the eye. Glaucoma occurs when an imbalance in production and drainage of fluid in 
the eye leads to an increase in intraocular pressure (IOP).  Left untreated, glaucoma 
results gradual loss of the visual field, and can permanently damage the optic 
nerves and eventually lead to blindness.[146, 147]  A 1996 study by Quigley 
estimated that glaucoma is the second leading cause of blindness globally, with 
50% of sufferers in the developing world unaware that they are suffering from the 
condition. [148]  
Treatment of glaucoma frequently requires self-administration of multiple 
medications at different times during the day. Due to a lack of symptoms, especially 
in the early stages of the disease, successful treatment of glaucoma requires a high 
level of commitment on the part of the patient as there is little positive feedback for 
adhering to the daily dosing regimen.  Studies into patient compliance in glaucoma 
have shown that a simple regimen with less frequent administration could promote 
compliance. [149, 150]   For patients who require more than 1 medication for IOP 
control, fixed combinations of drugs are more convenient than the concomitant use 
of the separate components. Other advantages include elimination of potential wash 
out effects, cost savings and the use of a combination product can also decrease 
the patient's daily ocular exposure to preservatives. Multi-dose ophthalmic solutions 
require the addition of antimicrobial preservatives such as benzalkonium chloride, 
which can be poorly tolerated by some patients. 
Combigan (brimonidine tartrate/timolol maleate) 0.2%/0.5% was approved by the 
FDA in 2005 for the reduction of elevated IOP in patients with glaucoma or ocular 
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hypertension who require adjunctive or replacement therapy due to inadequately 
controlled IOP. A twice daily dose of the combined drug formulation was found to be 
superior to an individual daily dosing regimen of BMT and TIM and was better 
tolerated than BMT alone.[151]  Use of the combination product twice daily results 
in a daily ocular exposure to preservative that is one third of that associated with the 
use of both component drugs twice daily.[152] 
Timolol Maleate (TIM) (-)-1 - (tert-butylamino)-3- [(4-morpholino-l, 2, 5-thiadiazol-3-
yl)-oxy]-2- propanol. Maleate, (Fig. 4.1) is a beta-adrenergic blocker that reduces 
IOP by decreasing the production of aqueous humour by the ciliary epithelium.[153] 
Brimonidine tartrate (BMT) [5-bromo-6-(2-imidazolidinylideneamino) quinoxaline    
L-tartrate] (Fig. 4.1) is an alpha-adrenergic receptor agonist, that reduces IOP by 
both decreasing aqueous production and increasing outflow. [154, 155]  
Several analytical methods have been reported in the literature for determination of 
BMT and related substances. In European Pharmacopeia, HPLC chromatographic 
methods have been described for individual determination of both BMT and TIM and 
their related substances in the drug substance.[156, 157]  A stability indicating 
method using hydrophilic interaction liquid chromatography (HILIC) was developed 
to assay BMT bulk drug powder.  No degradation of BMT was observed following 
acid, base, peroxide and photo-stressing of the drug powder.[158] However, a 
forced degradation study of BMT in ophthalmic solution by Ali et al., showed BMT to 
be susceptible to acid, base, peroxide oxidation and photolysis.  In solution the drug 
was particularly vulnerable to light stress with rapid degradation observed.[159] 
However, no details were given of the nature of the degradation products observed 
in either study.   
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An supercritical fluid chromatography (SFC) method for the quantitation of the (R)-
enantiomer in (−)-(S)- timolol maleate raw material resolves TIM enantiomers from 
the impurities specified in the European Pharmacopeia.[160]  Several HPLC 
methods are reported for the simultaneous determination of TIM in both 
pharmaceutical and physiological fluids.[161, 162] A combined assay and related 
substance method quantitates TIM, latanoprost, benzalkonium chloride and related 
substances in the presence of their degradation products in ophthalmic solution.  
The method uses a gradient elution to separate the two APIs, preservative and 3 
known impurities in 55 min.[163]  An extensive survey of literature revealed that 
there is only one HPLC method reported for the simultaneous analysis of BMT and 
TIM.[164]  The method is applied only for the analysis of drug substance in a 
nanoparticle formulation, is not stability indicating and does not quantitate the 
related substances of either API or additional impurities arising from the 
combination product. Therefore there is a need to develop a method to meet these 
requirements.  
4.1.2 Design of Experiment 
Conventionally, method development is carried out by varying one parameter while 
keeping the rest at a target level and then examining the effect of this single change 
on method performance.  The one factor at a time approach (OFAT) is often 
sufficient when developing methods for a single analyte with one or two well 
characterised impurities. This approach becomes very time consuming and 
therefore costly as the number of factors increase.  In addition, OFAT does not 
allow for interactions between different factors.[165] The simultaneous analysis of 
combination products containing t o or more API’s of differing polarities, their 
respective impurities and potential reaction products places a high demand on the 
developer and requires a more controlled approach. 
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Design of Experiments (DOE) describes a range of experimental techniques in 
 hich the process is ‘experimented on’ in a controlled manner and the results 
observed and analysed.  The aim is to identify the most important inputs to the 
process and to understand their effect on the process output.  A good design 
enables all the factors to be investigated at the same time with the minimum number 
of trials. [165] DOE is closely tied to the quality by design (QbD) approach 
championed by regulatory agencies such as the FDA, and ICH.[89, 166]  Several 
overviews of the application of DOE and QbD principles to analytical method 
development and validation have been provided by Rozet et al.[167] Molnar [168] 
and Wang et al. [169]  The DOE approach is very useful when applied to elements 
of a method that are subject to a great deal of variation such as sample preparation 
and pre-concentration using microextraction, solid phase extraction (SPE) 
supercritical fluid extraction (SFE) techniques.[170-173]  Recent examples of the 
use of DOE to screen for main effects and optimisation using chromatography 
simulation software include the separation by HPLC of lercanidipine and its three 
impurities using Drylab [174]; screening of 12 columns using factorial design 
followed by method optimisation to separate 16 peaks in a UHPLC method for 
multiple API’s.[175] 
The aim of this chapter was to develop a simple, rapid and precise UHPLC method 
for the simultaneous determination of BMT, TIM and their impurities; including two 
newly identified aza-Michael adducts, one of which was generated due to the 
combination  of BMT and TIM in a single solution.  A two-step strategy for method 
development and optimisation was used and involved the use of Minitab statistical 
software to determine the factors which had the greatest effect on the resolution of 
critical pairs of impurities and any possible interactions between factors.  Once initial 
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method conditions were found, Drylab modelling software was used to optimise the 
final method, which also resulted in an 88% reduction in runtime.  
The method was validated in accordance with the current USP Category I for BMT 
and TIM and Category II for impurities.[176] The validation also meets all the 
requirements under the ICH Q2 (R1) guidelines.[177] 
4.2 Materials and Methods 
4.2.1 Materials  
Ammonium acetate anhydrous (ACS reagent grade) and glacial acetic acid (HPLC 
Grade) were purchased from Sigma Aldrich.  HPLC grade acetonitrile and methanol 
were purchased from Merck.    Deionized water, purified to a resistance of greater 
than 18 MΩ,  as obtained from a Millipore Corporation Milli-Q system, Millipore 
(Bedford, MA, USA).   Brimonidine Tartrate (BMT), Timolol Maleate (TIM), and all 
related substances were provided by the Allergan Reference Standard Laboratory, 
Westport, Ireland.  Combigan aged samples were provided by Allergan, Westport, 
Ireland. All other chemicals were of analytical grade and were used without further 
purification.  
4.2.2 UHPLC Equipment and Chromatographic Conditions 
UHPLC analyses were carried out using a Waters ACQUITY UHPLC H-Class 
system (Waters Corporation, Milford, MA, USA) connected to an ACQUITY TUV 
detector (Waters Corporation, Milford, MA, USA).  Data acquisition and integration 
were performed by using the Waters Empower software.  The analytical column was 
a UHPLC Column: ACE, Excel 2 C18, Column Part# EXL-101-1002U (100 mm × 
2.1 mm, 2 µm particles) and Ace Excel UHPLC Pre-column Filter (Waters Acquity 
System Compatible) Part # EXL-PCF10/ACQ from ACE (Advanced 
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Chromatography Technologies Ltd., Aberdeen, Scotland), and it was maintained at 
either 30ºC or 40ºC.  The auto-sampler was held at room temperature.   UV 
Detection was performed at 264 nm. The chromatographic separations were carried 
out using a gradient elution.  Mobile phase A consisted of 50 mM Ammonium 
Acetate Buffer, with pH adjusted to 4.0, 4.5 or 5.0 (as per Table 4.1).  Mobile phase 
B: methanol (MeOH) or ACN (ACN).  The mobile phase was filtered through 0.22 
µm Millipore HVLP membrane filters prior to use.  A linear gradient was run from 4 
to 44% mobile phase B in 10 minutes, followed by a 5 minute equilibration at 4% 
mobile phase B.  Flow rates were 0.4, 0.45 and 0.5 mL/min (as per Table 4.1).   
 
4.2.3 Methods 
4.2.3.1 Standards and Sample Preparation 
A standard solution containing BMT and TIM was prepared with water as solvent 
and protected from light by use of amber glassware. Final dilution was made in 
water and contained 0.008% (w/v) BMT and 0.02% (w/v) TIM (as free base).   This 
working standard solution was used in all screening and optimization experiments.  
In addition, an aged Combigan sample spiked with approximately 0.2% (w/w) of 
BMT Related Substance 1 (RS1) and 0.2% (w/w) BMT acrylic adduct (RS9) was 
prepared by diluting 2 mL of sample into a 50 mL amber volumetric flask.  The aged 
sample contained BMT maleate adduct (RS5), BMT Related Substances 8 (RS8) 
and 10 (RS10) and TIM Related Substance 2 (TIM2), at concentrations high enough 
for quantitation. These solutions were used in the method optimization experiments.  
Studies on the stability of the APIs and impurities found that the standard and 
sample solutions were stable for 7 days when stored at ambient laboratory 
temperature in amber glassware. 
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4.2.3.2 Fractional Factorial Design Experimental Design 
A half fractional factorial  design experimental design was employed to evaluate the 
effects of five independent factors, namely flow rate of the mobile phase, mobile 
phase pH, column temperature, injection volume and the organic component of 
mobile phase B (MeOH or ACN) on the peak resolution between critical pairs and 
the symmetry factor of TIM (USP tailing).  Table 4.1 shows the different levels for 
the selected chromatographic factors and their studied responses.   
Table 4.1 Chromatographic factors and response variables for Fractional 
Factorial Design experimental design. 
Chromatographic factors Levels Used 
 Low Mid High 
    
Flow Rate, mL/min 0.4 0.45 0.5 
pH 4.0 4.5 5.0 
Column temperature, ºC 30 35 40 
Injection volume, µL 3 4 5 
Organic Solvent MeOH - ACN 
    
Response Goal   
USP tailing TIM Minimise < 1.5  
USP Resolution of Critical Pair(s) Maximise > 1.5  
1. RS1 & RS5 (maleate adduct)    
2. RS5 & TIM2    
3. RS9 (acrylic adduct) & BMT    
4. RS8 & RS10    
 
For the four continuous variables, experimental conditions were established on two 
levels (low and high) according to the half fractional factorial design. The fifth 
component, organic solvent in mobile phase B is a categorical input and is entered 
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as a text ‘methanol or acetonitrile’ variable.  A centre point  as entered for each of 
the numerical factors (pH, temperature, flow rate and injection volume) at the mid-
point level to detect non-linear effects.  As the organic solvent is a categorical input 
(either MeOH or ACN) and it is not possible to set the midpoint between 2 different 
types, Minitab created 2 different centre points (where all the factors are at their 
mid-points) – one for each type of solvent.   
A set of 25-1 = 16 experiments was carried out to determine the factors that made the 
most important contribution to the selectivity and resolution of the related 
substances and to the tailing factor of the TIM peak. The central points added 
another 2 experiments to the design.  Table 4.2 gives details of all 18 runs.  The 
following conditions were fixed for each of the experiments:   
gradient run time (tG) = 10 minutes, concentration of aqueous buffer, 50 mM. 
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Table 4. 2  Fractional Factorial Design to identify significant experimental 
parameters affecting resolution of critical pairs and tailing factor of 
TIM  
Run # MP B pH 
Column 
Temp, ºC 
Flow 
Rate, 
mL/min 
Injection 
Volume, µL 
1 MeOH 5.0 30 0.4 3.0 
2 MeOH 5.0 30 0.5 5.0 
3 MeOH 5.0 40 0.5 3.0 
4 MeOH 5.0 40 0.4 5.0 
5 ACN 5.0 40 0.5 5.0 
6 ACN 5.0 40 0.4 3.0 
7 ACN 5.0 30 0.5 3.0 
8 ACN 5.0 30 0.4 5.0 
9 ACN 4.0 30 0.4 3.0 
10 ACN 4.0 30 0.5 5.0 
11 MeOH 4.0 30 0.5 3.0 
12 MeOH 4.0 30 0.4 5.0 
13 MeOH 4.0 40 0.4 3.0 
14 MeOH 4.0 40 0.5 5.0 
15 ACN 4.0 40 0.4 5.0 
16 ACN 4.0 40 0.5 3.0 
Centre points 
17 MeOH 4.5 35 0.45 4.0 
18 ACN 4.5 35 0.45 4.0 
 
 
 
151 
 
The screening experiments were conducted using the Waters H-Class UHPLC 
system with a quaternary solvent manager, which can be programmed using Waters 
Empower software to control up to 4 different mobile phase combinations. In this 
study, samples were screened with MeOH/buffer and ACN/buffer as mobile phases. 
Because the compounds of interest are ionic, pH control of mobile phase buffers 
was essential. For each mobile phase combination, a 10 min short scouting gradient 
was run. Temperature, injection volume and flow rate are all programmable; the first 
16 runs were queued on and run sequentially by Empower, followed by the final two 
runs for the mid-point buffer pH 4.5.  Total analysis time for the 18 injection sets was 
2.5 days. 
4.2.3.3 Optimisation by Drylab Response Surface Design 
The screening experiments were followed by optimization of chromatographic 
performance using DryLab modelling software.  The peak retention times and areas 
from the pH and column temperature experiments were exported from Empower 
into DryLab for analysis.  Based on the retention data, the software simulates and 
predicts separations for a large number of variations in chromatographic conditions 
such as gradient, column dimension, and flow rate without running additional 
experiments.[178]   
4.2.4  Software 
Statistical analysis was performed using Minitab 15, purchased from Minitab Inc. 
(State College, PA, USA).  DryLab, version 4, chromatography modelling software 
package, purchased from Molnar-Institute (Berlin, Germany) was used for screening 
and optimization of gradient time, temperature, and pH.  
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4.3  Results  
4.3.1 Screening of method factors using Fractional Factorial 
experimental design 
A half-fraction factorial design was used in a preliminary screening study to 
determine the main effects of five independent factors affecting the peak resolution 
of 4 critical pairs of impurities and USP tailing of the TIM peak (Table 4.1).  Centre 
points were selected for each of the continuous variables resulting in an 18 run-
experimental set (Table 4.2).  The experiments  ere run in a single ‘block’ using the 
same column, UHPLC system and mobile phases to minimise the effect of variation 
over time. The results for each experiment are shown in Table 4.3.  USP resolution 
and tailing factors were generated using Waters Empower software.  A result of 
zero was recorded for impurity peaks that had either fully co-eluted or where more 
than half of one peak was no longer visible. 
 Analysis was performed using Minitab statistics software to determine which factors 
are statically significant i.e. there is a relationship (correlation) between the factor 
and the response.  From the results, a main effects plot, interaction plot and Pareto 
chart (not shown) were generated for each of the five pre-defined responses.   The 
main effect and interaction plots (disussed in Sections 4.3.1.1 and 4.3.1.2) provide 
an immediate visualisation of the factors that have a significant effect on the 
response.   
To determine if the pattern is statistically significant, multivariate regression analysis 
was performed using Minitab and a summary of the effect and probability values (p-
value) for each factor are shown in Tables 4.4.-1 and 4.4-2. The effect value is the 
average effect of moving a particular factor from its low to high setting.  P-values 
range from 0 to 1; the smaller the p-value the greater the statical significance of the 
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effect.  For example, p-values of < 0.05 indicate that there is a 95% probability that 
the effect is genuine i.e. not a chance or random event.[179] 
Table 4.3 Fractional Factorial Design and Response Results  
 
      Resolution Tailing 
# MP B pH 
Temp 
(ºC) 
Flow 
(mL/min) 
Inj. Vol 
(µL) 
RS9 
/BMT 
RS5 
/RS1 
TIM2 
/RS5 
RS8 
/RS10 
TIM 
1 MeOH 5.0 30 0.4 3.0 3.3 1.4 12.9 4.6 1.4 
2 MeOH 5.0 30 0.5 5.0 3.2 0 13.5 4.5 1.5 
3 MeOH 5.0 40 0.5 3.0 2.6 1.8 14.7 3.5 1.4 
4 MeOH 5.0 40 0.4 5.0 2.7 1.4 16.3 3.5 1.7 
5 ACN 5.0 40 0.5 5.0 5.0 1.2 12.8 1.1 1.8 
6 ACN 5.0 40 0.4 3.0 6.7 1.2 13.5 1.1 1.5 
7 ACN 5.0 30 0.5 3.0 5.5 0 9.2 1.2 1.5 
8 ACN 5.0 30 0.4 5.0 5.5 0 9.2 1.2 1.7 
9 ACN 4.0 30 0.4 3.0 0 0 2.5 0 1.4 
10 ACN 4.0 30 0.5 5.0 0 0 2.4 0 1.7 
11 MeOH 4.0 30 0.5 3.0 0 6.9 0 1.5 1.4 
12 MeOH 4.0 30 0.4 5.0 0 5.4 1.4 1.5 1.5 
13 MeOH 4.0 40 0.4 3.0 0 5.0 0 0 1.5 
14 MeOH 4.0 40 0.5 5.0 0 4.2 0 0 1.6 
15 ACN 4.0 40 0.4 5.0 0 0 2.0 1.1 1.8 
16 ACN 4.0 40 0.5 3.0 0 0 1.5 0 1.5 
17 MeOH 4.5 35 0.45 4.0 0 4.8 2.5 1.3 1.47 
18 ACN 4.5 35 0.45 4.0 1.8 2.6 0 0 1.61 
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4.3.1.1 Main Effect Plots 
The main effect plots for each of the responses are shown in Figures 4.2 to 4.6.  A 
summary of the effects is provided for each plot.  The effect of an input factor is 
calculated by subtracting the average result for when the factor is low from the 
average result when the same factor is high.  For each plot the slope of the line 
indicates whether or not there is main effect present.  When the line is not level, 
then there is a main effect present.  The steeper the slope of the line, the greater 
the magnitude of the effect.  When the line is horizontal there is no main effect 
present; each of the high and low levels of the factor affect the response in the 
same way and the response mean is the same across all the factor levels.   
 
 
Figure 4.2 
The average resolution 
between RS9 and BMT 
increased from 0 to 4 
when the pH was 
increased from 4.0 to 
5.0.  The steep slope 
indicates that pH is the 
most significant factor. 
Resolution also 
increased from 1.46 to 
2.82 when ACN was 
used as the solvent. 
The temperature, 
injection volume and 
flow rate were not 
significant factors in the 
resolution of RS9 and 
BMT.   
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Figure 4.3 
The average resolution 
between peaks RS5 
and RS1 increased 
from 0.3  to 3.2 when 
ACN was used as the 
solvent.  In contrast to 
the other impurities, the 
main effect plot shows 
the average resolution 
decreased from 2.7 to 
0.8 when the pH was 
increased from 4.0 to 
5.0.  The temperature, 
injection volume and 
flow rate were not 
significant factors in the 
resolution of RS5 and 
RS1  
 
Figure 4.4 
The average resolution 
between peaks TIM2 
and RS5 (maleate 
adduct) increased from 
0 to 12 when the pH 
was increased from 4.0 
to 5.0. The solvent, 
temperature, injection 
volume and flow rate 
were not significant 
factors in the resolution 
of TIM2 and RS5.  The 
mean resolution for all 
factors bar pH is high at 
approx. 7.   
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Figure 4.5 
The average resolution 
between RS8 and RS10 
increased from 0.6 to 
2.4 when the pH was 
increased from 4.0 to 
5.0. Resolution 
decreased from 2.4 to 
0.6 when ACN was 
used as the solvent 
and was reduced to a 
lesser extent when the 
temperature was 
increased from 30 to 40 
ºC. The injection 
volume and flow rate 
were not significant 
factors in the resolution 
of RS8 and RS10 
  
 
Figure 4.6 
The average tailing for 
TIM increased from 
1.45 to 1.65 when the 
injection volume was 
increased from 3 to 5 
µL. Tailing also 
increased from 1.45 to 
1.6 when ACN was 
used as the solvent and 
increased to a lesser 
extent when the 
temperature was 
increased from 30 to 40 
ºC.  The pH and flow 
rate were not significant 
factors in TIM tailing. 
 
 
4.3.1.2  Interaction Plots 
The interaction plot is used to view the interactions between factors.  If the lines on 
the interaction plot are not parallel, this indicates that an interaction exists.  The 
greater the difference in slope between the lines, the higher the degree of 
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interaction.  The interaction plots for the resolution of 3 pairs of impurities are shown 
in Figures 4.7 to 4.9.  No interactions were observed for the resolution of TIM2/RS5 
and TIM tailing. 
 
Figure 4.7 
The plot for RS9 and BMT 
indicates an interaction the 
pH and the choice of 
solvent. The resolution is 
higher for both solvents 
when the pH is increased 
from 4.0 to 5.0.  However, 
it appears that the 
difference in resolution 
between runs is more 
pronounced for ACN at the 
higher pH. In order to get 
the highest resolution for 
this critical pair, results 
suggest that the pH is set 
to 5 and ACN is used as 
mobile phase B. 
 
Figure 4.8 
The plot for RS5 and RS1 
indicates an interaction the 
pH and the choice of 
solvent. The resolution is 
higher for MeOH for both 
pH 4.0 and 5.0.  ACN does 
not reach minimum 
resolution for either pH. 
MeOH does achieve 
minimum resolution at pH 
5.0 but it is not fully 
resolved and further 
optimisation will be 
required. 
54
6
5
4
3
2
1
0
pH
M
e
a
n
meoh
acn
Solvent
Interaction Plot for Resolution RS5 RS1
Data Means
5 4 
6 
5 
4 
3 
2 
1 
0 
pH 
M
 e a
 n 
meoh 
acn 
Solvent 
Interaction Plot for Resolution RS9 BMT 
Data Means 
158 
 
 
Figure 4.9 
The plot for RS8 and 
RS10 indicates an 
interaction the pH and 
the choice of solvent. 
The resolution is higher 
for both solvents when 
the pH is increased 
from 4.0 to 5.0.  
However, the difference 
in resolution between 
runs is more 
pronounced for MeOH 
at the higher pH.  In 
order to get the highest 
resolution for this critical 
pair, results suggest 
that the pH is set to 5 
and MeOH is used as 
mobile phase B.  
 
4.3.1.3 Statistical Significance of the Main Effects and Interactions 
While the main effect and interaction plots provide an immediate visualisation of 
which factors are important in the study, they do not show whether the effect is 
significant or not.  Multivariate regression analysis was performed for each response 
using Minitab. Probability values (p-values) of less than 0.05 indicate that the effect 
is ‘significant’ or true and not simply a matter of chance.  The effect for each of the 
significant results is also shown.  Effects are either positive or negative. Results are 
provided in Tables 4.4-1 and 4.4-2 for each of the 5 responses. 
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Table 4.4-1 Regression coefficients and associated probability values (p-value) 
for peak resolution  
 
Term RS9 and BMT  RS5 and RS1  TIM2 and RS5 
 Effect 
p-
value 
 
Effect 
p-
value 
 
Effect p-value 
pH  4.29   0.019  -1.81 0.092  11.57 0.032 
Temperature - 0.695   0.685  - 0.283 
Flow rate - 0.325   0.934  - 0.567 
Injection volume - 0.360   0.316  - 0.610 
Solvent  1.40 0.055  -2.85 0.055  - 0.350 
pH x temp. - 0.695   0.181  - 0.190 
pH x flow - 0.325   0.576  - 0.960 
pH x Inj. vol. - 0.360   0.829  - 0.962 
pH x solvent 1.36 0.061  2.40 0.070  - 0.150 
Temp. x flow - 0.363   0.869  - 0.752 
Temp. x Inj. vol. - 0.390   0.551  - 0.962 
Temp. x Solvent - 0.305   0.335  - 0.603 
Flow x Inj. vol. - 0.305   0.454  - 0.606 
Flow x Solvent -    0.893  - 0.857 
     0.307  - 0.567 
 
 
Table 4.4-2 Regression coefficients and associated probability values (p-value) 
for peak resolution and USP Tailing of Timolol 
 
Term RS8 and RS10  TIM Tailing 
 Effect p-value 
 
Effect p-value 
pH  2.07 0.036  - 0.540 
Temperature - 0.132  0.09 0.048 
Flow rate - 0.436  - 0.889 
Injection vol. - 0.476  0.20 0.022 
Solvent  -1.64 0.043  0.12 0.035 
pH x temp. - 0.670  - 0.540 
pH x flow - 0.496  - 0.889 
pH x Inj. vol. - 0.452  - 0.433 
pH x solvent -1.19 0.063  - 0.262 
Temp. x flow - 0.476  - 0.690 
Temp. x Inj. vol. - 0.425  - 0.168 
Temp. x Solvent - 0.101  - 0.262 
Flow x Inj. vol. - 0.253  - 0.690 
Flow x Solvent - 0.523  - 0.303 
Injection vol. x Solvent - 0.464  - 0.358 
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4.4 Discussion 
4.4.1 Minitab screening study 
Main effect plots were generated by Minitab for each response (Figs. 4.2 to 4.6).  
The plots immediately highlighted conflicting trends in the resolution of the critical 
pairs.  Resolution was increased for three of the four pairs at the higher pH (5.0).   
One pair was more resolved using ACN as the organic modifier whereas resolution 
of two other critical pairs and the TIM tailing were improved by the use of MeOH.  
One pair of impurities (TIM2/RS5) were unaffected by the choice of solvent.  
Interestingly, with regard to the flow rate, the design showed that it was not a 
significant variable for all responses. This was surprising, as using HPLC, 
particularly on a gradient, tailing of a peak is typically lower at the higher flow rate. 
This was one of the many anomalies noted between the HPLC and UHPLC for 
gradient runs.[180] Likewise, temperature was not a significant variable for the 
resolution of impurities, but registered as significant factor for TIM tailing.  Across 
the range studied, the pH of the mobile phase is not a factor for TIM tailing.  With a 
pKa of 9.2, timolol will be fully ionised between pH 4 and 5, and so the absence of 
pH correlation in this range was expected.  The injection volume had no effect on 
the resolution of the impurities yet proved to be the factor that had the greatest 
effect on the TIM tailing. 
4.4.1.1 Resolution of Critical Pairs 
The primary goal of developing a UHPLC stability indicating method is to separate 
the API (s) and impurities (resolution Rs > 2.0) so that accurate reliable data can be 
recorded over the shelf life of the product and to ensure the quality of the 
pharmaceutical formulation.  
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Resolution between a set of peaks is calculated using the general equation  
Rs = 0.25*N1/2[(α−1/α)](k/1 + k) 
 
The selectivity parameter ‘α’ has the greatest impact on resolution. Selectivity can 
be changed by modification of the mobile phase composition, column chemistry and 
temperature. [181] 
 
Multivariate regression analysis using Minitab revealed that for the resolution of 4 
critical pairs of impurities, the factors that had the greatest impact were the mobile 
phase pH and the choice of organic solvent.  The direction of the slope indicates 
whether the factor has a direct or inverse effect on the response. The p-values and 
the condition that gave the highest resolution of each critical pair are summarized in 
Table 4.5.  The injection volume, temperature and flow rate were not significant 
variables in the resolution of impurities. 
 
Table 4.5 Summary of Main Effects and associated probability values (p-value) 
for peak resolution and USP Tailing of Timolol 
 
 Solvent pH Injection 
 Vol. 
Temp. Flow 
 p-value Max. p-value Max p-value Max.  p-value Max  
RS9 and BMT 0.05 ACN 0.01 5.0 -    - 
RS5 and RS1 0.05 MeOH - - -  -  - 
TIM2 and RS5 - - 0.03 5.0 -  -  - 
RS8 and RS10 0.04 MeOH  0.03 5.0 -  -  - 
TIM Tailing 0.03 MeOH - - 0.02 3 µl 0.04 30 - 
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Resolution of RS9 (Acrylic Acid Adduct) and BMT 
The main effects plot (Fig. 4.2) indicated that most significant factor for resolution of 
RS9 and BMT was buffer pH and that increasing the pH resulted in an increase in 
resolution. The effect value (Table 4.4-1) of 4.29 shows that the RS9 impurity co-
eluted with BMT at pH 4.0 and was fully resolved at pH 5.0.  Choice of solvent was 
also significant with an increase in resolution observed for ACN.  The interaction 
plot (Fig 4.7) shows that maximising the response by combining the pH and solvent 
preferences for RS9/BMT would lead to a resolution of 5.7, which was in excess of 
what was required.  As RS9 was the lone impurity for which ACN was preferred, 
optimisation for all responses meant that MeOH was selected.  The interaction plot 
indicates that a resolution of > 2.0 could still be achieved using MeOH as the 
solvent.  However, the results table (Table 4.3) shows that the pH must be > 4.5 
when using MeOH as the solvent as the centre-point trial resulted in co-elution of 
the peak.   
 
Resolution of RS5 (Maleate Adduct) and RS1 
 
This was the only critical pair for which pH was not the most significant factor.  The 
main effects plot (Fig. 4.3) indicated that greatest resolution would be achieved 
using MeOH as Mobile Phase B. Table 4.4-1 gives a negative effect value of -2.85 
for the solvent.  The value is negative because MeOH  as input as the ‘lo er’ value 
in Minitab, even though the solvent does not have a numerical value. It is the size of 
the effect that is important.  As resolution decreases with an increase in pH from 4.0 
to 5.0, the effect for pH is also negative, -1.81. This was the only critical pair where 
the lower pH resulted in higher resolution. The interaction plot (Fig. 4.8) shows that 
combining pH 4.0 and MeOH would result in a resolution of > 5; again this was 
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more than was needed.  Using MeOH and pH 5 would result in a max Rs of 1.4.  
This is below target and meant that further optimisation of the mobile phase pH was 
required.  The results table (Table 4.3) shows that at pH 4.5 when using MeOH as 
the solvent in the centre-point trial, the resolution improved dramatically to 4.8.  
Resolution of TIM2 and RS5 
The main effects plot (Fig. 4.4) indicated that most significant factor for resolution of 
TIM2 and RS5 was buffer pH and that increasing the pH resulted in an increase in 
resolution. Table 4.4-1 confirms this with a single large effect (11.57) noted for the 
pH factor. The pH was the only significant effect with a strong preference for the 
higher pH (5.0).  This was the only critical pair for which the solvent choice was not 
a significant factor.  TIM2 is the main degradant impurity of Timolol maleate and is 
structurally very different from the BMT impurity RS5.  The differences in ionisation 
and polarity ensure that the risk of co-elution was lower than for other impurities.  
However, co-elution was observed (Table 4.3) for the central point result using ACN 
as Mobile Phase B at pH 4.5. When the same mid-level conditions were run using 
MeOH as the solvent, resolution of 2.5 was achieved.  As MeOH was optimal for 
two sets of critical pairs and for TIM tailing, it was therefore selected as Mobile 
Phase B. There were no statistically significant interactions (p < 0.05) between 
factors for the resolution of TIM2 and RS5.   
Resolution of RS8 and RS10 
The main effects plot (Fig. 4.5) indicated that most significant factor for resolution of 
RS8 and RS10 was buffer pH and that increasing the pH resulted in an increase in 
resolution.  The plot also shows that the highest resolution achieved was 2.5 using 
pH 5.0.  Choice of solvent was also significant, with an increase in resolution 
observed for MeOH.  An interaction between pH and solvent was observed (Fig. 
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4.9) that indicates that maximum resolution could be achieved by combining the 
effects of using MeOH as Mobile Phase B and setting the pH of the buffer to 5.0.  
 
4.4.1.2 USP Tailing for Timolol Peak 
USP tailing is a measure of the asymmetry of a peak. A chromatographic peak with 
a tailing factor of 1 means that it is symmetrical. A tailing factor greater than 1 
means peak tailing while a tailing factor less than 1 means peak fronting.[181] The 
results table (Table 4.3) shows that TIM tailing was present across all conditions.  
Having this information on a single chart is one of the reasons why a DOE is so 
worthwhile.  A great deal of time can be wasted fine tuning a single response, 
whereas knowing what factors are not significant and can therefore be eliminated 
from future trials is a huge benefit.  The main effects plot (Fig. 4.6) indicated that 
most significant factor for tailing was the injection volume and that increasing the 
injection volume resulted in an increase in tailing. The combined drug formulation 
contains 0.2% BMT and 0.5% TIM.  As the method is designed to quantitate the 
API’s simultaneously the concentration of the sample injected needs to be sufficient 
for BMT without overloading the column with TIM.  Naturally, the higher the injection 
volume, the greater the concentration of TIM loaded on the column.  The accuracy 
and precision of TIM was determined for each condition trialled.  The average 
recovery for TIM was 100.3% and the %RSD was 0.09 for the 18 runs. This clearly 
demonstrates that the tailing does not impact on the accuracy and precision of the 
method. As the injection volume had no impact on the resolution of critical pairs, but 
significantly affected tailing, it was set to 3 µL, minimising tailing. Choice of solvent 
and temperature also had an impact on tailing.  As the lower temperature reduced 
tailing from 1.6 to 1.5 it was selected for optimal conditions.  In summary, to reduce 
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tailing for TIM, results suggest that the injection volume be set to 3 µL, MeOH be 
used as Mobile Phase B and the temperature of the column be maintained at 30ºC. 
There were no statistically significant interactions (p < 0.05) between factors for the 
TIM tailing response. 
4.4.1.3  Response Optimisation 
The DOE results (discussed in Sections 4.4.1 and 4.4.2) show that further 
optimisation of the method conditions were required.  Results of individual injection 
sets show that all five requirements were only met for run 3 (Table 4.3).  This is 
unsurprising as the main effect plots showed conflicting responses for both solvent 
and pH for different pairs of impurities.  Response Optimizer is a function of the 
Minitab software which can identify the combination of factor settings that jointly 
optimize a single response or a set of responses. A weighing was attached to each 
response based on experience with the assay.  For example, resolution of the 
acrylic acid adduct RS9 from the BMT main peak was given a high weighting as this 
was one of the primary aims in developing the assay.  Likewise resolution of the 
RS1 and RS5 maleate adduct was also of importance. A target value of Rs = 2.5 
was set for the critical pairs containing RS5 and RS9, whereas lower target of Rs = 
2 was set for the other two pairs.  Impurity peaks RS8 and RS10 are similar in size 
and observed at low levels (< 0.2% (w/w) of BMT LS).  As a result they are fully 
resolved at Rs = 2.   By way of contrast, while it is desirable to limit the tailing factor 
of TIM to below 1.5, results illustrated that the tailing did not have an impact on the 
accuracy or precision of the result.  Table 4.6 details the target values and weight 
assigned to each of the five responses. 
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Table 4.6  Factors and targeted criteria used in Minitab optimization  
Response Goal Lower Target Upper Weight 
RS9 and BMT Target 1.5 2.5 3 1 
RS5 and RS1 Target 1.5 2.5 3 1 
TIM2 and RS5 Target 1.5 2 4 2 
RS8 and RS10 Target 1.5 2 3 2 
TIM Tailing Target 1.0 1.2 1.6 3 
 
The Response Optimizer was used to generate the factor optimization plots (Fig. 
4.10 and 4.11) along with the optimized method condition for the five responses.  
Fig. 4.10 is an example of the optimal conditions suggested to reduce TIM tailing 
based on a target of 1.2.  The results show that under optimal conditions, a tailing 
factor of 1.3 was the best that could be achieved.  When the response for TIM 
tailing was combined with the resolution criteria (Fig. 4.11) trade-offs were required 
to achieve optimal results for all responses, with the tailing factor increased to 1.4. 
when the temperature of the column was increased to 40ºC.  The optimisation plot 
shows the effect of each factor (columns) and the responses or composite 
desirability (rows). Minitab allows the user to manually adjust the settings (red lines) 
and displays the change in target response.   
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Fig. 4.10 Factor optimization plot for TIM Tailing generated using Minitab. 
 
Fig. 4.11 Factor optimization plots for Resolution of 4 Critical Pairs and TIM 
Tailing generated using Minitab. 
Cur
High
Low0.54977
D
Optimal
d = 0.54977
Targ: 1.20
TIM Tail
y = 1.3351
0.54977
Desirability
Composite
methanol
acn
3.0
5.0
0.40
0.50
30.0
40.0
4.0
5.0
Column T Flow rat Injectio SolventpH
5.0 30.0 0.50 3.0 methanol
Cur
High
Low0.00000
D
Optimal
d = 0.00000
Targ: 1.20
TIM Tail
y = 1.4288
d = 0.62789
Targ: 2.50
RS8 10
y = 3.4303
d = 0.00000
Targ: 2.50
T2 RS5
y = 14.8083
d = 0.98067
Targ: 2.50
RS9 BMT
y = 2.5483
d = 0.21597
Targ: 2.50
RS5 1
y = 1.7160
0.00000
Desirability
Composite
methanol
acn
3.0
5.0
0.40
0.50
30.0
40.0
4.0
5.0
Column T Flow rat Injectio SolventpH
5.0 40.0 0.50 3.0 methanol
168 
 
As a starting point for further optimisation using Drylab, the following conditions 
were selected as nominal, based on this section.  
Table 4.7  Nominal Conditions for Method Optimisation 
Parameter  
Mobile Phase A: 50 mM Ammonium acetate buffer, pH 5.0 
Mobile Phase B: MeOH 
Column Temperature: 30ºC 
Flow rate 0.5 ml/min 
Injection volume 3 µL 
 
4.4.2  Method Optimisation Using Drylab 
 
Following the recommendations of the screening study in Section 4.4.1, MeOH was 
selected as Mobile Phase B; injection volume was set to 3 µL and the flow rate to 
0.5 mL/min.  It is critical to select a pH at which the method is robust, to ensure that 
minor changes in the buffer preparation will not have a negative influence on the 
resolution of peaks. Based on the DOE screening study, a pH of 5.0 with a 50 mM 
acetate buffer was found to be optimum for three of the four sets of impurities.  The 
centre-point results (rows 17 and 18, Table 4.3) indicated that further work was 
required to establish the acceptable limits of the pH of the mobile phase.  
Investigation of the variation of the aqueous eluent between pH 4.6 and 5.2 was 
carried out using the fast/slow gradients described in Table 4.8.  Chromatograms 
were integrated using Empower software and the results were exported directly to 
the Drylab modelling software for analysis.  A 2-D resolution map of pH and gradient 
time (tG) was generated and is shown in Fig. 4.12.  The warm orange colour shows 
the parameter region in which the resolution of the four critical peak pairs was 
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higher than 2.0 (Rs,crit > 2.0).  This region is surrounded on all side by green and 
blue bands which show that resolution for all critical pairs was not achieved at pH 
below 4.6 and above 4.9.  The map shows the pH was both critical and limited. 
Table 4.8  Additional Drylab Sets 
 pH  Gradient 
(min) 
Column 
Temperature 
(ºC) 
Flow rate 
(mL/min) 
1 pH 4.6 10 30 0.5 
2 pH 4.6 26 30 0.5 
3 pH 5.0 10 30 0.5 
4 pH 5.0 26 30 0.5 
5 pH 5.2 10 30 0.5 
6 pH 5.2 26 30 0.5 
7 pH 4.8 10 30 0.45 
8 pH 4.8 26 30 0.45 
9 pH 4.8 10 45 0.45 
10 pH 4.8 26 45 0.45 
 
The colour code in the resolution map represents the value of the critical resolution, 
 ith  arm “red” colours representing large resolution values (Rs > 2.0) and cold 
“blue” colours representing lo  resolution values (Rs < 0.5).[168] It can be seen 
from the resolution map that the method was robust in the pH range between 4.7 
and 4.9 and a gradient time of 6 and 10 min and provides the highest peak 
resolution (Rs > 2.0).  The flow rate of the assay was adjusted using the Drylab 
software and demonstrated that the resolution was achieved for flow rate from 4 to 5 
mL/min.   Based on this map, the nominal pH of the mobile phase was set to 4.8 for 
all subsequent experiments. 
 
 
170 
 
 
 
Fig. 4.12  tG and pH model at 30ºC using MeOH as Mobile Phase B; the warm 
orange colour shows the parameter region in which the resolution of 
the four critical peak pairs was higher than 2.0 (Rs,crit > 2.0).  This 
region is surrounded on all side by green and blue bands indicating 
regions where all critical pairs were not achieved. 
 
Once the pH was established, a final set of experiments were carried out to 
examine the influence of the column temperature (runs 7 – 10 in Table 4.8).  The 
Response Optimisation charts showed a conflicting set of responses for the column 
temperature, with the USP tailing of TIM favouring the lower temperature and the 
resolution of impurities favouring a higher temperature. Investigation of the variation 
of the temperature between 30 and 45ºC was carried out using the fast/slow 
gradients described in Table 4.8. The aqueous mobile phase consisted of a 50 mM 
ammonium acetate buffer at pH 4.8.  A 2-D resolution map of temperature and 
gradient time was generated and is shown in Fig 4.13. Results showed a greater 
range for temperature than for pH,  ith a ‘s eet spot’ belo  35 ºC. The temperature 
RS > 2.4 
RS = 1.5 
RS = 0.2 
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was robust between 28 and 32 ºC a gradient time between 6 and 10 min and 
providedthe highest peak resolution (Rs > 2.0).  
 
 
Fig. 4.13  tG and temperature using a pH of 4.8 and MeOH as Mobile Phase B; 
the red/orange colour showed the parameter region in which the 
resolution of the four critical peak pairs was higher than 2.0 (Rs,crit > 
2.0).   
 
Results from the Drylab study indicated that the method was capable of 
withstanding adjustments to mobile phase pH, temperature and flow rate using a 10 
minute linear gradient.  A robustness study was performed by varying 
chromatographic parameters and the nominal conditions were validated in 
compliance with ICH Q2R1 guidelines.  The final method conditions are shown in 
Table 4.9 
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Table 4.9 UHPLC Method Conditions for the Analysis of BMT, TIM and 
Impurities in Finished Drug Product Ophthalmic Solution 
Parameter Nominal Robustness Tests 
Mobile Phase A: Ammonium Acetate 50 mM 45mM, 55 mM  
Mobile Phase A: pH 4.85 4.80,  4.90 
Column Temperature: 30ºC 28, 32 
Flow rate 0.45 ml/min  0.4, 0.5  
Mobile Phase B MeOH -  
Injection volume 3 µL  
 
 
Figures 4.14 and 4.15 illustrate the predicted and experimental retention times for 
11 peaks (BMT, TIM and 9 impurities). 
 
 
Fig. 4.14 Drylab predicted chromatogram for conditions at pH 4.8, tG = 10, 
column temperature 30ºC 
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Fig. 4.15 Experimental chromatogram of a drug product sample  for conditions at 
pH 4.8, tG = 10, column temperature 30ºC 
 
4.5 Conclusion 
The goal of this chapter was to develop a fast UHPLC separation of BMT and TIM 
(in combined drug product) and 11 potential impurities.  Of particular interest was 
the resolution of two aza-Michael adducts that were only found in the combined 
drug product.  The UHPLC method developed here will be used in Chapter 5 for the 
quantitation of acrylic adducts formed by the reaction of BMT and TIM with both 
methyl acrylate and acrylic acid. 
Despite assumptions of scientific impartiality, method development involves a 
certain amount of personal bias.  Based on past experience (good and bad) 
scientists tend to favour certain brands of column, buffer salts or combinations of 
organic solvents.  Using a DOE strategy allows the developer to remove themselves 
from the study and let the results speak for themselves.  This is especially useful 
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when preliminary scouting gradients show that there is little difference between the 
conditions selected and there is no clear ‘best set’ of conditions.   
In this chapter a two-step strategy for method development and optimisation was 
used.  Due to the complicated nature of a combined drug product the first step was 
to screen the main effects of factors that significantly affected the resolution of 
critical pairs of impurities and tailing of the TIM peak.  Multivariate regression 
analysis was successfully employed to establish which factors had the greatest 
impact.  Graphical methods were used to analyse the results by generating the main 
effect and interaction plots.  Optimized method conditions were obtained by 
analysing the response data using the Minitab Response Optimizer feature.  The 
most significant factors for the resolution of impurities were mobile phase pH and 
choice of organic solvent.  MeOH was selected as the optimal solvent, which greatly 
reduced the number of experiments required for the final optimisation step.  All 
experiments (DOE screening and Drylab optimization study) were completed within 
one week. 
Step two involved the use of chromatography modelling software, to find a suitable 
separation (Rs,crit > 1.5) for 11 impurities, by proper adjustments of gradient, 
temperature and pH, while maintaining analysis time lower than 15 min. The final 
method resulted in the baseline separation of 13 peaks in 10 min.    Compared to 
the current HPLC assay, the runtime has been reduced from 65 to 15 minutes, the 
preparation time has been reduced so that overall the method can be completed in 
12.5% of the previous time and the volume of organic waste produced has been 
reduced by 90% for each injection. 
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Chapter 5: 
Investigation of aza-Michael reaction in formulated drug 
product:  amine- acrylate screening study  
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5.1 Introduction 
Analytical monitoring of impurities in new drug substances is a key component of 
the recent guideline issued by the International Conference on Harmonization (ICH). 
As per ICH guidelines for impurities in new drug substances, for a maximum daily 
dose ≤ 2 g/day of a drug substance, the reporting and identification thresholds are 
0.05% and 0.10%, respectively.[98] Therefore it is a mandatory requirement from 
regulatory authorities to identify and characterize any unknown impurity present at 
or above 0.1% level in drug substance.  
Forced degradation studies provide data to support the identification of potential 
degradation products that may form during formal stability studies conducted on 
drug substances and drug products.[182, 183]  Occasionally, impurities are 
detected in stability studies that were not observed in the forced degradation 
studies. These impurities are often the result of a potential interaction of the drug 
substance with formulation excipients, packaging or shipping materials and will not 
be evident unless studies are designed to look for these potential interactions. In the 
majority of cases, migration of components of the packaging into drug substance or 
product will result in simple contamination.  However, migratory species may also 
be reactive and form new drug-related impurities.[184] In a recent example, acrylic 
acid was detected as a leachable in pre-filled syringes containing therapeutic 
proteins. A direct Michael addition reaction between the acid and proteins resulted 
in impurities of between 0.02 and 0.3%.[185]   
The search for reliable reaction indicators was reported in a number of drug-
excipient compatibility tests carried out by Bruni et al.   The objective was to develop 
a simple methodology with high predictive ability that could be applied during pre-
formulation of solid dose drugs.[186]  Ester formation was highlighted in a number 
182 
 
recent drug excipient compatibility reports. [123, 187, 188]  A liquid formulation 
containing the carboxylic acid cetirizine, formed approximately 1% of the monoester 
impurity after 1 week in the presence of the excipients sorbitol and glycerol.  The 
ester was unstable at higher temperatures (40, 60 and 80ºC) and degraded over 
time.[188]  Schou-Pedersen et al. repeated this experiment examining the 
esterification of cetirizine but employed the use of microwave technology in place of 
a conventional oven for accelerated stability testing of drug excipient reactions.[187] 
The typical time taken for esterification was reduced from weeks to hours when two 
liquid formulations and one solid dose were investigated.  Results for the liquid 
formulations were in agreement with the earlier study but caution was advised in 
using microwave for studies of solid dose forms.   
Active pharmaceutical ingredients (APIs) containing secondary and tertiary amine 
moieties have been shown to react with olefins such as maleate and tartrate salts 
and with acrylates migrating from packaging.  A major degradation product resulting 
from an interaction between phenylephrine hydrochloride (PHN) and the maleate 
salt of chlorpheniramine was identified by Marin et al. in a 2005 study.[85]  The 
maleate adduct was present in several commercial formulations tested by the 
authors.  A follow up study contested the structure of the adduct reported by Marin 
but confirmed the degradant as a Michael addition product of phenylephrine and 
maleic acid. [189] Phenylephrine was the subject of another excipient interaction in 
a later study by Trommer et al.  This time the adduct was formed by an interaction 
with its own bi-tartrate salt.[86]  Results of all three studies indicate that 
phenylephrine is very susceptible to conjugate addition, especially in liquid 
formulations.  
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There are no reports in the literature of interactions between reactive amines and 
acrylates migrating from drug-packaging.  Yet, both methyl acrylate and acrylic acid 
have been detected as leachables in ophthalmic solutions during an in house 
evaluation of digital labels from potential vendors at our laboratory (data not 
published).  In a recent example acrylic acid was found to have reacted with the 
drug substance (timolol) in the product under evaluation.  Even though a small 
amount (from 0.05% to 0.3%) of the timolol drug substance was found to be 
modified by acrylic acid, the modified drug could potentially be harmful due to the 
toxicity of acrylic acid. After being modified by acrylic acid, the properties of the drug 
substance may change due to charge and hydrophobicity variations.  Scheme 5.1 
shows the proposed formation of an acrylic adduct 3 (2-[tert-butyl-[(2S)-2-hydroxy-3-
[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propyl]amino]acetic acid)  via the aza-
Michael reaction of timolol 1 with acrylic acid 2. 
 
 
Scheme 5.1 Aza-Michael addition of timolol to acrylic acid 
 
In Chapters 2 and 3 the secondary amine 1-phenylpiperazine was reacted with a 
number of acrylates, including methyl acrylate and acrylic acid, in a variety of 
aqueous buffered solutions.  The results show that given sufficient time, even the 
less electrophilic acrylic acid will yield an acrylate adduct.  The salt, 1-phenyl 
piperazine hydrochloride also reacted with both methyl acrylate and acrylic acid 
when left standing to 6 and 12 days. 
1 2 3 
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The aim of this chapter was to investigate the extent to which the aza-Michael 
reactions explored in earlier chapters could occur in pharmaceutical formulations 
with APIs containing amine groups. A number of ophthalmic solutions containing a 
variety of amine drug substances in aqueous buffered solutions were spiked with 
acrylates to determine the levels of acrylate adduct impurities generated under 
conditions that mimicked the routine storage of drug products.  Test APIs included 
primary, secondary and tertiary amines, with both aliphatic and aromatic 
compounds included. A protocol was designed to pre-screen the packaging 
material-drug substance compatibility.  All methods used were validated stability 
indicating methods used for the quantitation of the API and its related substances. 
Formation of acrylate adducts was observed for all secondary and tertiary amines.  
No reaction was observed for the primary amine epinastine hydrochloride (EPT).  
Amine reactivity was governed by structure, with yields significantly reduced for 
secondary amines  ith alkyl substitution at α-carbon.  With the exception of PHN, 
hydrolysis of the β-amino ester product was evident for all amines.  Tertiary amines 
(N-methyl substituted) produced stable adducts in the reaction with acrylic acid. 
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1. Gatifloxacin (GAT) 2.  Ofloxacin (OFL) 3. Alcaftadine (ALC) 
 
 
 
4.  Phenylepherine.HCl (PHN) 5. Levobunolol.HCl (BUN) 6. Epinastine.HCl (EPT) 
 
 
7. Brimonidine Tartrate (BMT) 8. Timolol Maleate (TIM) 
 
Figure 5.1 Structures of the compounds related to this study  
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5.2 Materials and Methods 
5.2.1 Materials  
Methyl acrylate and acrylic acid were purchased from Sigma Aldrich.  HPLC grade 
acetonitrile and methanol  ere purchased from Merck.  Tetrahydrofuran ‘Super 
purity solvent’  as purchased from Romil.  Ammonium acetate anhydrous (ACS 
reagent grade), ammonium phosphate monobasic (ACS reagent grade) and glacial 
acetic acid (HPLC Grade) were purchased from Sigma Aldrich. Heptane sulfonic 
acid sodium salt and sodium phosphate dibasic (ACS reagent grade) were 
purchased from VWR.  Triethylamine (ACS Grade), potassium phosphate dibasic 
and ortho-phosphoric acid 85.0 % min (ACS grade,) were purchased from 
Applichem.  Deionized  ater, purified to a resistance of greater than 18 MΩ  as 
obtained from a Millipore Corporation Milli-Q system, Millipore (Bedford, MA, USA). 
Ophthalmic solutions containing Phenylephrine Hydrochloride (PHN), Gatifloxacin 
(GAT), Ofloxacin (OFL) Alcaftadine (ALC) Brimonidine Tartrate (BMT), Timolol 
Maleate (TIM), Levobunolol Hydrochloride (BUN) and Ephinastine Hydrochloride 
(EPT) were provided by the Allergan Stability Testing Laboratory, Westport, Ireland.  
All samples had exceeded the manufacturer’s expiry date by a minimum of 14 
months at the time of use.  All aged samples had been stored at 25ºC/RH 60%.  All 
other chemicals were of analytical grade and were used without further purification. 
5.2.2 HPLC/UPLC Equipment and Chromatographic Conditions 
HPLC analyses were carried out using a Waters Alliance 2695 system (Waters 
Corporation, Milford, MA, USA) with a quaternary solvent manager and auto-
sampler connected to a Waters 2489 UV/Visible UV detector (Waters Corporation, 
Milford, MA, USA).  UV spectral analysis was carried out using a Waters 2998 photo 
diode array (PDA) detector.  UHPLC analyses were carried out using a Waters 
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ACQUITY UPLC H-Class system (Waters Corporation, Milford, MA, USA) 
connected to an ACQUITY TUV detector (Waters Corporation, Milford, MA, USA).  
Data acquisition and integration were performed by using the Waters Empower 
software. The auto-sampler was held at room temperature.  Details of the column, 
instrument parameters and mobile phase used to assay each of the ophthalmic 
solutions are provided in Appendix A.  
5.2.3 Methods 
5.2.3.1 Sample Preparation 
Refer to Appendix A  for details of the sample diluent and final concentration of the 
API in each solution tested. Class A volumetric pipettes and flasks were used for 
each preparation. 
5.2.3.2.  Generation of Reaction Products  
Approximately 150 mL of each ophthalmic solution was pooled into a sample jar.  
Using a Class A glass pipette, 10 mL of pooled sample was transferred into 10 
separate 15 mL amber glass sample jars.  Each sample was spiked with either 
methyl acrylate or acrylic acid using a micropipette.  Details of the molar 
concentration of each amine in 10 mL of solution and the amount of acrylate added 
are provided in Table 5.2. 
Each sample was prepared in duplicate, tightly capped and stored in climatic 
chambers under the following conditions of temperature and relative humidity (RH); 
25 ºC/60% RH and 40 ºC/75% RH for a period of up to 8 weeks.  A control sample 
from the same pooled sample was stored under identical conditions and tested at 
each time-point. 
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Table 5.1  Molar Concentration of Acrylates (µL) in 10 mL of Ophthalmic Solution  
Acrylate MW 
g/mol 
Density 
g/cm
3
 
10 µL/10 mL 
(mmol) 
20 µL/10 mL 
(mmol) 
40 µL /10 mL 
(mmol) 
Methyl 
Acrylate 
86.09 0.9535 11.0  22.1  44.3 
Acrylic Acid 72.06 1.051 14.5  29.1 58.34 
 
 
Table 5.2  Molar Concentration of Amines in 10 mL of Ophthalmic Solution  
and Amount of Acrylate Added 
 
Drug Substance  
 
Conc. 
mg/mL 
 MW 
g/mol 
mmol in  
10 mL 
µL MA µL AA 
       
GAT 5  375.4 13.3 40 40 
BUN 5  327.9 15.2 40 40 
TIM 6.8  432.5 15.7 40 40 
OFL 3  361.4 8.3 20 20 
ALC 2.5  307.4 8.1 20 20 
PHN 1.3  203.7 6.4 20 20 
BMT 2  442.2 4.5 20 20 
EPT 0.5  285.8 1.8 10 10 
 
5.2.4  Quantitative analysis  
With the exception of the BMT-acrylic acid adduct, no reference compounds of the 
aza-Michael impurities were available. The quantitative measurements of the 
acrylate adduct formed in the reaction studies were therefore performed using the 
reaction mixtures obtained as described in Section 5.2.3.2, Table 5.2.  
A number of sample controls were run for each assay and the average peak area of 
both the amine peak and the impurity peaks were calculated. The extent of each 
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reaction was calculated by comparing the peak area of each reacted sample to that 
of the control sample.  The % loss of amine for each replicate was calculated.  The 
reaction products were quantitated as a % peak area with respect to the loss of 
amine in the control samples.   
5.3 Results and Discussion 
The main objective of this research was to establish whether the reaction between 
an API containing an amine functional group and a component of the packaging 
(acrylate) was feasible under conditions of routine and accelerated storage.  The 
APIs chosen for this study were Gatifloxacin (GAT), Ofloxacin (OFL), Alcaftadine 
(ALC), Phenylepherine. HCl (PHN), Levobunolol.HCl (BUN), Epinastine.HCl (EPT), 
Brimonidine Tartrate (BMT) and Timolol Maleate (TIM), shown in Figure 5.1. These 
compounds were chosen to enable a comprehensive investigation into the chemical 
parameters which impacted upon the reaction, and ranged from primary to 
secondary to tertiary amines, and included both salts and free bases, as detailed in 
Table 5.3. Two acrylates were chosen, acrylic acid (AA) and methyl acrylate (MA), 
as both are have been found to be present in packaging components, and both 
were shown in Chapter 3 to act as acrylate donors in the aza Michael reaction. 
The design of this study combined elements of drug-excipient/packaging 
compatibility studies and forced degradation studies.  A forced degradation study 
subjects drug products and substances to conditions more severe than accelerated 
conditions to determine the stability of the molecule and to generate degradation 
products in greater amounts for further study.  The stressed samples can be used to 
develop stability indicating analysis methods and to produce a degradation profile 
similar to that of what would be observed in a formal stability study under ICH 
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conditions.[182] Drug packaging compatibility studies often involve extraction of 
components of the packaging by direct immersion in the finished product solution at 
elevated temperatures [190]. Borrowing from the forced degradation study example, 
the reaction was accelerated by direct addition of the acrylate rather than immersion 
of the components in sample.  The reaction of 1-Phenylpiperazine (1PP) and methyl 
acrylate (MA) in Chapter 3 demonstrated that the aza-Michael  reaction was feasible 
in buffered solutions when samples were left standing at room temperature, and 
resulted in the formation of unanticipated products. Hydrolysis of the ester product 
was noted also. To get a more complete picture of the feasibility of the reaction, all 
reactions in this study were carried out at both 25 and 40ºC. The study consisted of 
three main components: 
- determination of impurity adduct formation;  
- evaluation of impact parameters on impurity adduct formation; 
- characterisation of impurity adducts formed. 
5.3.1 Determination of impurity adduct formation on reaction with 
Methyl Acrylate 
All amines with the exception of EPT reacted with MA to form an impurity adduct.  
Reaction was calculated by comparing the concentration of the amine in the spiked 
sample to that of the un-spiked control.  Table 5.3 ranks the reactivity of the amines 
based on the greatest % loss observed at the first time point. The time point 
selected was dictated by the laboratory schedule and it was not possible to assay 
each product on the same day.  As a result there is some variation between the 
days for different products.  The concentration of the impurity as a % of the amine in 
the control was also recorded. Tables of results for individual amines are provided in 
Appendix B. 
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 The relative response factor (RRF) for each impurity has not been established and 
therefore the % loss of amine is not equivalent to the % increase in the impurity for 
all amines, with the exception of PHN.   The area of the PHN-MA adduct is equal to 
the % loss of PHN.  An RRF of 2.4 has been determined and applied to the BMT-
MA adduct.   
Table 5.3 Reactivity of APIs on incubation with MA at 40ºC 
Reactivity API % Loss 
Amine 
% IMP # Days 
incubated  
Amine 
classification 
High PHN 100 100 11 2º salt HCl 
High BMT 85 88 7 2º salt Tartrate 
Medium ALC 34 14 5 3º free base 
Medium OFL 32 26 7 3º free base 
Medium GAT 33 17 11 2º free base 
Low TIM 10 11 11 2º salt Maleate 
Low BUN 3 6 19 2º salt HCl 
Nil EPT 2 0 7 1º salt HCl 
 
PHN was most reactive amine, in terms of the impurity yield on reaction with MA at 
both temperatures.  Complete conversion of PHN to the MA adduct was observed 
after 11 days storage at 40ºC.  BMT, another secondary aliphatic amine, also 
proved highly reactive with 85% loss of amine after 7 days storage at 40ºC.  Of 
medium reactivity were three cyclic amines, the fluoroquinolones GAT and OFL and 
ALC, an antihistamine.  All three achieved approximately 30% loss after 5-11 days 
storage.  TIM showed moderate/low reactivity with 10% amine loss after 11 days.  
This was not unexpected, as during an earlier accelerated study of TIM in a 
combination formulation, a small percentage (< 1.0%) of an acrylic adduct was 
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detected.  The % loss of BUN did not correspond to any increase in impurity at the 
initial time-point (19 days) with a small amount of the MA adduct detected after 40 
days.  Finally, the primary amine EPT was unreactive over the course of the study.  
A small reduction in peak area of the amine was detected at the second time-point 
but this was within the day to day variation of the method. 
5.3.2 Evaluation of Impact Parameters on Impurity Adduct 
Formation  
5.3.2.1  Effect of Amine Structure on Reactivity 
Of interest to this study was whether the structure of given amine could predict its 
reactivity in the aza-Michael reaction with an acrylate ester. While in no way 
comprehensive, the results of the study broadly support the contention of Bunting 
and Heo and that it is the structure of the amine and not its basicity that plays a 
greater role in its nucleophilicity.[31, 36]  Substitution of the α and β carbons  to the 
nitrogen atom were shown to have the greatest impact on the nucleophilicity of the 
amine.  Two features were identified as key; steric hindrance as a result of 
increasing substitution at the α carbon led to a reduction in reactivity  hereas sp2 
hybridisation or the presence of a hydroxyl group at the β carbon led to a significant 
enhancement in amine reactivity.  The full structure of each compound is shown in 
Figure 5.1.  Figure 5.2 focuses on the groups next to the amine.  
Figure 5.2 row 1, contains the amines PHN, TIM and BUN.  PHN, a secondary N-
methyl amine, was the most reactive of the 8 amines tested.  Its amine backbone is 
identical to that of TIM and BUN.  All three are unhindered at the α carbon and 
contain a hydroxyl group on the β carbon.  Ho ever, the steric hindrance afforded 
by the t-butyl group attached to the nitrogen of TIM and BUN completely negated 
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any enhanced reactivity and they proved to be the two most unreactive secondary 
amines examined.   
 
 
PHN TIM and BUN 
 
  
OFL GAT ALC 
 
 
EPT BMT 
 
Figure 5.2 Chemical structures of amines investigated in this study. EPT is a 1º 
amine, PHN, TIM, BUN, GAT and BMT are 2º amines and ALC and 
OFL are 3º amines.  
TIM resulted in 10% loss of amine and BUN in a 3% loss after 11 and 19 days 
storage respectively.  TIM conversion did increase over time at 40ºC where a very 
small increased was noted in the reaction with MA after 32 days.  Results for BUN 
after 40 days showed 11% loss of amine in one replicate at 40ºC and a 
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corresponding increase in the MA adduct to 6.8%.  Results for BUN were not 
reproducible in either of the replicates or at either temperature.   
Steric hindrance came into play once more when comparing the reactivity of the 
three cyclic amines, OFL, GAT and ALC.  Based on the previous nucleophilicity 
studies (of Mayer, Heo, Brotzel), the GAT secondary amine was expected to be far 
more reactive than its tertiary counterpart, OFL. [30, 31]  GAT and OFL are almost 
identical in structure, consisting of a phenyl piperazine ring system.  Based on the 
results of Chapter 2 and 3 which used the model amine 1-phenyl piperazine, the 
reaction of GAT with MA was expected to be extremely fast at both temperatures.  
Instead, all three amines studied here yielded very similar results for % loss of 
amine. Even though GAT is a secondary amine while ALC and OFL are tertiary.  
The low reactivity of GAT could be ascribed to the steric hindrance of the methyl 
group adjacent to the nitrogen.[33]   While N-methyl substitution of the tertiary 
amines was not a barrier to their reactivity, the results show that amine loss and 
generation of products is less predictable and reproducible than for the secondary 
amines.  Stability of the tertiary amines is discussed in Section 5.3.4.1. 
The primary amine EPT was unreactive after 7 and 34 days.  Some loss of amine 
was noted (approx. 4%) but no subsequent increase in adduct was observed.  The 
presence of t o nitrogen’s beta to the primary nitrogen and an α-β unsaturated 
bond would lead to build up of electron density in the vicinity of the nucleophilic 
centre, making approach to the electrophile difficult.   Interestingly, the same moiety 
is present as one of the groups on BMT, one of the most reactive amines studied.  
The second group is a bromo-benzene ring.  Overall, the results are in agreement 
with the amine nucleophilicity scales discussed in the literature review; secondary 
amines are more nucleophilic than their primary counterparts, with the additional 
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alkyl group on the secondary amine lending increased stability to the positively 
charged ammonium intermediate.  Results for the tertiary amines are in agreement 
with the contention of Bunting and Heo [31]that nucleophilic attack by the amine is 
no longer the rate limiting step, rather the ease at which the carbanionic 
intermediate is protonated by the reaction medium determines reactivity.   
5.3.2.2  Effect of Acrylate Donor – Methyl Acrylate versus Acrylic 
Acid 
As previously discussed, all amines with the exception of the primary amine, EPT 
reacted with MA.  While it was not expected that AA would be as effective an aza-
Michael donor, as seen in Chapter 3, a reaction with AA will take place over time if 
the amine is sufficiently nucleophilic.  As seen in Table 5.4, reaction with AA did 
result in the formation of impurity adducts for a number of APIs investigated, though 
not with the same trend as observed with MA. While the reaction was similar for 
some amines, e.g. for the reaction of PHN with AA, 71% loss of amine was 
observed after 32 days at 40ºC, the less reactive secondary amines GAT, BMT, TIM 
and BUN showed no significant reaction with AA.   
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Table 5.4 Reactivity of APIs on incubation with AA at 40ºC 
API Reactivity 
with MA 
% Loss 
Amine 
Reactivity 
with AA 
% Loss 
Amine 
Amine 
classification 
PHN High 100 High 71 2º salt HCl 
BMT High 85 Low 3 2º salt Tartrate 
ALC Medium 34 Medium 36 3º free base 
OFL Medium 32 Medium 16 3º free base 
GAT Medium 33 Low 6 2º free base 
TIM Low 10 Low 3 2º salt Maleate 
BUN Low 3 Nil 0 2º salt HCl 
EPT Nil 2 Nil 0 1º salt HCl 
 
Where previously, GAT, OFL and ALC all reacted similarly with MA, for the reaction 
with AA, GAT did not show any significant reaction while the two tertiary amines, 
OFL and ALC, reacted with AA at both temperatures and formed stable impurity 
adducts.  The reaction of OFL with AA over 32 days resulted in the formation of 
adducts amounting to 3 and 10% at 25ºC and 40ºC respectively.  The results were 
more pronounced for ALC with 6 and 18% of the ALC-AA adduct formed after 32 
days. See Tables 5.5 and 5.6 for details. In this instance therefore, the basicity of 
the amine as well as the structure would appear to have affected the formation of 
the impurity adduct.  In every scenario, there was a lower reactivity for the API with 
AA than with MA. This was expected, as AA is not as efficient a donor as MA.  
5.3.2.3 Effect of Temperature  
With the exception of PHN, the % loss of amine API was greater at higher 
temperature for secondary amines.  The reaction of PHN with MA was complete 
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after 11 days at both temperatures.  The model amine 1PP reacted with MA in 
Chapter 2 showed a similar effect i.e. if the amine was sufficiently nucleophilic the 
reaction was rapid and temperature did not have an effect.  When PHN was reacted 
with AA however, the effect of temperature was evident; at 40ºC the rate of 
formation of the acid adduct was greater at both time-points tested.  At 40ºC the % 
loss of amine increased from 50 to 71%.  Over the same period at 25ºC, the 
increase was 10% to 24%.  
The same overall trend was noted for GAT, BMT, TIM and BUN with higher 
concentrations of adduct formed in the reaction with MA at 40ºC.  However, the % 
loss of amine and subsequent increase in adduct was not as straightforward as with 
the PHN reaction.  GAT for example, demonstrated good reproducibility between 
replicates for the % impurity formed at both temperatures and time-points, but the  
% loss of amine was out of trend.  Initially, at 25ºC, a 21% loss of amine resulted in 
4% of MA adduct whereas at 40ºC a loss of 25/34% for replicates A/B resulted in 
17% of impurity.  After a further 22 days, the loss of amine was similar across both 
temperatures (29-38%) but the 25ºC impurity increased from 4 to 13% whereas the 
40ºC impurity only increased from 17 to 20%.  No additional impurities were 
observed.  A similar anomaly between % loss of amine and increase in impurity was 
observed for OFL, ALC and BUN. 
5.3.3 Stability of the Adducts Formed 
5.3.3.1  Ester Hydrolysis 
While outside the scope of this study, an interesting observation was made in 
relation to the rate of hydrolysis of the β-amino ester products resulting from the 
aza-Michael addition of an amine and an ester. In Chapter 3, the model amine 1PP 
was reacted with both AA and MA and left standing. Hydrolysis of the ester was 
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identified in the MA reaction mixture. After 6 days, the ratio of ester:acid product 
was 80:20, which increased to 45:55 after 12 days in PBS at room temperature.  
The hydrolysis observed is in agreement with results of a study by Carlise et al. who 
investigated the effects of pH and temperature on the hydrolysis of β-amino esters 
and acids. A significantly increased rate of hydrolysis  as reported for the β-amino 
esters across a range on temperatures and pH.  The half-life of the tertiary amine 
esters was very fast at both temperatures (37ºC and 80 ºC) and over the range of 
pH investigated (3 to 9). [191] The same acceleration was not observed in esters 
lacking the neighbouring nitrogen atom i.e. the presence of the nitrogen greatly 
enhanced the rate of hydrolysis.  The results for hydrolysis of the carboxylic acid 
products were unpredictable and did not follow the expected trend.  Further studies 
carried out by McCoy et al., on the acceleration effect of the amine on ester 
hydrolysis were in agreement with the finding of Carlise and was termed 
neighbouring group effect (NGE) by the authors.[192] 
In this study, a single adduct was observed at the same retention time for the 
secondary amines BMT, TIM, GAT when the amines were reacted with either MA or 
AA.  The MA adduct peak formed in the reaction with BMT has been positively 
identified by LC-MS and NMR as the brimonidine-acrylic acid adduct.  The MA 
adduct of TIM has also been identified as the timolol-acrylic acid adduct.  As the AA 
monomer did not react with either product, it was assumed that complete ester 
hydrolysis occurred in the PBS solution (pH 7-8).   
5.3.3.2  Stability of Adducts - Tertiary Amine Adducts 
As shown in Figure 5.3, the product of the aza-Michael addition of a tertiary amine 
to an acrylate acceptor is a positively charged quaternary ammonium compound.  
These charged amines are features of many antimicrobial compounds.  A study into 
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the spontaneous hydrolysis of antimicrobial betaine esters was carried out by 
Lindstedt et al. in 1990. [193]  Unlike the β-amino esters where hydrolysis was rapid 
across a range of pH values and at high and low temperatures, Linstedt reported a 
more complex temperature and pH dependence for the quaternary ammonium 
esters.  For example, a small reduction in the storage temperature from 30 to 25ºC 
doubled the half-life of the betaine ester studied.  A reduction in the free activation 
energy for alkaline hydrolysis as a consequence of the positively charged nitrogen 
atom led to increased instability of the ester bond. At low pH the bond was stable 
whereas increasing the pH of the buffer had the opposite effect, with 50% hydrolysis 
taking place within 5 hours at pH 7.  
 
Figure 5.3 Quaternary ammonium ester hydrolysis [193] 
The complex dependence of ester adduct formation with temperature was also 
evident in this study, in reactions of the tertiary amines ALC and OFL with MA.  In 
contrast to the secondary amines, the % amine loss for both ALC and OFL reacted 
with MA was greater at 25ºC than at the higher temperature. This was not observed 
for any of the other amine APIs investigated. Instead, for these amines the observed 
trend was for a higher %adduct formation at higher temperatures, as expected.  
Moreover, the trend for lower % amine loss at higher temperature seen with MA was 
not observed for the reaction of ALC and OFL with AA.   When AA was used as 
OH
 -
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acrylate donor, a higher %adduct formation was observed with higher temperature, 
in keeping with the other amines investigated. Tables 5.5 and 5.6 provide a 
summary of the results for the reaction of OFL and ALC with MA and AA.   
The difference in adduct formation relationship with temperature was not the only 
difference between the MA and AA studies for ALC and OFL. Two impurity peaks 
were observed at each time-point for the reaction with MA, whereas only impurity 
peak was observed at each corresponding time point for the reaction with AA. The 
impurity observed with AA was deemed to be the acid adduct, with RRT (0.35). The 
two impurities observed with MA eluted at RRT (0.35) and RRT (0.42). The impurity 
at RRT (0.35) was found to be the same as the AA impurity, the acid adduct. The 
impurity at RRT (0.42) was deemed to be the ester adduct.   Hydrolysis to the acid 
adduct was observed in all samples reacted with MA at both temperatures.  By 
comparing the chromatograms of the MA and AA spiked samples it was possible to 
determine the RRT of the AA adduct as it was the only impurity present in the AA 
spiked samples.  For example, a HPLC chromatogram of OFL samples stored at 
25C and 40C for 32 days is shown in Figure 5.4. The main MA adduct was 
observed at RRT (0.42).  Results show a decrease in the MA adduct RRT (0.42) at 
the higher temperature and a concomitant increase in the AA-adduct RRT (0.35) in 
the same sample. The acid adduct increased from 1.3% to 5.5% in the 25 ºC 
sample and from 7 to 9.5% in the 40ºC sample. 
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Figure 5.4.  HPLC chromatograms illustrating  adducts formed , with UV detection at 
294 nm of OFL samples overlaid reacted with MA stored at 25 ºC and 40ºC 
for 32 days. HPLC separation conditions as per section xx. 
As discussed above, the results for the reaction of MA and tertiary amines confirm 
that the MA adduct was not stable over time.  However, for the corresponding 
reactions with AA, a steady loss and subsequent increase in the AA adduct was 
observed at the two time-points under both conditions.  For example, for OFL, 
compared to the levels of the MA impurity detected, results for level of AA adduct 
formed (RRT (0.35)) were identical in the A and B replicates under both conditions.  
This shows that once formed the AA adduct was remarkably stable over time. 
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Table 5.5 Ofloxacin (OFL) Reactivity, monitored in terms of % API loss, and % 
impurity formation, monitoring at both 0.35 and 0.42 relative retention 
times (RRT). 
   7 Days   32 Days  
% 
API 
loss 
 % IMP % IMP % 
API 
loss 
 % IMP % IMP 
Methyl 
acrylate  
 RRT 
(0.35) 
RRT 
(0.42) 
 
  
RRT   
(0.35) 
RRT   
(0.42) 
25°C A 32.0  1.3 25.5  34.3  5.8 22.2 
 B 31.2  1.3 26.2  22.1  5.4 14.2 
40°C A 20.1  7.2 11.0  16.2  9.9 3.5 
 B 17.0  7.0 8.9  12.8  9.5 2.6 
           
Acrylic 
Acid 
   RRT 
(0.35) 
    RRT   
(0.35) 
 
25°C A 0.0  0.7   6.8  2.8  
 B 0.0  0.6   1.2  2.8  
40°C A 6.2  4.1   13.2  9.7  
 B 4.4  4.0   13.9  9.7  
 
In the reaction with MA results for ALC were in line with those of OFL.  Hydrolysis 
was greater at the higher temperature with no ester adduct detected after 32 days in 
sample 40°C.  However, for the MA sample at 40°C, sample A had a 9% amine loss 
with only 1.7% AA adduct detected, while sample B had full recovery of the amine 
yet a 23% AA-adduct was detected.  This is despite the fact that at the first time 
point, comparable results were obtained from both samples.  This highlighted the 
unpredictability of the adduct formation under these conditions. As with the OFL 
sample, reaction with AA was viable and showed steady increase over time, 
especially at 40°C. 
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Table 5.6 Alcaftadine (ALC) Reactivity, monitored in terms of % API loss, and 
% impurity formation, monitoring at both 0.34 and 0.64 relative 
retention times (RRT). 
Acrylate Donor   5 Days   32 Days 
 
% API 
loss 
 % IMP % IMP % API 
loss 
 % IMP % IMP 
Methyl acrylate  
 (0.34 
RRT) 
(0.64 
RRT) 
 
  
(0.34 
RRT) 
(0.64 
RRT) 
25°C A 21.0  14.0 9.4  23.3  14.8 16.0 
 B 19.1  15.1 16.5  19.4  13.9 9.5 
40°C A 27.0  3.2 15.3  9.2  1.7 0.0 
 B 34.2  3.3 14.3  0.0  23.2 1.6 
Acrylic Acid 
   (0.34 
RRT) 
    (0.34 
RRT) 
 
25°C A 8.6  1.1   23.2  5.8  
 B 8.0  1.0   21.1  5.6  
40°C A 29.9  6.7   34.9  18.6  
 B 30.6  6.5   36.0  18.1  
           
 
5.3.3.3 UV Spectra of Adducts 
All samples were assayed at the wavelength specified by the relevant method.  A 
UV spectrum for each impurity was generated using photodiode array.  Both AA and 
MA contain UV chromophores and can be observed in chromatograms acquired at 
low wavelengths.  PDA was used to identify and eliminate responses resulting from 
unreacted  MA and AA in samples assayed at low wavelength.  In addition, the UV 
spectrum of each adduct was generated.  The UV chromatogram and the 
accompanying UV spectra for the amine and corresponding adducts are shown in 
Appendix C.   
In a report into the interaction of cetirizine and alcohol excipients, the authors used 
the drug substance for quantification of the formed ester reaction products on the 
assumption that the esters had the same UV molar absorptivity as cetirizine.  [187] 
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While this is a practical approach to quantitation during screening, results of this 
study demonstrate that accurate quantitation of impurity adducts requires synthesis 
of the impurity standard. 
5.4 Conclusion 
Chapter 3 indicated that the aza-Michael reaction between amines and acrylates in 
buffered ophthalmic solution was viable and rapid conversion was expected for the 
reaction of secondary cyclic amines and methyl acrylate.  This chapter has shown 
that substitution next to the nitrogen atom has a marked effect on the amine’s 
reactivity and the aliphatic secondary amines were more reactive than expected.  
Likewise, the two cyclic tertiary amines studied were highly reactive, forming stable 
adducts when reacted with acrylic acid. The β-amino and quaternary ammonium 
esters formed were highly susceptible to hydrolysis.   
It has been clearly illustrated here that drugs which are tertiary amines (not just 
secondary amines as sometimes reported) undergo the aza-Michael reaction with 
both methyl acrylate and acrylic acid under pharmaceutically relevant conditions.  
This work demonstrated the complexity of reactions between secondary and tertiary 
amines and acrylate components migrating from packaging in to liquid formulations.  
While evaluation of the reaction kinetics in pharmaceutical formulations containing 
amine drug substances is beyond the scope of this research, the results obtained 
here strongly suggest that formation of acrylate adducts may constitute a significant 
problem upon long-term storage of ophthalmic solutions in their final packaged 
configuration.  Companies need to mitigate against the migration of acrylate 
products through careful selection of low-migration packaging components. 
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Previous label extraction studies have identified the acrylic acid adduct of BMT, 
TIM, and GAT as impurity adducts in pharmaceutical formulations (data not 
published) .  While acrylic acid is listed as a component of certain ink formulations 
and label adhesives, the results of this study indicate that the acrylate donor was 
most likely an acrylate ester and the impurity detected was the acid hydrolysis 
product of that ester. The acrylic acid adduct of ALC has also been detected in 
compatibility study for digital labels under accelerated conditions (40/75 RH).  The 
results of the present study show that the reaction was viable with both the ester 
and acid acrylate.  As both are components of the digital label, migration of either 
impurity could be the source of this impurity.  
This case study demonstrates that leachable compounds that migrate into the drug 
product can react with the active ingredients to form active ingredient related 
impurities, and shows clearly the need for compatibility studies when selecting 
secondary container closure components.  However, in many cases, the 
development scientist will not know whether a specific nitrogen-containing drug will 
be compatible with a particular packaging configuration or not, usually due to 
significant structural variations such as inclusion of the nitrogen within rings or the 
presence of functionality which would greatly diminish the nucleophilicity of the 
amine drug. The present findings suggest a relatively simple experimental design to 
probe this question, namely, direct addition of an acrylate ester and acrylic acid to 
the drug product and storage at pharmaceutically relevant conditions.  The protocol, 
as detailed in section 5.2, would be a worthwhile addition to the forced degradation 
stress studies carried out as part of method development.  Use of the stability 
indicating method specific to the formulation is also recommended.   
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6.0 Conclusion  
This study set out to explore the issue of drug packaging interactions between an 
API containing an amine functional group and a component of the packaging 
(acrylate) in ophthalmic solutions and to identify the conditions under which such 
reactions are accelerated.  Through systematic reaction monitoring of the 
mechanism underpinning the interactions (the aza-Michael reaction) a better 
understanding was gained of the role of each of the reactants, amine and acrylate.  
While the general theoretical literature on the aza-Michael reaction is substantial, 
there are currently no reports in the literature of interactions between reactive 
amines and acrylates migrating from drug-packaging.  Several of the reactions 
performed in aqueous buffered solutions and those using acrylic acid as an 
acceptor have not been reported previously. 
The study sought to answer a number of key questions; 
1. Is the aza Michael addition of an amine and acrylate viable using water as 
the reaction medium, and does water have a unique solvent property? 
2. What are the factors that impact on impurity adduct formation when the 
reaction is performed under conditions relevant to ophthalmic solutions? 
In the literature, two hypotheses regarding the aza-Michael reaction mechanism 
have been proposed, one detailing an “on- ater” acceleration of the reaction in 
aqueous solution, and the other detailing nucleophilic addition and proton transfer to 
the carbanion.  In Chapter 2 the question of  hether this reaction  as ‘accelerated’ 
using  ater as the reaction medium  as explored.  The “on- ater” hypothesis 
required a heterogenous mixture to promote acceleration.  While the reaction in 
water was heterogeneous, the reaction in methanol was not, however the reaction 
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yields were comparable for both solvents. These results show that the while the rate 
of reaction in water was exceptionally fast, it was the nature of the solvent itself 
(polar-protic) rather than any ‘unique’ property of  ater that  as responsible for the 
acceleration. This work therefore supports the hypothesis that the aza Michael 
reaction proceeds via a stepwise mechanism, with the formation of an addition 
intermediate followed by a proton transfer.  Supporting this hypothesis, in Chapters 
2 and 3 the secondary amine 1-phenylpiperazine (1PP) was reacted with a number 
of acrylates, including methyl acrylate and acrylic acid, in a variety of aqueous 
buffered solutions.  Both of the aqueous ophthalmic buffers investigated (PBS and 
boric acid) were analogous with water in terms of reactivity. In answer to the first 
key question therefore, yes, the aza Michael addition of an amine and acrylate is 
viable using water as the reaction medium, but water does not have a unique 
solvent property. Instead it is  ater’s polar-protic property which results in its 
accelerative effects, and other solvents which also exhibit these properties also 
impart these accelerative effects. 
The second key question in this thesis explored which factors impacted on impurity 
adduct formation when the reaction was performed under conditions relevant to 
ophthalmic solutions, with the nature of the solvent and the structure of both the 
amine donor and acrylate acceptor identified as being of key importance. 
As discussed above, the role of the solvent in the acceleration of the aza-Michael 
reaction was determined by its ability to protonate the carbanionic intermediate.  
The poor reactivity of the aprotic solvents and the solvent free reaction in Chapter 2 
was consistent with the proposed mechanism in the reaction of a secondary amine 
and acrylate.  With respect to the neat reaction, the ease of purification of the 
reaction product (no solvent to remove) is often cited as an example of its green 
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credentials.[20] However, in Chapter 2 it was shown that in order to perform the 
reaction successfully an excess of the amine reactant is required.  As the amine is 
typically the more expensive reactant, the solvent free route may not be the best 
option for this reaction. 
In the conjugate addition of amine nucleophiles to neutral olefin acceptors the 
reactivity of the amine is predicated on its structure. [31] Chapter 5 examined the 
reactivity of eight amines, primary, secondary and tertiary, with a variety of 
substituents.  The reactivity of the amines with methyl acrylate and acrylic acid was 
in agreement with the reactivity described in the literature; with amine structure 
having a major impact on reactivity in the case of the secondary amines PHN, TIM 
and BUN.  It was found that the structure of both the amine donor and acrylate 
acceptor had a profound effect on adduct yields. This is of significant potential 
concern to the pharmaceutical industry.   Critically, in this research, neither the 
amine salt nor poorly reactive acrylic acid prevented the formation of adducts under 
conditions of longer term storage, raising a concern regarding the interaction 
between amine drugs and acrylate leachables in ophthalmic solutions.  
In addition to the key questions that this thesis sought to answer, this work has 
added to our understanding of the impurity products themselves. The hydrolysis of 
the ester in product observed in Chapters 3 and 5 was in agreement with several 
reports on the increased rate of hydrolysis of β-amino esters compared to esters 
lacking a neighbouring nitrogen group [191]. This is supported by the fact that the 
methyl acrylate ester spiked into the ophthalmic solutions in Chapter 5 did not 
hydrolyse over the course of the standing experiments. It had been thought in our 
laboratory that the acrylic acid adducts detected in a number of samples were the 
result of hydrolysis of an ester acrylate migrating from the packaging and that it was 
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acrylic acid that reacted with the amine drug substance. This study shows that it 
more likely that the reaction  as  ith the ester follo ed by hydrolysis of the β-amino 
esters.  Furthermore the effect of temperature on the hydrolysis on quaternary 
ammonium compounds, such as OFL and ALC in Chapter 5 was consistent with 
and adds to that presented by Lindstedt et al. in 1990 on the hydrolysis of betaine 
esters.[193] The results of this study show a similar pattern of hydrolysis in 
quaternary ammonium compounds that are also β-amino esters.   
Reports on conjugate addition to acrylic acid acceptors are rare.  However, the poor   
yield for the reaction of 1PP and acrylic acid in water was expected as acrylic acids 
are generally less active Michael addition partners [142]. What was surprising was 
the yield of the same reaction when the reactants were left standing for 6 days. The 
90% yield shows that even the unreactive acid will form adducts given sufficient 
time.  The result was evident in Chapter 5, where several amine drug substances 
(PHN, ALC, OFL) reacted with acrylic acid over time.   
The screening platform developed in this research in Chapter 5 provided a great 
deal of insight into merit of performing a controlled study and several aspects of 
what was discovered would inform future studies.  Firstly, performing the reaction at 
two temperatures provided insight into how the amines would perform under routine 
(25ºC) and accelerated storage (40ºC), particularity in relation to the rate of 
hydrolysis of the ester adducts and the reactivity of acrylic acid.  Similarly, the 
addition of both the ester and acid acrylate is to be recommended.  Information from 
the use of both acrylates and the low/high temperatures are a good indication of 
how reactive an amine is likely to be.  Amines like PHN, BMT and ALC reacted with 
both acrylates at both temperatures during the study; something that is backed up 
by packaging compatibility studies in our own laboratory.  Whereas no adducts have 
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been detected in unreactive amines such as BUN and EPT during routine stability 
storage.  One of the objectives of forced degradation study is to generate sufficient 
amounts of impurity for identification and tracking.  To this end, it is not 
recommended that the study be performed at elevated temperatures. The same 
principle would apply to a direct addition study as described in Chapter 5. In reality, 
the level of adducts formed as a result of migration from drug packaging is 
extremely low and catastrophic degradation of the amine or the generation of 
additional degradation products is not desirable.   
Finally, where possible samples should be stored for a number of weeks and 
examined at two time-points.  The results of the case study show that 1 week and 1 
month would provide representative samples for impurity analysis.  Considering the 
simplicity of the reaction which consisted of the addition of an acrylate to an amine 
in an aqueous solution, the complexity of the results was surprising.  The 
equilibration effects noted in Chapter 3 whereby the unreactive amine hydrochloride 
salt and acrylic acid both generated significant yields of product on standing, were 
also evident in Chapter 5.  Again, this steady upward trend in the concentration of 
impurities is the same effect observed during long-term storage of packaged drug 
products.   
This case study demonstrates that leachable compounds that migrate into the drug 
product can react with the active ingredients to form active ingredient related 
impurities and the results obtained here strongly suggest that formation of amine-
acrylate adducts may constitute a significant problem upon long-term storage of 
ophthalmic solutions in their final packaged configuration.   
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The present findings suggest that the relatively simple experimental design 
described in Chapter 5 for the direct addition of a reactive species to the drug 
product could be applied to other types of drug product interactions such as the 
direct interaction between the drug substance and excipients or with impurities of 
excipients, and interaction of the drug substance with impurities from packaging 
materials. For example, ethylene glycol is a reactive impurity formed through the 
hydrolysis of ethylene oxide (ETO) in buffered saline products following ETO 
sterilisation. Ethylene glycol once formed can react with a carboxylic acid containing 
drug substance to form an ester impurity.  The reaction of drug substances with 
added antioxidants (either as excipients or from packaging) such as sodium 
metabisulfite would also be suited to the protocol described in Chapter 5. 
As discussed above, there are currently no reports in the literature of interactions 
between reactive amines and acrylates migrating from drug-packaging.  The work 
presented here provides a detailed investigation of potential aza-Michael addition 
mediated impurities in ophthalmic formulations between amine containing drug 
substances and acrylate compounds migrating from pharmaceutical packaging. The 
mechanisms responsible for these impurities have been investigated, and the 
critical parameters elucidated. The resultant screening platform provides a useful 
tool to determine the extent to which potential leachables can interact with drug 
substances and generate impurities. This thesis may therefore provide a valuable 
tool as part of drug excipient interaction investigations in quality risk management in 
pharmaceutical development. 
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7.1 Appendix A - Analysis Parameters for Amines: PHN, GAT, OFL, 
ALC, BMT, TIM, BUN and EPT  
 
Phenylephrine Hydrochloride (0.13%) 
HPLC Conditions   Column 
Column Temperature 25ºC  Lichrocart 100, C8, 250 mm, 4.6 mm x 
5µm 
Flow Rate  1 mL/min   
Injection Volume,  30 µL  
Runtime 20 mins  Mobile Phase: 
0.3 mM HSA/ACN/TFA (85/15/10 v/v/v) Wavelength, 272 nm  
    
Sample Diluent Water   
Conc. Sample % (w/v) 0.0026%   
 
Gatifloxacin (0.5%) 
HPLC Conditions   Column 
Column Temperature 40ºC  YMC Basic, C8 Mixed, 100 mm, 4.6 mm 
x 3µm 
Flow Rate  1 mL/min   
Injection Volume,  25 µL  
Runtime 60 mins  Mobile Phase: 
75mM KH2PO4, 1% TEA, pH 5.1/ACN 
(92/8 v/v) 
Wavelength, 325 nm  
    
Sample Diluent 0.1% 
Phosphoric 
Acid 
  
Conc. Sample % (w/v) 0.02%   
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Ofloxacin (0.3%) 
HPLC Conditions   Column 
Column Temperature 37ºC  Waters Xbridge, C18, 150 mm, 4.6 x 
3.5 µm 
Flow Rate  0.9 mL/min  Mobile Phase A: 
50 mM Na2HPO4, pH 6.4/MeOH 
(85/15 v/v) 
 
Mobile Phase B: MeOH 
Injection Volume,  10 µL  
Runtime 27 mins  
Wavelength, 294 nm  
    
Sample Diluent 0.05N HCl  Gradient: % B 
0 – 40% in 16 mins 
Conc. Sample % (w/v) 0.006%   
 
Alcaftadine (0.25%) 
HPLC Conditions   Column 
Column Temperature 257ºC  Phenomenex Gemini, C18, 250 mm, 
4.6 x 5 µm 
Flow Rate  1.0 mL/min  Mobile Phase A: 
5mM K2HPO4, pH 8.4  
Mobile Phase B:  
ACN/5mM K2HPO4, pH 8.4 (70/30 v/v) 
Injection Volume 5 µL  
Runtime 55 mins  
Wavelength 286 nm  
    
Sample Diluent 50% MeOH  Gradient: % B 
25 – 50% in 30 mins 
Conc. Sample % (w/v) 0.05%  50 – 100% in 42 mins 
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Brimonidine Tartrate (0.2%) and Timolol Maleate (0.5%) 
UHPLC Conditions   Column 
Column Temperature 30ºC  ACE Excel, C18, 100 mm, 2.1 x 2µm 
Flow Rate  0.45 mL/min   
Mobile Phase A: 
50 mM(NH4)Acetate, pH 4.85 
Injection Volume  3 µL  
Runtime 15 mins  
Wavelength 264 nm  
   Mobile Phase B: 
50 mM(NH4)Acetate, pH 4.85/MeOH        
(50/50 v/v) 
Sample Diluent Water  Gradient: % B 
8 – 88% in 10 mins 
Conc. Sample % (w/v) 0.008% BMT 
0.02% TIM 
  
 
Timolol Maleate (0.5%) 
HPLC Conditions   Column 
Column Temperature 30ºC  Waters Sunfire, C18, 75 mm, 4.6 x  
3.5 µm 
Flow Rate  1.5 mL/min   
Mobile Phase A: 
0.01% TFA in Water 
Injection Volume  10 µL  
Runtime 22 mins  
Wavelength 295 nm  
   Mobile Phase B: 
0.1% TFA in MeOH 
 
Sample Diluent Water  Gradient: % B 
10 – 35% in 10 mins 
Conc. Sample % (w/v) 0.02%   35 – 90% in 15 mins 
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Levobunolol Hydrochloride (0.5%) 
HPLC Conditions   Column 
Column Temperature 44ºC  Waters Sunfire, C18, 150 mm, 4.6  
x 3.5 µm 
Flow Rate  1.0 mL/min   
Mobile Phase: 
0.43 mM HSA  
Buffer/MeOH/Acetic Acid (54.5/45/0.5 
v/v/v) 
Injection Volume 5 µL  
Runtime 20 mins  
Wavelength 254 nm  
    
Sample Diluent 50% MeOH   
Conc. Sample % (w/v) 0.02%    
 
Epinastine Hydrochloride (0.05%) 
HPLC Conditions   Column 
Column Temperature 50ºC  Inertsil ODS-3, C18, 150 mm, 4.6 x 5 
µm 
Flow Rate  1.5 mL/min   
Mobile Phase: 
43 mM (NH4)H2PO4  
Buffer,pH4.5/ACN/THF (80/19/1 v/v/v) 
Injection Volume  25 µL  
Runtime 20 mins  
Wavelength 210 nm  
    
Sample Diluent Mobile Phase   
Conc. Sample % (w/v) 0.01%    
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7.2 Appendix B - Reactivity of Amines with Methyl Acrylate and 
Acrylic acid 
 
Table 7.1 Phenylephrine Hydrochloride (PHN) Reactivity as determined by 
monitoring % loss of the initial API, and % formation of impurity adduct, 
observed at two distinct relative retention times (RRT), with MA and AA 
used as acrylate donors 
Acrylate 
Donor 
  11 Days   32 Days  
% API 
loss 
 % IMP 
formed 
% IMP 
formed 
% API 
loss 
 % IMP 
formed 
% IMP 
formed 
Methyl 
acrylate  
 (0.31 
RRT) 
(1.24 
RRT) 
 
  
(0.31 
RRT) 
(1.24 
RRT) 
25°C A 99.1  78.9 21.2  99.8  99.9 0.0 
 B 99.2  79.7 20.5  100.0  98.1 0.0 
40°C A 100.0  112.6 0.0  100.0  124.6 0.0 
 B 100.0  112.3 0.0  100.0  121.2 0.0 
   11 Days   32 Days  
% API 
loss 
 % IMP 
formed 
% IMP 
formed 
% API 
loss 
 % IMP 
formed 
% IMP 
formed 
Acrylic Acid    (0.29) (0.34)    (0.29) (0.34) 
25°C A 11.0  7.7 1.0  26.1  29.6 1.8 
 B 9.8  6.9 1.0  24.6  28.0 1.9 
40°C A 50.4  41.2 3.7  71.1  58.0 3.3 
 B 53.0  43.4 3.7  74.8  58.0 3.3 
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Table 7.2 Brimonidine Tartrate (BMT) Reactivity as determined by monitoring % 
loss of the initial API, and % formation of impurity adduct, observed at 
two distinct relative retention times (RRT), with MA and AA used as 
acrylate donors 
  BMT+TIM  
7 days 
 BMT only 
20 Days 
% API 
loss 
 % IMP 
formed 
% API 
loss 
 % IMP 
formed 
Methyl acrylate        
25°C A 46.3  20.3  26.8  9.0 
 B 45.0  20.7  26.4  8.9 
40°C A 85.1  37.7  82.2  30.8 
 B 83.9  35.5  78.2  29.5 
Acrylic Acid         
25°C A 1.4  0.05  1.2  0.0 
 B 2.4  0.05  1.3  0.0 
40°C A 1.7  0.21  2.9  0.3 
 B 0.0  0.23  2.3  0.3 
 
Table 7.3 Alcaftadine (ALC) Reactivity as determined by monitoring % loss of the 
initial API, and % formation of impurity adduct, observed at two distinct 
relative retention times (RRT), with MA and AA used as acrylate donors 
Label   5 Days   32 Days 
 
% API 
loss 
 % IMP 
formed 
% IMP 
formed 
% API 
loss 
 % IMP 
formed 
% IMP 
formed 
Methyl 
acrylate  
 RRT 
(0.34) 
RRT 
(0.64) 
 
  
RRT 
(0.34) 
RRT 
(0.64) 
25°C A 21.0  14.0 9.4  23.3  14.8 16.0 
 B 19.1  15.1 16.5  19.4  13.9 9.5 
40°C A 27.0  3.2 15.3  9.2  1.7 0.0 
 B 34.2  3.3 14.3  0.0  23.2 1.6 
Acrylic Acid 
   RRT 
(0.34) 
    RRT 
(0.34) 
 
25°C A 8.6  1.1   23.2  5.8  
 B 8.0  1.0   21.1  5.6  
40°C A 29.9  6.7   34.9  18.6  
 B 30.6  6.5   36.0  18.1  
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Table 7.4 Ofloxacin (OFL) Reactivity as determined by monitoring % loss of the 
initial API, and % formation of impurity adduct, observed at two distinct 
relative retention times (RRT), with MA and AA used as acrylate donors 
   7 Days   32 Days  
% API 
loss 
 % IMP 
formed 
% IMP 
formed 
% API 
loss 
 % IMP 
formed 
% IMP 
formed 
Methyl 
acrylate  
 RRT 
(0.35) 
RRT 
(0.48) 
 
  
RRT 
(0.35) 
RRT 
(0.48) 
25°C A 32.0  1.3 25.5  34.3  5.8 22.2 
 B 31.2  1.3 26.2  22.1  5.4 14.2 
40°C A 20.1  7.2 11.0  16.2  9.9 3.5 
 B 17.0  7.0 8.9  12.8  9.5 2.6 
           
Acrylic Acid 
   RRT 
(0.35) 
    RRT 
(0.35) 
 
25°C A 0.0  0.7   6.8  2.8  
 B 0.0  0.6   1.2  2.8  
40°C A 6.2  4.1   13.2  9.7  
 B 4.4  4.0   13.9  9.7  
 
Table 7.5 Gatifloxacin (GAT) Reactivity as determined by monitoring % loss of the 
initial API, and % formation of impurity adduct, observed at an the same 
relative retention times (RRT), with MA and AA used as acrylate donors 
Acrylate  11 Days  33 Days 
 
% API 
loss 
 % IMP 
formed 
% API 
loss 
 % IMP 
formed 
Methyl acrylate        
25°C A 21.2  4.4  29.2  12.7 
 B 21.2  4.4  32.0  12.8 
40°C A 25.3  17.1  28.9  20.3 
 B 33.5  17.1  38.5  21.2 
         
Acrylic Acid         
25°C A 5.4  0.5  2.3  1.4 
 B 6.7  0.5  2.6  1.4 
40°C A 2.2  3.3  5.7  7.6 
 B 3.4  3.3  6.6  7.3 
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Table 7.6 Timolol Maleate (TIM)  
Reactivity as determined by monitoring % loss of the initial API, and % 
formation of impurity adduct, observed at an the same relative retention 
times (RRT), with MA and AA used as acrylate donors 
  TIM only 
11 Days 
 TIM only 
40 Days 
 
% API 
loss 
 % IMP 
formed 
% API 
loss 
 % IMP 
formed 
Methyl acrylate        
25°C A 2.7  1.8  3.6  1.5 
 B 2.5  1.6  1.3  1.3 
40°C A 9.9  11.1  13.0  9.1 
 B 9.8  11.2  13.4  9.1 
         
Acrylic Acid 
        
25°C A 1.2  0.0  0.7  0.0 
 B 1.1  0.0  0.0  0.0 
40°C A 0.1  0.2  2.5  0.1 
 B 0.0  0.2  2.3  0.1 
         
 
Table 7.7 Timolol Maleate (TIM) Reactivity in Combined Drug Product as 
determined by monitoring % loss of the initial API, and % formation of 
impurity adduct, observed at an the same relative retention times (RRT), 
with MA and AA used as acrylate donors 
  TIM+HTL  
11 days 
 TIM only 
11 Days 
 
% API 
loss 
 % IMP 
formed 
% API 
loss 
 % IMP 
formed 
Methyl acrylate        
25°C A 4.0  3.2  2.7  1.8 
 B 3.8  3.4  2.5  1.6 
40°C A 7.7  9.0  9.9  11.1 
 B 8.1  9.5  9.8  11.2 
         
Acrylic Acid 
        
25°C A 0.9  0.0  1.2  0.0 
 B 0.6  0.0  1.1  0.0 
40°C A 0.1  0.0  0.1  0.2 
 B 0.0  0.0  0.0  0.2 
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Table 7.8 Levobunolol (BUN) Reactivity as determined by monitoring % loss of the 
initial API, and % formation of impurity adduct, observed at an the same 
relative retention times (RRT), with MA and AA used as acrylate donors 
  19 Days  40 Days 
% API 
loss 
 % IMP 
formed 
% API 
loss 
 % IMP 
formed 
Methyl acrylate        
25°C A 6.7  0.9  8.1  1.8 
 B 3.1  0.9  3.6  1.9 
40°C A 0.0  2.4  11.2  6.8 
 B 3.9  5.6  1.3  3.0 
         
Acrylic Acid         
25°C A 0.8  0.0  2.0  0.0 
 B 0.4  0.0  0.0  0.0 
40°C A 0.0  0.1  2.8  0.1 
 B 0.0  0.1  0.0  0.1 
         
 
Table 7.9 Epinastine (EPT) Reactivity as determined by monitoring % loss of the 
initial API, and % formation of impurity adduct, observed at two distinct 
relative retention times (RRT), with MA and AA used as acrylate donors 
  7 Days  34 Days 
% API 
loss 
 % IMP 
formed 
 % API 
loss 
 % IMP 
formed 
Methyl acrylate        
25°C A 2.2  0.1  3.0  0.5 
 B 2.9  0.1  5.6  0.9 
40°C A 1.5  0.0  2.4  4.0 
 B 1.9  0.0  5.9  7.2 
         
Acrylic Acid         
25°C A 1.5  0.0  4.1  0.0 
 B 1.4  0.0  4.4  0.0 
40°C A 1.8  0.0  1.1  0.0 
 B 1.3  0.0  0.8  0.0 
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7.3 Appendix C -   UV Chromatograms and Spectra  
 
 
 
 
 
Figure 7.1  (Top) HPLC chromatogram with UV detection at 325 nm of GAT samples 
reacted with MA and AA stored at 40ºC/75% RH for 32 days. The samples 
are overlaid with the GAT 40ºC/75% control sample, which also contains the 
methyl acrylate adduct. 
(bottom) UV spectrum of GAT samples reacted  with AA (left) and MA (right) 
stored at 40ºC/75% RH for 33 days. A single peak was observed for both 
the MA and AA adducts.  The UV spectrum was identical for both the MA 
and AA adduct with a maximum absorbance at 291.02 nm. The max 
absorbance of the GAT peak was 292.2 nm in both samples.  
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Figure 7.2  HPLC chromatograms with UV detection at 210 nm of PHN samples 
reacted MA (top) and AA (bottom) stored at 25ºC/60% RH for 11 
days.  
 
Figure 7.3  UV spectrum of PHN samples reacted AA (left) and MA (right) stored 
at 25ºC/60% RH for 11 days.  
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The BMT-AA adduct was the only one for which a reference standard was available. 
As mentioned in Section 5.2, a UV response factor of 2.4 was established for the 
BMT-AA adduct.  An overlay of the UV spectra of MA, BMT, BMT-MA and BMT-AA 
is given in Figure 7.4.  A small shift in  max from 246.5 nm (BMT) to 241.0 nm (MA 
and AA adducts) can be seen in the overlay. The overlay also includes the spectrum 
for unreacted MA in the sample.  The UV detector was set to 264 nm in the UHPLC 
assay for BMT and a small peak was detected in the samples at 3.7 min.  As the 
MA-adduct peak eluted at 3.8 min, the PDA was used to good effect when 
identifying the impurity adducts. The spectrum of the unreacted MA was easily 
distinguished from the BMT sample and adducts. 
 
Figure 7.4 UV spectra of BMT samples reacted AA and MA stored at 25ºC/75% 
RH for 7 days.  A shift in the maximum absorbance for BMT (246.5 
nm), AA adduct and MA adduct (241.0 nm) was noted.  The UV 
spectrum for unreacted MA remaining in the sample is included and 
has a maximum absorbance of 214 nm. 
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The HPLC chromatograms and UV spectra for OFL, TIM and BUN are given in 
Figures 7.5 to 7.8.  The HPLC-PDA chromatograms  ere processed using the ‘MAX 
PLOT’ as the derived channel in Empo er, which is the maximum absorption of the 
spectrum at every given time point. Using this feature, the unreacted MA peak was 
visible in the OFL and BUN chromatograms.    
  
Figure 7.5  (Top) HPLC chromatogram with UV detection at 294 nm of OFL samples 
reacted with MA stored at 40ºC/75% RH for 32 days.  
 
Figure 7.6 UV spectra of OFL samples reacted AA and MA stored at 40ºC/75% RH for 
32 days. A slight shift in the maximum absorbance is noted for OFL (289.5) 
nm, AA adduct (288.9 nm) and MA adduct (288.2 nm).  The MA and AA 
adduct peaks were baseline resolved chromatographically. 
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Figure 7.7  (Top) HPLC chromatogram with UV detection at 295 nm of TIM samples 
reacted with MA and AA stored at 40ºC/75% RH for 32 days.  
(bottom) UV spectrum of TIM samples reacted  with MA (left) and AA (right) 
stored at 40ºC/75% RH for 32 days. A single peak was observed for both 
the MA and AA adducts.  The UV spectrum is identical for TIM and the MA 
and AA adducts with a maximum absorbance at 295.8 nm.  
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Figure 7.8  (Top) HPLC chromatogram with UV detection at 254 nm of BUN samples 
reacted with MA and AA stored at 40ºC/75% RH for 40 days.  Unreacted 
MA is detected at 254 nm. The AA adduct was not detected in samples. 
(bottom) UV spectrum of BUN sample reacted with MA  stored at 40ºC/75% 
RH for 40 days.  The MA adduct spectrum closely correlated with that of the 
BUN drug substance. 
 
